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Abstract 
Due to their multipotency, mesenchymal stem cells (MSCs) are used to model and regenerate 
many connective tissues. Their behaviour varies with the environment they are maintained 
within, therefore different tissue scaffolds are required for each application to suitably mimic 
the tissue being engineered. Although hydrogels used as cell scaffolds are able to mimic certain 
tissue properties, this is often at the expense of others. Collagen for example is cell adhesive, 
but lacks the mechanical properties of native tissues. One method to address this challenge is to 
create hybrid scaffolds, combining materials that separately mimic one, or more of the desired 
tissue properties, resulting in an optimal scaffold. Furthermore by adjusting the composition of 
the components within such a gel, a panel of scaffolds can be designed with variable properties 
for multiple MSC applications. Both collagen and poly(NIPAM-co-styrene-graft-NVP) (NSN) 
hydrogels undergo gelation at physiological temperatures, enabling cell encapsulation, but 
individually are less than ideal as cell scaffolds. In this thesis it was demonstrated that 
combining these two materials produced hydrogels with the biocompatibility and cell 
adhesiveness of collagen and the mechanical strength of NSN. Through varying the 
composition of these bio-synthetic hydrogels, a repertoire of materials was produced with a 
range of mechanical properties and porosities. Hydrogels with low concentrations of NSN, 
contained fibrillar collagen networks, with no evidence of syneresis whilst gels with higher 
concentrations of NSN had superior mechanical properties, but were prone to syneresis. Two 
applications of MSCs were examined using the collagen-NSN gels, the development of an 
artificial lymph node model and injectable scaffolds for cartilage repair. The backbone of the 
lymph node consists of a heterogeneous network of stromal cells, which are mesenchymal. 
Through treating MSCs with the factors involved in lymph node organogenesis, they were 
induced into a lymphoid mesenchyme phenotype. These were seeded hybrid gels with low 
concentrations of NSN to develop 3D networks. Increasing the NSN concentration perturbed 
the morphology and migration of the MSCs within the hydrogels, and produced a scaffold with 
mechanical properties that mimic those of the lymph node. The tougher hydrogels were also 
able to support MSCs in 3D. Although the mechanical properties of these gels approached 
native cartilage, the chondrogenic capacity of the encapsulated cells was reduced compared with 
MSCs cultured in cell-only 3D pellets. The gels require further optimising for use as scaffolds 
for cartilage repair. The novel collagen-NSN hydrogels presented in this thesis, have potential 
as scaffolds for numerous applications as the exact composition of the gels can be tuned to alter 
their physical properties and therefore direct cell fate. 
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 Introduction Chapter 1
1.1 Background to the project 
Tissue engineering and regenerative medicine aims to replace or repair tissues that have 
become damaged or worn out. The term tissue engineering was coined by the pioneers 
in the field, Robert Langer and Joseph Vacanti in their 1993 Science Paper1. They 
defined ‘Tissue engineering is an interdisciplinary field that applies the principles of 
engineering and the life sciences toward the development of biological substitutes that 
restore, maintain or improve tissue function’1. Where the biological substitutes were 
either a) the use of isolated cells or a cell substitute, b) tissue inducing substances, such 
as growth factors in combination with methods for delivery; or c) cells placed within or 
on matrices1. The research in this thesis concerns the latter method, using a combination 
of cells seeded within a three dimensional (3D) scaffold and delivery of the appropriate 
soluble cues and growth factors to stimulate growth into the tissue of interest. The terms 
tissue engineering and regenerative medicine are often used interchangeably, generally 
tissue engineering defines the creation of a tissue in-vitro, whilst regenerative medicine 
encompasses the whole field, including tissue engineering as well as the use of cells, 
scaffolds and bioactive molecules in-vivo to generate tissues using the body’s own 
ability to repair.  
1.2 Tissue Engineering and Regenerative Medicine 
Due to improvements in health care and lifestyle, the population is living longer, and 
with an increasing ageing population. The worldwide population of older persons (aged 
60 plus) was 841 million people in 2013, and this is expected to rise to over 2 billion by 
20502. It was also predicted that for the first time in 2047, the older population will 
exceed the number of children2. Associated with this increase in the older population, 
will be the increase in age-related disorders and degenerative disease, and therefore high 
demand to replace damaged and failing tissues and organs. Current treatments include 
organ donation, implantation of artificial prosthetics and drug therapies however these 
treatments are not always ideal. There are limited sources of donor organs3, and where 
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they are available they can be rejected by the immune system of the patient4. Artificial 
prosthetics such as hip and knee replacements have a limited life span5, and they can 
release metal and polymer wear particles which stimulate immune responses and are 
prone to loosening6,7. Whilst drug therapies may only have short term results or simply 
help to alleviate pain and inflammation8. Ultimately the best way to repair a tissue is 
with an exact functional replica, using patient’s own cells, which is the goal of 
regenerative medicine.  
Tissue engineering also has in-vitro applications in research and therapeutics. Through 
creation of models of tissues and organs we can further our understanding of human 
body physiology. Tissues within the body are complex, made up of multiple cell types, 
including parenchyma, supporting stromal cells and vasculature all contained within a 
complex mix of extracellular matrix (ECM) proteins. Models enable a reductionist 
bottom -up approach to research. Basic models using a single cell type and simplified 
ECM can be probed to study the effect of a single stimulus on a system, to build a 
bigger picture of in-vivo behaviour.  In-vitro models could also reduce the need for 
animal models in research. Animal research is now banned for the testing of cosmetics, 
and tissue engineering approaches have been used to develop skin models as 
alternatives. Such skin models are also used for wound healing when there is no source 
of allogeneic or autogenic donor tissue.  
The research within this thesis describes the development of a novel thermoresponsive 
hydrogel composed of collagen I and poly(N-isopropylacrylamide) (PNIPAM), for use 
as a cell scaffold to support mesenchymal stromal cells (MSCs). The blend of collagen 
and PNIPAM in the hydrogel can be easily tailored, which results in variation of the 
physical properties, therefore the hydrogel has potential for use in multiple applications. 
Within this introduction the phenotype and differential capacity of MSCs will be 
discussed, followed by an introduction into how cells respond to their 3D environment. 
An introduction will then be given to PNIPAM with examples of PNIPAM based 
materials currently used in tissue engineering. 
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1.2.1 Historical perspective     
Research into the field began with the approaches clinicians were taking to replace and 
reconstruct tissues, using donor tissue from another site of the body or the implantation 
of prostheses.  Early methods involved tissue replacements that were more structural, 
rather than functional. For example repair of the bladder was initially performed using 
synthetic, non-biodegradable materials, including rubber and silicone. These generally 
failed due to infection and host-foreign body reactions9. Grafts of peritoneum, placenta, 
pericardium were used as alternatives, however removal of tissue from another site of 
the body can often lead to donor site morbidity. The next logical step, was to evaluate 
whether tissue could instead be engineered. 
One of the earliest examples of tissue replacement was the development of skin 
substitutes to provide barrier function and reduce infection following wounding. 
Autologous grafts have been used since the 19th century10, and more recently cadaveric 
grafts11. In many patients autologous grafting is not an option, due to the extent of 
damage and shortage of donor skin, this is particularly the case for patients with burns, 
therefore replacement approaches moved towards the use of cultured epithelial cells to 
reconstitute the epidermis. Billingham and Green demonstrated this in animal models12, 
and this was followed by Rheinwald and Green, who developed improved techniques to 
culture human epidermal keratinocytes in multilayer sheets using lethally irradiated 
fibroblasts as a feeder layer 13,14, these could then be transferred as intact sheets as grafts 
onto the wound15. These multilayer cell sheets were however very fragile and 
integration and healing was poor where the underlying dermis was also damaged and 
not well vascularised16. 
Therefore biological and synthetic biomaterials were developed as dermal substitutes to 
cover the wound bed and promote revascularisation prior to epidermal repair16. One of 
the leading products is Integra, an off-the-shelf product, composed of bovine collagen 
and shark chondroitin sulphate on a silicone membrane, which acts as a temporary 
wound dressing17. Allogenic donor skin is also used in a similar manner18.  More 
recently bilayered products have been developed, which provide a barrier function like 
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the dermal substitutes and an epidermal layer composed of differentiated 
keratinocytes16. Apligraf® a ‘living’ skin construct, is composed of a differentiated 
layer of keratinocytes in the epidermal layer, and a dermal layer of fibroblasts within a 
bovine collagen scaffold19,20. It has been soon to be efficacious in the treatment of 
chronic ulcers compared with control treatments20. 
Methodologies for culturing and expansion of other primary cells were also developed, 
and contributed to the development of the growing field. For example, corneal epithelial 
cells that can be grown in sheets or on matrices for corneal repair21, schwann cells to be 
used alongside tubular grafts for peripheral nerve repair22, chondrocytes for cartilage 
repair23, urothelial cells for bladder regeneration24, hepatocytes to restore liver 
function25 and mesenchymal cells26 that can be differentiated into bone and cartilage. 
The latter will be discussed in more detail in the following sections. 
In addition to developing methods to culture and expand primary cells and fabricate 
scaffolds, inductive growth factors and proteins have potential in tissue engineering. 
Prior to the identification of bone morphogenetic proteins (BMPs), it had been 
suggested in articles by Lacroix, as early as 194527 and later by Urist28, that bone 
contained a protein that could promote new growth. Urist showed transplantation of 
demineralised bone could induce the growth of new bone in rats and rabbits28. These 
proteins were later identified as the growth factors, bone morphogenetic proteins 
(BMP’s)29.   
In 1993 Joseph Vacanti and Robert Langer pulled together the research that had been 
developing in the field and defined tissue engineering in their seminal science paper1. 
Research groups across the world were developing methodologies to engineer tissues 
derived from all three germ layers. Prior to this Langer had successes, publishing 
seminal papers which paved the way for the field. He developed new polymeric 
materials for sustained drug release over 100 days30. Previous materials that had been 
developed elicited inflammatory responses in-vivo. In collaboration with Vacanti, 
Langer also published the first example of primary cell culture within 3D matrices in-
vitro. They demonstrated primary hepatocytes and intestinal cells could be cultured 
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within synthetic polymers and subsequently engrafted in-vivo31. The ‘Vacanti Mouse’ 
also raised interest in the field, particularly media hype, where a  polyglycolic acid-
polylactic acid (PGA/PLA) scaffold seeded with bovine chondrocytes was grafted on to 
the back of a athymic mouse 32. Although the ear was purely cosmetic the study 
demonstrated how synthetic scaffolds could be fabricated into precise geometries. 
In 2006, Antony Atala et al, demonstrated autologous bladder repair could be performed 
using a biopsy of healthy bladder from each patient and expanding the urothelial and 
muscle cells in culture. These were then seeded on a shaped scaffold of collagen or a 
composite of collagen and PGA. When implanted the composite scaffold led to normal 
bowel function, and improved bladder function24. Another major success of the field 
followed in 2008, when a tissue engineered trachea was used to replace a narrowing 
bronchus of a 30-year old women with end-stage airway disease33. A donor trachea was 
decellularised and seeded with culture expanded epithelial cells and chondrocytes 
derived from the patient, within a specialised bioreactor. When implanted in-vivo to 
replace the damaged left bronchus, functionality was immediately restored. Five years 
later the patient has had no complications34, providing very promising results to the 
field. 
The above examples demonstrate research in the field is very multidisciplinary combing 
polymer chemistry, molecular biology, anatomy, cell biology, cell signalling and 
engineering disciplines. These collaborations have enhanced understanding and will 
continue to further the successes in the field. 
1.3 Mesenchymal stromal cells 
In response to injury and during homeostasis, adult stem cells proliferate and 
differentiate to remodel and repair damaged tissues. Due to their ability to differentiate 
into many cell types, they are a popular cell source in regenerative medicine. They are 
defined by their ability to self renewal and asymmetrically divide producing identical 
daughter cells. They exist as small populations within specialised “stem cell” niches 
found in many tissues, and self renew in the absence of differentiation cues. Currently 
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several types of adult stem cells have been identified, including haematopoietic and 
mesenchymal, which both have niches in the bone marrow. Several niches of stem cells 
are present in the skin, which have been demonstrated to maintain the epidermis, hair 
follicle and sebaceous glands35–37.  Within the crypts of the intestine there are a 
population of stem cells which differentiate into the epithelial cells of the intestine38, 
and neural stem cells have been identified within niches in the brain and spinal cord39–
41. The ability to stimulate stem cell differentiation to repair tissues offers great promise 
in the field of medicine.  
MSCs can be easily isolated and expanded in-vitro from a range of tissues. Typically 
tissue explants are digested enzymatically and/or mechanically to release a single cell 
suspension. The mononuclear cell fraction is then isolated by centrifugation into mono-
nucleated cells, and contaminating red blood cells are removed by cell lysis. MSCs are 
then enriched by their plastic adherence, where lymphocytes are lost in cell passaging. 
 
Figure 1-1: Differential capacity of mesenchymal stromal cells.  
Within the niche MSCs remain multipotent and self renew. Given the right stimuli they can 
differentiate towards multiple lineages42. 
 
Although MSCs are considered stem cells, the isolated cell populations are more 
appropriately referred to as mesenchymal stromal cells, as the cell population is 
heterogeneous, and only a fraction of the cells are multipotent. MSCs have the capacity 
to differentiate into various mesenchymal and connective tissues including and probably 
not limited to bone43–45, cartilage 46–48, fat49,50, muscle51,52 , ligament and tendon53. 
Furthermore undifferentiated and differentiated MSCs are non-immunogenic, and may 
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have immunosuppressive properties and can therefore be used therapeutically from 
allogeneic sources54,55.  
 
1.3.1 Sources of MSCs 
MSCs can also be isolated from other sources as well as bone marrow, including 
adipose tissue derived (ADSC)56–58, umbilical cord blood59,6061 (UC-MSC), 
periosteum62, dermis and skeletal muscle63. The use of ADSCs as a source of 
autologous or allogeneic cells for regenerative medicine is increasing in popularity as 
the cells can be harvested far easier than bone marrow, and generally in larger quantities 
when isolated from adipose tissue lipoaspirates. Isolation of UC-MSCs is not as 
reproducible as ADSCs and BM-MSCs therefore these cells are less well 
characterised64,65, furthermore some groups have shown UC-MSCs may not be able to 
undergo adipogenic differentiation61,65.  
ADSCs share many similarities with BM-MSCs, cells from both sources can 
differentiate into bone, fat and cartilage and express the frequently used MSC markers 
CD73, CD90 and CD10556–59,66. However comparison of differentiation specific genes 
have shown ADSCs may have a greater adipogenic potential than BM-MSCs, whilst 
BM-MSCs are more osteo- and chondrogenic6768, indicating that while some of the 
MSCs found within each tissue are multipotent, there may be a larger proportion of 
tissue specific progenitors.  
1.3.2 Cell surface markers of MSCs 
The international society for cellular therapies classifies a MSC as a cell which is plastic 
adherent in culture, able to differentiate into adipocytes, osteoblasts and chondrocytes 
in-vitro and expresses the cell surface markers CD73, CD90 and CD105 but not CD45, 
CD34, CD14 or CD11b, CD79 or CD19 and HLA-DR in order to exclude 
haematopoietic cells69. This combination of cell surface markers is crucial for defining 
MSCs, as no one cell surface marker is specific for only MSCs. CD73 and CD105 are 
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expressed by endothelial lineage cells found in the bone marrow, and CD90 is also a 
marker of T-lymphocytes, neuronal and innate lymophoid cells70.  
MSCs maintained in culture are likely to become senescent and lose their multipotency, 
thus hindering their therapeutic use. The common MSC markers CD73, CD90 and 
CD105 are unaffected by passage number71 and differentiation72 and although they can 
be used to define MSCs, they may not be a useful indication of their differential 
capacity. Stro-1 and CD106 are both expressed by mesenchymal progenitors, and 
decrease with time in culture and induction of differentiation72,73. Selection of double 
positive Stro-1+ CD106+ cells enriched the isolated mono-nuclear cells from bone 
marrow for colony forming unit – fibroblasts (CFU-Fs), another characteristic of MSCs, 
indicating these markers may be the more useful for identifying the most multipotent 
MSCs74. 
There is also some variation seen in cell surface markers between BM-MSCs and 
ADSC’s. Zuk et al. isolated CD34-, CD106 (VCAM-1)-, Stro-1+ expressing ADSCs56,57, 
whilst Gronthos et al observed the opposite66. Comparative studies of BM-MSCs and 
ADSCs, have also yielded conflicting results, both Kern and Noel et al. found only BM-
MSCs to express CD106, and only ADSCs expressing CD3465,68. Whilst Wagner et al. 
isolated CD34- CD49d- CD106+ BM-MSCs and CD34- CD49d+ CD106- ADSCs.  These 
differences may be explained by variations in the experimental techniques used for 
isolation and passage number at analysis58. 
1.3.3 Differential capacity of MSCs 
Multipotent cells within bone marrow were first identified by Friedenstein75,76 and 
Owen43,77,78, who showed whole bone marrow aspirates or in-vitro expanded bone 
marrow fibroblastic cells implanted in-vivo within diffusion chambers or beneath the 
renal capsule, could differentiate into bone, marrow and cartilage. Initially all cells in 
the chambers differentiated toward a chondrogenic lineage, and regions of bone tissue 
were formed later, similarly to endochondral ossification during embryonic 
development46,77–80. Cell seeding density and proximity to vasculature and nutrients also 
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effected cell commitment, chondrogenesis favoured high cell density and hypoxic 
conditions whilst the opposite was found for bone formation81,82. Friedenstein also 
demonstrated that isolated bone marrow cells seeded at low density in-vitro were able to 
form colonies from single cells, now named CFU-Fs83. The colonies were able to 
undergo at least 30 population doublings in culture and still differentiate in-vivo towards 
cartilage and bone84. Differential capacity was found to vary between clones, indicating 
the bone marrow stromal cell (BMSC) population is a heterogeneous containing a mix 
of progenitors26.   
Following on from research on in-vitro haematopoietic stem cell (HSC) colony 
differentiation assays, Owen et al. explored in-vitro differentiation of BMSC. BMSC 
colonies maintained in culture displayed alkaline phosphatase activity, a marker of 
osteogenesis, where the expression varied between colonies and was enhanced when the 
cells were treated with hydrocortisone45. BMSCs were also shown to differentiate into 
adipocytes when they were used to support haematopoietic stem cells in-vitro. The 
presence of horse serum and hydrocortisone induced the differentiation, characterised 
by the accumulation of lipids within the cells49,50,85. Many in-vitro and in-vivo studies 
on BMSC followed, with varying conditions used to induce differentiation86,87. In-vitro 
culturing of MSCs in the presence of dexamethasone stimulated both adipogenesis and 
osteogenesis88, where the osteogenesis could also be enhanced with bone 
morphogenetic protein 2  (BMP-2)89. Human BMSCs expressed alkaline phosphatase 
in-vitro but repeating diffusion chamber studies with the human BMSCs failed to 
stimulate osteogenesis90. Nevertheless when the cells where implanted in-vivo on 
calcium phosphate scaffolds bone formation occurred91. Bennett et al. performed in-vivo 
diffusion chamber studies on fibroblastic and adipogenic induced colonies derived from 
the same rabbit bone marrow. Both cell types were able to form bone in-vivo indicating 
that fat and bone cells have a common pre-cursor92. Successful in-vitro chondrogenic 
differentiation was performed using low oxygen concentrations93, transforming growth 
factor– β3 (TGF-β3) treatment and densely packing cells into pellets to maintain the 
cells in a spherical morphology47. Due to the ability of the BMSC to differentiate 
towards mesenchymal tissues, they were later named mesenchymal stem cells44.  
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Although MSCs were first reported by Friedenstein, the first study which proved the 
existence of a multipotent population of cells in the human bone marrow with capacity 
to differentiate into fat, bone and cartilage was by Pittenger et al. nearly 40 years later26. 
Similarly to the observed differentiation of BMSCs to osteoblasts and adipocyctes when 
treated with hydrocortisone, Pittenger also used glucocorticoids to stimulate in-vitro 
differentiation. MSCs were induced towards fat with 1-methyl-3-isobutylxanthine 
(IMBX), dexamethasone (DEX), insulin, and indomethacin, characterised by the 
presence of oil red O (ORO) staining lipids within the cells. Osteogeneic differentiation, 
demonstrated by alkaline phosphate activity, occurred when MSCs were treated with 
DEX, β-glycerol phosphate, and ascorbate, whilst chondrogenesis was induced by 
culturing MSCs in dense cell pellets, in serum free media supplemented with TGF- β3, 
where the pellets contained a matrix rich in type II collagen and proteoglycans. These 
differentiation conditions are now widely accepted and used for MSC differentiation. 
Pittenger examined the tri-lineage potential of six MSC colonies derived from single 
cell clones26. Each clone had the same cell surface marker expression. Every colony 
could differentiate into bone, five were fat forming and only two could form cartilage. 
This again demonstrated the MSC population contained within bone marrow is 
heterogeneous, although some cells have a tri-lineage potency, others are limited and 
may be progenitors for a specific mesenchymal tissue.  
Additionally MSCs may have a trans-differentation potential, where under specialised 
culture conditions or in co-culture with other cell types, can differentiate into somatic 
cells of differing germ layers. MSCs injected into central nervous system of neonatal 
mice engrafted within the brain and expressed markers of mature astrocytes and 
neurons94. In-vitro this result was repeated by exposing MSCs to beta-mercaptoethanol 
or dimethylsulfoxide and butylated hydroxyanisol95. Treated cells displayed a neuronal 
phenotype, expressing neuron-specific enolase, NeuN, neurofilament-M, and tau. 
Morphologically the cells resembled neurons with long processes and filopodia at their 
extremities95. However the extent of the differentiation process was questionable. The 
transition to a neuronal phenotype was rapid and reversible. When the differentiation 
conditions were applied to other cells types, cytoplasmic retraction and actin 
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reorganisation was also observed in fibroblasts, HEK293 cells, rat PC-12 cells, as well as 
MSCs 96,97. Characterisation of untreated MSCs also demonstrated cells subjected to in-
vitro ageing express neuronal markers98, suggesting that the morphological and 
phenotypic changes observed in the MSCs were likely to be artefacts of the culture 
system.  
In-vivo MSCs may potentially differentiate into cardiomyocytes. Although MSCs 
injected into the heart of CB17 SCID/beige mice had low engraftment (0.44 % after 4 
days), immunohistochemistry revealed the engrafted cells expressed markers β-myosin 
heavy chain, α-actinin, cardiac troponin T, and phospholamban and levels similar to the 
host cardiomyocytes99. In co-culture with neonatal rat cardiomyocytes in aligned 
conformations, a proportion of the MSCs differentiate into cardiomyoctes in-vitro100. 
Dependant upon the alignment the MSCs were conductive and expressed cardiac 
markers, sarcomeric α -actinin, cardiac troponin I and connexion100. As with the 
neuronal differentiation these results have also been questionable101. Although other 
reports demonstrate the expression of cardiac markers on MSCs, the action potentials 
are less repeatable102,103, potentially due to the age of cell donor or contaminating CD45 
cells.  
1.4 The in-vivo cell microenvironment 
In-vivo MSCs are situated within specialised niches, a complex environment of ECM, 
stromal cells, vascular networks and soluble molecules, which maintain their self-
renewal capacity and potency. In this environment the MSCs make a plethora of cell-
cell and cell-ECM adhesions, whilst in-vitro they are cultured in a two dimensional 
(2D) sheet, on a flat and rigid polystyrene surface that does little to recapitulate the in-
vivo stem cell micro-environment. Therefore to appropriately engineer and model 
tissues and organs, it is important to consider the composition and architecture of their 
in-vivo microenvironment and how these affect the cellular behaviour and the properties 
of the tissue. 
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1.4.1 The extracellular matrix  
The ECM is compiled from a mix of proteoglycans and fibrous proteins, and has broad 
variation between tissues. Collagen is the most abundant protein within the ECM, 
providing the general structure of tissues, in the form of fibrils and networks. Collagen 
types I, II, III, V and XI are fibril forming, creating structures that resist shear, 
compressive and tensile strains and therefore are found in tendons, cartilage and skin. 
Collagen I is the most abundant and found in most tissues. Networks of collagen types 
IV, VIII and X are found in basement membranes providing surfaces for cell attachment 
and organising other ECM components into barriers between tissues104,105.  
The basic unit of all collagens is the collagen molecule, a triple helix of polypeptide 
alpha chains, where each polypeptide chain contains approximately 100 amino acids 
(Figure 1-2). The collagen I triple helix contains two α1 chains and a α2 single chain, it 
is 300 nm in length and 1.5 nm wide. For every type of collagen the basic molecule 
contains three alpha chains, where these may or may not be identical (Figure 1-2,  
Table 1-1).  The amino acid sequence of each chain contains repeats of glycine-X-Y, 
where the glycine residue lies in the centre of the helix allowing the chains to tightly 
pack together, and X and Y are generally proline or hydroxyproline. The fibril forming 
collagens contain uninterrupted Gly-X-Y triplets, resulting in banded fibrils106. When 
secreted from the cell the individual collagen molecules laterally assemble into collagen 
fibrils, crosslinked together through aldol bonds. Collagens IX and XII contain 
interruptions in the alpha chains, where non collagenous sequences are present. These 
collagens associate with the fibril forming collagens. 
Alongside collagen, elastin fibres are present in the skin and blood vessel to provide 
further resilience and as their name suggests, elasticity107. Linking the various ECM 
components together is a series of adhesive proteins, including laminin, fibronectin and 
tenasin108,109. These proteins are essentially the glue of the ECM, binding collagen and 
cells and playing roles in cell adhesion, migration and differentiation. Deficiencies in 
these proteins can result in the weakening of tissues and muscular dystrophies110.   
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Type Chain Molecular structure 
Supermolecular 
structure Localisation 
I α1(I)2, α2(I) 300 nm 
67 nm banded 
fibrils 
Soft tissues, 
bone 
II α1(II)3 300 nm 
Small 67 nm 
banded fibrils 
Cartilage, 
vitreous humor 
III α1(III)3 300 nm 
Small 67 nm 
banded fibrils All soft tissues 
IV α1(IV)2, α2(IV) 
390 nm C 
globular domain 
Non-fibrilliar 
networks 
All basement 
membranes 
V α1(V), α2(V), α3(V) 300 nm N globular domain Small fibres 
Most intestinal 
tissues 
VI α1(VI), α2(VI), α3(VI) 
150 nm N and C 
globular 
domains 
Microfibrils, 100 
nm banded fibrils 
Most intestinal 
tissues 
VII α1(VII)3 450 nm dimer 
Anchoring 
fibrils 
VIII α1(VIII)3 ? networks 
Some 
endothelial 
cells 
IX α1(IX), α2(IX), α3(IX) 
200 nm N 
globular domain 
Associated with 
fibril forming 
collagens 
cartilage 
X α1(X)3 
150 nm C 
globular domain 
Small fibres, 
networks 
Hypertrophic 
cartilage 
XI α1(XI), α2(XI), α3(XI) 300 nm Fibril forming cartilage 
 
Table 1-1: Structures and composition of collagen proteins.  
Adapted from106 . 
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Figure 1-2: Structure of the collagen molecule.  
Cross-section through and side view of a collagen triple helix. In each type of collagen the basic 
molecule is a triple helix of polypeptide alpha chains. The amino acid sequence is generally repeats 
of Gly-X-Y, where the small glycine residue is situated in the center of the helix.   
 
Most of the extracellular space within tissues is occupied by large aggregates of 
proteoglycans, which consist of a core protein, with glycosaminoglycan (GAGs) side 
chains, which vary from one side chain in decorin, to over 100 in the larger cartilage 
proteoglycan, Aggrecan. GAGs are formed of repeating disaccharides, containing an 
amino sugar and numerous sulphated and carboxylate sugars, which give proteoglycans 
their high negatively charge. As a result of the high charge density and structure, 
proteoglycans remain unfolded as large extended structures, providing additional 
compressive strength within tissues and maintaining large volumes of water. This high 
negative charge also causes an osmotic pressure and proteoglycans can guide the 
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migration of small molecules within the ECM. Within the ECM the small leucine-rich 
proteoglycans also organise and stabilise the collagen network. 
1.4.2 Cell-ECM Adhesions 
Many cell types are dependent upon attachment and cell-cell and cell- ECM adhesions 
to provide signals to instruct cell fate. In the absence of a surface to adhere too, cells 
undergo controlled cell death by anoikis111. Cells adhere to the ECM through 
transmembrane receptors of the integrin family, which become activated and linked to 
the actin cytoskeleton of the cell through the anchoring protein talin (Figure 1-3). 
Integrins are composed of an α and β subunit, currently 18 α and 8 β subunits have been 
identified that assemble into 24 different integrins112. Integrins are not specific for one 
particular ECM component, the ligands expressed on the ECM can be bound by more 
than one integrin, and most ECM proteins can bind to several integrins, therefore 
identifying their specificity is complex. The amino acid sequence, arginine-glycine-
aspartic acid (RGD) is a common ligand found on fibronectin, laminin, vitronectin and 
tenasin113. As it can be recognised by many integrins and cell types, and is only 3 amino 
acids long, enabling easy synthesis, the RGD sequence is frequently used in cell 
adhesion studies and often introduced into polymeric biomaterials to improve cell 
adhesion114. Similarly collagen I has a short recognition sequence for integrins α1β1 and 
α2β1115. 
Where there are integrin ligands at high density, they cluster together to form tight focal 
adhesions, enhanced by the binding of vinculin to the integrin/talin complex116,117. 
Using the RGD sequence, 440 nm, the ‘Hubbell limit’, was found to be optimal for 
integrin binding, and a ligand spacing of 140 nm was shown to be optimal for the 
development of focal adhesions117–119. Associated with focal adhesions is a large 
complex of molecules forming the adhesome, which transmits the action of cell 
adhesion into re-organisation of the actin cytoskeleton and multiple signalling pathways 
(Figure 1-3) 119. Activation of the focal adhesion kinase by integrin binding regulates 
GTPases of the Rho and Arf families, which can subsequently modulate cell adhesion 
and migration through actin polymerisation120.  
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Figure 1-3: Cell-ECM adhesions. 
Cells bind to the ECM via integrins, which recognise ECM ligands (amino acid sequences, for 
example RDG) in collagen and fibronectin within the ECM. Within the cell the cytoplasmic domain 
of the integrins is activated by talin and vinculin, linking the ECM to the cell actin cytoskeleton. 
Where a high density of ECM ligands is present, integrin clustering occurs leading to the formation 
of a focal adhesion. Within the cell the integrins are associated with the focal adhesion 
kinase(FAK), and the actin cytoskeleton re-organises into aligned stress fibres. 
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Figure 1-4: Differences in 2D cell culture compared with in-vivo and 3D culture conditions 
In 2D culture cells are grown as a flat monolayer on rigid TCP. The cells make adhesions with the 
TCP and minimal cell-cell adhesions only in one plane. In-vivo, or 3D culture cells make multiple 
cell:ECM and cell:cell adhesions, in multiple directions. The cells are cuboid in morphology and 
oxygen/nutrient/metabolite gradients also exist the further the cells are from the blood supply/air 
interface. 
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1.5 2D versus 3D cell culture 
Cell adhesion differs with regards to cells interacting with synthetic surfaces, as these 
do not contain the ligands found in natural ECM. Polystyrene tissue culture plastic 
(TCP) is probably the most frequently used synthetic surface for cell attachment. 
Polystyrene is a hydrophobic surface, and is therefore plasma treated to give the surface 
a negative charge and stimulate protein absorption. When cultured in serum containing 
media, fibronectin, vitronectin and other adhesive proteins found on the cell surface can 
adhere to the charged TCP, and subsequently cells can indirectly adhere via integrin 
binding to the proteins. In the absence of serum, the attraction of cell surface proteins to 
the charged surface can also promote cell adherence. Alternatively TCP can be coated 
with collagen or fibronectin prior to cell culture to provide a cell adhesive surface. 
Furthermore during culture cells synthesise ECM components, which can also bind the 
TCP and permit cell adhesion of proliferating and migratory cells. Cell culture on TCP 
also differs from the in-vivo microenviroment, as the cells are cultured in 2D flat 
monolayers. The cell-cell and cell-TCP interactions are limited to one side of the cell, 
and the cells become spread and flattened, exhibiting morphologies that differ from the 
in-vivo microenvironment (Figure 1-4).  
When grown within a 3D scaffold cells are in a more natural environment, with 
similarities to their in-vivo microenvironment. Rather than the apical-basal polarisation 
cells experience when cultured on TCP, scaffolds promote multi-directional cell-ECM 
adhesions and cell-cell interactions in multiple directions to neighbouring cells. 
Although some cells types, for example epithelial cells, where the polarisation is 
relevant, for most cell types, including MSCs, it is unnatural. Therefore cells also 
exhibit a different morphology than in 2D, depending on the cell type and availability of 
ligands for cell attachment (discussed in more detail later) cells are more cuboidal and 
rounded in morphology121. This change in morphology can result in a change in cell 
phenotype, where the most significant example of this is chondrocyte cell culture. When 
grown on 2D surfaces, chondrocytes dedifferentiate, when re grown back in 3D culture 
within gels their physiological phenotype is then restored122. 
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Accompanying the change in adhesions and cell shape, are changes in the cytoskeleton 
of the cell123. As previously discussed, integrin binding and the formation of focal 
adhesions are linked directly to the actin cytoskeleton of the cell116. Clusters of focal 
adhesions induce the formation of aligned stress fibres within the cell cytoskeleton. 
Through these adhesions any movement within the ECM is directly transduced into the 
cell, via mechanotransduction124. In response to forces, cell-cell, and cell-ECM 
adhesions the cytoskeleton of the cell is a dynamic structure which constantly adapts to 
its environment. Within the cell the Rho G-proteins (Rho, Rac) have been shown to be 
involved in changes in gene expression with changes in the cell shape. They play roles 
in actin polymerisation, focal adhesion formation and cytokinesis125. Rho and Rac 
activate the serum response factor (SRF) and the transcription factor NF-κB125, and it 
has been shown endogenous expression of RhoA increases in differentiating MSCs in 
response to cell shape123. Therefore in 2D, where the substrate is flat and static and cells 
are flattened and these influences on cell behaviour are likely to be minimal or absent. 
Furthermore the 3D environment provides stimuli to cells that may not occur in 2D. 
Induction of chondrogenesis in MSCs and chondrocytes requires a 3D pellet of cells to 
promote cell condensation and differentiation26. The sprouting of new blood vessels in 
angiogenesis is promoted by hypoxia and gradients of pro-angiogenic factors such as 
vascular endothelial cell growth factor and angiopoietin-1, which are also absent in 
2D126,127. In 2D culture, generally speaking, every cell is exposed to the same 
concentrations of nutrients and oxygen, as every cell has a similar surface area 
interacting with the surrounding environment, i.e. the cell culture media. In 3D 
scaffolds and in-vivo gradients of oxygen and nutrients are present128. The further a cell 
is located from a blood supply or the deeper it is within the scaffold, the less oxygen 
and nutrients will be available as they are unable to diffuse into the tissue. Therefore a 
cell located closer to a blood supply may be phenotypically different than another at a 
greater distance under hypoxic conditions129,130. 
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1.6 Using matrix properties to direct cell fate 
In standard in-vitro assays of MSCs the growth media in supplemented with soluble 
molecules to promote differentiation, however cell behaviour and differentiation can 
also be controlled by physical factors. The microenvironment in which a cell is found 
influences its behaviour, where cell shape, adhesions, substrate mechanical properties, 
substrate topography and applied forces all act together to determine cell fate.  
Therefore it is important to understand these physical mechanisms when designing 
biomaterials, to provide the appropriate physical cues and improve the biomimicry of 
engineered tissues.  
1.6.1 Matrix elasticity 
Most tissues within the body are soft and viscoelastic, having mechanical properties 
similar to both a viscous liquid than can flow when deformed, and an elastic solid that is 
able to deform and return to its original structure when the stress in removed. Adipose 
and brain tissue are examples of the softest materials in the body, and muscle, cartilage 
and tendon are at the other end of the spectrum (Table 1-2). The mechanical properties 
of each tissue are essential for function; tendon and ligament require high elasticity and 
strength to withstand the tensile forces exerted upon them during movement.  
Variation in the elasticity of substrates that cells are adhered too, effects their 
differentiation. When a cell makes adhesions onto a soft hydrogel, the gel has low 
resistance to the forces exerted onto it, and can be easily deformed and give way, 
resulting in a rounded cell with few adhesions and an absence of focal adhesions. On 
stiffer materials cells are less able to contract the matrix and spread out, making 
multiple focal adhesions with the gel131. With an increase in focal adhesions the actin 
cytoskeleton within the cell is under greater tensile forces, and becomes aligned and 
contains pronounced stress fibres. Substrates with variable mechanical stiffness have 
been fabricated from acrylamide gels coated with collagen or fibronectin, to allow for 
cell attachment. When fibroblasts, epithelial and endothelial cells were seeded at low 
density onto these surfaces, the degree of cell spreading, focal adhesions and actin stress 
fibres increased with surface stiffness131,132. A similar effect is observed in 3D collagen 
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systems. Fibroblasts within stiff gels anchored to TCP, contained pronounced stress 
fibres. In free floating gels where the fibres were unconstrained, the cells were rounded 
and no actin bundles were observed133.  
Tissue Tissue source Elastic Modulus 
Achilles tendon Rat 310 MPa (T) 
Articular cartilage Bovine 950 KPa (C) 
Skeletal muscle Rat 100 KPa (T) 
Carotid artery Mouse 90 KPa (P) 
 
Cardiac muscle Mouse 20 - 150 KPa (T) 
Skeletal muscle Mouse 12 KPa (A) 
Lung Guinea pig 5-6 KPa (T) 
Breast tumour Human 4 KPa (C) 
Kidney Swine 2.5 KPa (R) 
Breast Human 2.2 KPa (I) 
Liver Human 640 Pa (C) 
Brain Swine 260 - 490 Pa (I) 
Lymph node Human 120 Pa (V) 
Fat Human 17 Pa (I) 
 
Table 1-2 Elastic moduli of several tissues and organs. 
As determined by compression (C), tension (T), perfusion (P), indentation (I), rheology (R), AFM 
(A), indentation (I) and vibrational resistance (V)134.  
 
Culturing of MSCs on acrylamide gels of increasing elasticity, directed their 
differentiation towards either neurons, myoblasts and osteoblasts135. MSCs varied in 
morphology on the different substrates, on the gels approximating brain tissue (E = 0.0-
1 KPa) MSCs were highly branched. As the elasticity increased to mimic muscle tissue 
(E = 8-17 KPa), MSCs were spindle shaped and on the stiffest matrices (E = 25-40 
KPa), comparable to osteoid, MSCs displayed an osteoblastic cuboidal morphology. 
Accompanying the morphological changes were the expression of early stage lineage 
specific RNA transcripts135. Addition of blebbistatin or myosin light chain kinase 
inhibitor, ML7, at the time of cell plating, prevented the matrix specific cell spreading, 
indicating non muscle myosin II is involved in matrix directed differentiation. Therefore 
suggesting MSCs can be directed towards a specific lineage by matching the 
mechanical properties of the substrate to the native tissue.  
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Matrix elasticity is also able to influence cell migration, akin to chemotaxis. 3T3 cells 
cultured on collagen/acrylamide matrices which has a gradient of elasticity, 
preferentially migrated from the soft to stiff regions and in doing so increased in speed 
and spreading136. Cells on the stiffer gel retracted at the soft gel boundary, and changed 
orientation. There are exceptions however to this behaviour, activated neutrophils 
grown on acrylamide gels of variable stiffness are able to spread out and adhere to even 
the softest gels (2 Pa) as well as on glass surfaces, suggesting some cell types are able to 
spread on matrices without exerting high traction forces132. Likewise malignant cells are 
able to grow in a substrate independent manner. H-ras-transformed NIH 3T3 cells could 
spread and were more metabolically active on soft substrates compared with 
untransformed cells137. 
1.6.2 Matrix porosity and pore size 
To remain viable cells require a supply of oxygen and nutrients and removal of 
metabolic waste products. In-vivo localised vasculature performs this role. Cell 
scaffolds need to contain a level porosity to allow mass transfer to occur, as cells 
situated 100 – 200 µm from a capillary or oxygen supply will not survive138. Porosity 
and pore size also effects the ability of cells to migrate into matrices139. Where the pore 
size is too small, cells are unable to migrate into the centre of the matrix and 
preferentially adhere to the periphery of the scaffold. Conversely when the pore size is 
too large the density of ligands for cell attachment may not be high enough to allow 
cells to properly adhere140,141. Furthermore cells require pores large enough to permit 
cell-cell interactions and voids to produce ECM142. 
The effect of pore size on attachment can be cell type dependent143. Fibroblasts, smooth 
muscle cells (SMC) and micro-vascular endothelial cells (MVEC) cultured on collagen 
– GAG matrices with varying pore sizes (106-150, 63-106, 38-63 and >38 µm) and 
porosity (99% and 75%) had differing behaviour. Every cell type was unable to migrate 
into the centre of the 75% porosity matrices. On the 99% porosity matrices fibroblasts 
were adherent on all pore sizes and displayed no variation in metabolic activity. SMCs 
favoured matrices with larger pore size, whilst MVECs showed little difference in 
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metabolic activity between matrices but could assemble into multicellular networks as 
the pore size decreased. Every cell type was unable to migrate into the centre of the 
99% porosity matrices where the pore size was less than 38 µm143.  
MC3T3-E1 osteogenic cells were also cultured on collagen-GAG matrices with variable 
pore sizes (mean pore size 85 - 325 µm)144,145. Cell attachment and proliferation showed 
a non-linear dependence with pore size. Initially cell numbers were high on matrices 
with 120 µm pores, low on matrices with intermediate pore sizes and were at there 
maximum in matrices with 325 µm pores. After 7 days the number of cells in each 
matrix increased linearly with pore size.  These results suggest osteoblasts initially 
adhere strongly to small pores, however they are unable to migrate within the matrix 
and therefore the cell number remains low, while in matrices with larger pores, cells can 
migrate through the matrix and proliferate resulting in higher cell number139. The effect 
of the pore size on osteogenesis was not examined in this study. Chondrocytes seeded 
in-vitro on collagen I sponges of variable pore size de-differentiated with time in 
culture. However in sponges with smaller pores (20 µm), a larger number of 
chondrocytes maintained the chondrogenic phenotype displaying a rounded 
morphology, and expressing higher level of GAGs146. 
MSCs seeded onto silk scaffolds with varying porosity with depth and cultured in 
osteogenic media, initially formed a greater number and thinner trabecular like 
structures in the small pores (112-224 µm) however with 5 weeks in culture there was 
no significant difference between the small and large pores (400 - 500 µm)147. In-vivo, 
pore size had a more pronounced effect on osteogenesis. Osteocalcin content and 
alkaline phosphatase activity, markers of osteogenesis, peaked in hydroxyapatite 
scaffolds loaded with BMP-2 scaffolds with pore sizes of 300 – 400 µm148. Capillaries 
were also present in some of the larger pores. Differentiation of MSCs in honeycomb 
BMP-2 hydroxyapatite scaffolds, containing a series of tunnels of differing width also 
showed how the size of voids influenced osteogenesis. In small tunnels (90 -120 µm) 
cartilage tissue was found throughout, bone formation only occurred on the periphery or 
within wider tunnels (300 – 400 µm) where vasculature was also present149. Taken 
together these results demonstrate pore size not only effects cell attachment but also the 
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availability of nutrients through diffusion and capillary infiltration in larger pores in-
vivo, with chondrogenesis occurring in the hypoxic areas of scaffolds.  
It is important to consider cell seeding of scaffolds with regards to pore size and 
porosity. Cell encapsulation during in-situ matrix formation, which is common among 
stimuli responsive hydrogels should lead to a uniform distribution of cells. Therefore 
the range of pore sizes required for the matrix would be smaller, as larger pores would 
not be required to permit cell migration throughout the matrix. However in-situ 
encapsulation of cells may force cells into smaller pores than they would migrate into 
and exert mechanical forces onto the cells also directing their behaviour. Also highly 
porous scaffolds implanted in-vivo may have poor mechanical properties. 
1.6.3 Cell shape  
As matrix stiffness and pore size, influences cell spreading and morphology, they are 
closely linked to the impact of cell shape on cellular behaviour. Although in-vivo 
adipose tissue and cartilage have completely different mechanical properties, MSC 
differentiation towards adipocytes and chondrocytes both favour rounded cell 
morphologies, which have been achieved through culturing on soft acrylamide gels150. 
Therefore simply mimicking the ECM stiffness may be less important compared with 
how the matrix stiffness, porosity and topography contribute together to effect cell 
shape. Changes to cell shape and adhesions directly correlate with changes inside the 
cell and re-organisation of the cytoskeleton, which in turns regulates gene expression 
through Rho proteins125.   
Using micro-patterned substrates with adhesive fibronectin regions, the effect of cell 
shape and size on cell behaviour has been examined. Endothelial cells seeded onto such 
surfaces spread to the size of fibronectin regions, where apoptosis decreased with 
increasing the size of the adhesive area118. The cell shape, and metabolic activity also 
increased when the endothelial cells were cultured on arrays of regularly spaced 
fibronectin islands, allowing cell spreading over a wide area. Focal adhesions were 
concentrated on the fibronectin islands. MSC differentiation is also affected when 
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adhered to similar surfaces. MSCs cultured on large islands, were able to spread and 
make multiple substrate adhesions, differentiating towards osteoblasts, whilst MSCs 
cultured on small regions, were unable to spread and displayed adipogenic 
commitment123. As cell density can also effect cell spreading, shape and size it is not 
surprising that it also affects MSC differentiation. Cultured in a combined adiopogenic 
and osteogeneic media, cells at high density which are less able to spread, differentiate 
towards adipocytes, while cells at low density can spread and differentiate towards 
osteoblasts151,152. Chondrogenesis is also affected by cell shape. In classical in-vitro 
assays of MSC differentiation, adipogenesis and osteogenesis can be induced from 2D 
monolayers of MSCs using a cocktail of soluble factors, whilst chondrogenic 
differentiation requires the cells to be maintained in a rounded state, using high density 
cell pellets48. Similarly chondrocytes will lose their in-vivo phenotype when removed 
from cartilage and cultured in 2D monolayers153. Culturing of embryonic stem cells 
(ESCs) at a high density, preventing cell spreading, also promotes chondrogenesis. 
Under these conditions, the cells have rounder nuclei and express cellular condensation 
and chondrogenic markers, type II collagen and SOX9151.  
The nano-scale topography of cell culture surfaces has also been shown to affect cell 
shape. Micro-patterened acrylamide hydrogels with alternating 100 µm regions of 
variable stiffness, to mimic neurogenic and myogenic ECM’s were fabricated to assess 
the impact of both topography and stiffness on ADSC behaviour. ADSCs preferentially 
adhered, aligned and elongated on the stiffer myogenic gel sections, expressing 
myogenic marker β-tubulin154. Surfaces patterned with pits and pores have been shown 
to stimulate osteogenesis of MSCs in the absence of soluble factors. On the patterned 
surfaces MSCs have a less fibroblastic morphology, and show greater spreading, 
adhering to the surface features155,156. In a similar manner to MSCs on the large 
fibronectin adhesive regions, nickel patterned surfaces are also osteogenic. MSCs 
spread out along the surface features and have a high number of focal adhesions and 
actin stress fibres157. Surprisingly chondrocytes cultured on the same patterned surfaces, 
exhibited a rounded morphology, maintaining their in-vivo phenotype, possibly due to 
the limited areas for adhesion, in contrast to the MSCs, which spread across the 
pores158. 
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However the caveat with most of these studies is they are performed in 2D 
environments. In 3D, the cell surface for attachment is unlikely to be flat and additional 
cell-cell and cell-ECM contacts would occur in all directions. They are however good 
examples of probing in-vivo cellular behaviour with respect to one feature.  In summary, 
the elasticity, surface patterning, and porosity of materials can all contribute to cell 
attachment, the shape and size a cell adapts. This provides outside-in-signalling to direct 
cellular behaviour.  
1.7 Cell scaffold 
The cell scaffold is a template for new tissue growth and repair, providing support to the 
residing cells. From the above discussion it is clear that scaffolds need to be designed 
carefully for tissue engineering application. Additionally to directing cell fate, when 
designing the scaffolds the following must also be considered. Biodegradability: does 
the scaffold need to remain permanently or be replaced by newly regenerated tissues? 
and how fast should be scaffold degrade to promote optimal tissue repair? Scaffold 
mechanical properties: again in addition to directing cell fate the scaffold needs to be 
mechanically compatible with the environment it is to be implanted within. A scaffold 
with a low tensile modulus would not be compliant for tendon repair. The main classes 
of scaffolds are polymers, encompassing natural and synthetic materials, ceramics and 
glasses. Decellularised tissues are also commonly used, falling into the natural polymer 
catergory. These 3D materials are typically fibrous networks or porous structures. 
Ceramics and bioactive glasses and glass ceramics are popular candidates for bone 
tissue engineering scaffolds. These are crystalline scaffolds made from inorganic 
compositions, and range from non-porous, inert materials such as aluminium oxide, to 
non-porous surface active ceramics that attach to the bone surface159. The original 
bioglass was developed by Larry Hench and is composed of silicon dioxide, sodium 
oxide, calcium oxide and phosphorous pentoxide in varying proportions160. The silicon 
dioxide content influences the formation of the glass and its bioactivity. Naturally 
occurring hydroxyapatite present in teeth and bones, has an osteoinductive effect, and 
therefore it is produced synthetically for use as a bone scaffold, or as coating for bone 
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scaffolds implants161. Cells are seeded onto the glasses after fabrication and allowed to 
infiltrate into the scaffold. 
Polymeric materials are popular scaffold choices as they can be designed and tailored to 
control the chemical and structural properties of the resulting materials. Biodegradable 
PGA/PLA systems have tuneable degradation rates based on the composition of PGA 
versus PLA162. For cell attachment, RDG sequences can incorporate into synthetic 
polymers during synthesis163. Tunebility in the structural and physical properties of the 
polymers is also beneficial for the development of methods for fabrication. 3D printing 
for example requires polymers with optimal viscosity for droplet formation and 
subsequent gelation/setting. Polymer scaffolds can be fabricated as fibrous networks by 
electro-spinning on cross-linked into hydrogels by chemical cross-links or physical 
cross-linking162.  
1.8 Hydrogels as cell scaffolds 
Hydrogels are an attractive choice for use as cell scaffolds. These are highly hydrophilic 
3D polymer networks, which can maintain large volumes of water and have visco-
elastic mechanical properties similar to soft tissues. IUPAC defines a hydrogel, as a ‘gel 
in which the swelling agent is water’164.  They can be made from natural or synthetic 
polymers or a combination of both. Hydrogels are formed from polymer chains joined 
together into a network through crosslinking by chemical covalent bonds or through 
physical interaction between chains, such as entanglements, electrostatic attractions, van 
der Waals and the hydrophobic effect. They can be as simple as a mix of single linear 
polymers that are chemically crosslinked, and may contain copolymers to add 
additionally functionality. They may also be made from polymers with branching and 
grafts to modify the size and shape of the networks formed, or exist as interpenetrating 
polymer networks, where two distinct polymer networks are formed around each other. 
Further information about the different hydrogels used in tissue engineering and 
regenerative medicine can be found in the comprehensive reviews by Mooney165,166 and 
Hubbell167. 
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1.8.1 Biological hydrogels 
One obvious method to mimic the environment of cells in-vivo is to use a natural ECM 
or components from it. Hydrogels can be formed from collagen, fibrinogen and GAGs 
as well as gels made from components of algea and seaweed. ECM based hydrogels 
offer advantages over synthetic materials as they are biocompatible and already contain 
ligands for cell attachment and migration.  
Collagen and gelatine 
Collagen I is the most common biological based hydrogel used as a cell scaffold. It is 
the most abundant protein in the ECM and can easily be extracted from rat-tail 
tendon168,169 and bovine dermis170. Dissolving rat tail tendons in acetic acid breaks 
down the collagen fibrils into the collagen molecules. These can self-assemble in-vitro 
in a temperature dependent manner when neutralised. As the gel formation is 
temperature dependent cells can be encapsulated within a collagen matrix during the 
gelation.      
To permit cell migration and mass transfer, collagen gels containing a low mass fraction 
are required for cell culture (0.2 -0.4 wt%). At these concentrations the gels are 
mechanically weak and prone to cell contraction, and therefore unsuitable for some 
applications which require slower degradation and remodelling, or for fabrication of 
micro- and nano-structured scaffolds. Increasing the mass fraction of collagen is one 
method to improve the mechanical strength of the resulting gel. Equilibrium moduli of 
collagen gels prepared at 37 oC, increased from 30 Pa for a 3 wt% gel to 1800 Pa for a 
20 wt% gel171. This increase in mechanical strength was attributed to an increase in 
fibre numbers, as there was no change in fibril diameter when the concentration was 
increased. The high mass fraction gels displayed some biocompatibility, due to the 
increase in fibre density and therefore a probable decrease in pore size and mass 
transfer, the remodelling and cellular invasion in the gels was significantly decreased171.  
Changing the gelation temperature of the collagen gels may also increase their 
mechanical strength. Initially small numbers of collagen molecules laterally nucleate 
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together followed by growth into fibrils. At lower temperatures the lag phase during 
nucleation is extended as the hydrophobic effect is weakened and lateral growth 
dominates, leading to larger collagen fibrils. There are conflicting results over the effect 
of larger fibrils on mechanical strength, where Yang et al. have shown low temperature 
gelation and larger fibrils increases mechanical strength172, whilst Raub et al. found the 
opposite173. 
Collagen can be denatured by hydrolysis, which disrupts the triple helix of the collagen 
molecules to produce gelatine an alternative collagen based hydrogel174. The denaturing 
process is irreversible; therefore gelation is not possible without the use of glutaldehyde 
to crosslinks the molecules to to form hydrogels. As no fibrillar assembly occurs either 
in gelatine hydrogels they are mechanically weak compared with collagen.   
Polysaccharide gels 
As another major component of the ECM, and their ability to maintain large volumes of 
water, hyaluronan (HA) and GAGs are common choices for hydrogels. HA is a non-
sulphated linear polysaccharide containing repeats of β-1,4-D-glucuronic acid and β-
1,3-N-acetyl-D-glucosamine, and is involved in wound healing and regeneration in-
vivo, as well as promoting angiogenesis (Figure 1-5) 175,176.  As HA is water soluble it 
requires cross–linking to form gels. The hydrogels can degraded and remodelled in-vivo 
by hyaluronidase177. 
Hydrogels can also be made from naturally occurring polysaccharides, chitosan and 
alginate from the exoskeletons of crustaceans and brown algae respectively (Figure 
1-5).  In contrast 
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Figure 1-5 Chemical structures of polysaccharide based gels.  
Hyaluronan contains repeats of β-1,4-D-glucuronic acid and β-1,3-N-acetyl-D-glucosamine. 
Chitosan contains a mixture of chitin (N-acetyl-D-glucosamine) and deacetylated chitosan (β-1,4-
glucosamine), dependant on the the degree of deacetylation. In alginate sugars exist in 
homopolymeric blocks of α-L-guluronic acid and β-1,4-D-mannuronic. Agarose is composed of D-
galactose and 3,6-anhydro-L-galactopyranose. 
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to HA chitosan contains a random distribution of saccharides, β-1,4-glucosamine 
and N-acetyl-D-glucosamine, dependant on the degree of deacetylation. Alginate 
contains homopolymeric blocks of α-L-guluronic acid and β-1,4-D-mannuronic. Both 
require addition of ionic species in order to form gels, chitosan through complexes with 
polyelectrolytes178, and alginate with divalent cations such as calcium179. The properties 
of the resulting hydrogels are determined by the ratio of each saccharide unit, which 
varies between sources, and their molecular weight180. Chitosan gels can be degraded 
in-vivo by lysozyme. Although alginate gels are not degradable, loss of calcium ions 
results in collapse of the gel, therefore many alginate gels are also chemically 
crosslinked. Without modification alginate gels are not cell adhesive, and are commonly 
functionalised with adhesive ligands such as RGD sequences179, while the positive 
charge of chitosan at physiological pH promotes cell adhesion. 
Agarose is another naturally derived polysaccharide extracted from seaweed and 
composed of D-galactose and 3,6-anhydro-L-galactopyranose (Figure 1-5). It is 
commonly used for electrophoresis and non-cell adhesive coatings for TCP as it not cell 
adhesive. Agarose was one of the first hydrogels used to maintain chondrocytes in-vitro 
as the cells were unable to adhere and spread, and maintained their in-vivo phenotype122. 
1.8.2 Synthetic Hydrogels 
However the use of naturally occurring materials as scaffolds does have its limitations. 
Natural hydrogels can be quickly remodelled and degraded by cell secreted proteases 
and are generally mechanically weak, unless used at high concentrations which do not 
permit mass transfer. They also have the risk of disease transmission from animal 
derived materials. Synthetic polymers are an alternative, their chemistry and 
architecture can be tailor made and tuned to vary water content, mechanical properties 
and degradation rates to create hydrogels fit for purpose. This includes the addition of 
biological molecules and peptide sequences to improve cell adhesion and behaviour. 
Synthetic hydrogels have been used in contact with body for many years, poly(2-
hydroxyethyl methacrylate) (PHEMA) has FDA approval and is used by large numbers 
of the population in the form of contact lenses181.  
Introduction 
 
 
 
44 
Furthermore many hydrogels are stimuli-responsive and undergo conformation or 
chemical changes in response to an external stimulus. This is very advantageous for use 
in regenerative medicine, as hydrogels networks can be formed in response to 
temperature change and pH, stimuli that exist within the body, rather than by use of 
crosslinking that often requires harsh chemical conditions in which cells and biological 
materials may not survive. Therefore stimuli-responsive polymers have many 
opportunities in biological systems. The most researched examples to date include 1) 
cell encapsulation in polymer solutions prior gelation to obtain uniform distributions of 
cells, 2) subsequent cell release for hydrogels analysis by reversing the stimuli, 3) drug 
molecule release from hydrogels upon changes of temperature and pH and 4) non-
invasive delivery of hydrogels by injection, allowing hydrogels to form in-situ. 
Polymers can respond to a whole range of stimuli additionally to temperature and pH 
including biological agents such as antigens/enzymes, exposure to mechanical forces 
application of an electrical and magnetic field, changes in ionic strength and light, and 
in some cases the polymers can multiple responses to different stimuli.  
1.8.3 Temperature responsive polymers 
Temperature-responsive polymers undergo a conformation change when heated or 
cooled, for the biological polymers previously mentioned: gelatine and agarose this 
occurs with a decrease in temperature, at their upper critical solution temperature. More 
surprising a class of thermoresponsive synthetic polymers display the reverse behaviour, 
becoming insoluble with increases in temperature in a reversible manner. Polymers of 
N-isopropylacrylamide (NIPAM) are the best characterised examples used for 
biological applications, as their lower critical solution temperature (LCST), the 
temperature where they become insoluble is close to body temperature. Other 
acrylamide based polymers also possess LCSTs which vary with the hydrophobicity of 
amide substituent182 (Figure 1-6). Poly(N-vinylcaprolactam) (PVCAP)183, poly(methyl 
vinyl ether) (PMVE)184, poly(vinylpyrrolidone) (PNVP)183, poly(ethylene glycol) 
(PEG)185 also exhibit insolubility with increases in temperature, but have LCSTs close 
to room temperature, or significantly higher than 37 oC and therefore are less suitable 
for biological applications. 
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Figure 1-6: Thermoresponsive polymers that exhibit a LCST 
 
1.9 Poly(N-isopropyacrylamide) hydrogels  
Upon an increase in temperature, when dissolved in aqueous solution, chains of 
PNIPAM undergo a phase transition and collapse from an elongated random coil 
confirmation into a smaller globule. The physical change is based upon the structure 
and immobilisation of the polymer. PNIPAM chains immobilised on a surface, will 
collapse when heated changing the surface properties from hydrophilic to hydrophobic. 
Free chains in solution collapse into globules and aggregate together, while crosslinked 
networks exhibit deswelling and swelling as a function of temperature (Figure 1-7).  
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Figure 1-7 The conformational change of PNIPAM upon increase in temperature is 
dictated by polymer structure.  
With an increase in temperature above the LCST, PNIPAM grafted onto surfaces collapses 
into globules, changing the surface wettability from hydrophilic to hydrophobic, rendering 
the surface cell adhesive (A). PNIPAM crosslinked networks deswell with an increase in 
temperature (B) and free PNIPAM chains in solution, collapse into globules and 
precipitate, creating physically cross-linked hydrogels (C).  
 
1.9.1 Temperature dependent behaviour of PNIPAM 
NIPAM monomers contain a hydrophilic amide group and hydrophobic isopropyl group 
(Figure 1-6). When polymers of NIPAM are dissolved in water, below the LCST, the 
amide group is able to hydrogen bond with water, whilst the isopropyl groups cannot 
and water molecules surrounding the hydrophobic groups become ordered into ice –like 
cages. It is the balance between the hydrophilic and hydrophobic groups in PNIPAM 
that govern the phase transition (Figure 1-8).  
The mixing of a polymer in a solvent at a given temperature is a spontaneous process 
and the Gibbs free energy of mixing, ΔGmix, is negative.  
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∆𝐺!"# =   ∆𝐻!"# − 𝑇∆𝑆!"#      where ∆𝐺!"# = change in Gibbs free energy of mixing 
        ∆𝐻!"# = change in enthalpy of mixing 
        𝑇         = temperature 
         ∆𝑆!"# = change in entropy of mixing 
PNIPAM is able to dissolve in water below the LCST as the exothermic formation of 
hydrogen bonds between the amide and water out weight the negative entropy change of 
water ordering around the isopropyl groups. As the temperature is increased hydrogen 
bonds between the amides and water begin to break and in order for ΔGmix to remain 
negative, the entropy of the system has to increase. The PNIPAM chains collapse into 
globules reducing the hydrophobic groups exposed, and the water molecules can be 
release from the ordered cages. This is analogous to the hydrophobic effect seen when 
proteins fold in aqueous solutions.  
 
Figure 1-8 Coil- globule collapse of PNIPAM in aqueous solution at the LCST.  
Below the LCST, PNIPAM exists as extended coils (blue line), the amide groups (circled in red) 
hydrogen bond with water, whilst water orders in cages around isopropyl groups (circled in blue). 
Above the LCST, PNIPAM collapses into globules releasing ordered water molecules. 
 
Introduction 
 
 
 
48 
The LCST for a given polymer in solution is determined experimentally from the phase 
diagram of the polymer/ water mixture. The LCST is the minimum point in the phase 
separation curve, that is plotted from polymer concentration versus temperature. A 
representative phase diagram of a polymer with a LCST is shown in Figure 1-9. Where 
a phase diagram has not been drawn, but instead the temperature is determined for only 
one concentration this is referred to as the cloud point, when it has been determined by 
turbidity, or phase transition temperature rather than the LCST. Throughout this thesis 
the temperature measurements performed refer to cloud points/phase transition 
temperatures rather than the LCST.  
 
 
Figure 1-9: Representative phase diagram showing the concentration dependence of the phase 
transition temperatures of a polymer in aqueous solution. 
The LCST is the minimum point of the curve. 
 
When the phase transition occurs, the change in PNIPAM chain conformation is not a 
simple coil – globule switch, as there are several intermediate states involved in the 
collapse. The change in polymer chain conformation has been explored experimentally 
by using extremely dilute solutions (0.001 – 0.0005 wt%) to enable the study of 
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individual PNIPAM chains when the phase transition occurs . The transition precedes 
by at least a two-step mechanism, initially single chains collapse into crumpled coils, 
which then later aggregate together.186–190  
Winnik et al. used double labelled PNIPAM chains with donor and acceptor 
chromophores to investigate this coil-globule collapse187,191. Non-radiative energy 
transfer occurred between the chromophores when they were in close proximity, where 
the efficiency of the energy transfer increased with the polymer collapse. In the absence 
of interactions between neighbouring chains, an increase in the efficiency of the transfer 
occurred just before the phase transition temperature, indicating intra-chain collapsing 
occurs. This initial intra-chain collapses was also shown using Time-Resolved 
Anisotropy Measurements (TRAMS). Where the segmental mobility of individual 
polymer chains sharply decreased below the phase transition temperature.186,188 
Static (SLS) and dynamic light scattering (DLS) measurements have also demonstrated 
the presence of a crumpled coil prior to globule formation. By measuring the radius of 
gyration, Rg, the hydrodynamic radius, Rh, and the ratio of Rg and Rh, one can calculate 
the size and conformation of the polymer chains at a given temperature190,192,193. As the 
temperature of the PNIPAM solutions is increased from the theta temperature (the 
temperature where a polymer in solution behaves ideally, any interactions between 
monomers are neglected and the polymer is in a coil confirmation) to 30.6 oC,  <Rg > = 
<Rh >, whilst Rg and Rh decrease in value, indicating the conformation of the polymer is 
not changing, whilst the size is. In this initial stage of the phase transition the polymer 
coils collapse into crumpled coils, but the overall volume the polymer occupies does not 
change.  Above 30.6 oC,   <Rg > / <Rh > rapidly decreases and the coils collapse into 
tight globules which aggregate together. 194 Fluorescence techniques to analyse the coil-
globule transitions also demonstrate the presence of a crumpled state.191  
1.9.2 Factors effecting the LCST 
Linear polymers of PNIPAM typically have an LCST of 32 oC 195, which varies with the 
molecular weight of the polymer. The balance of hydrophobic and hydrophilic groups in 
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a thermoresponsive polymer, controls the temperature of the phase transition and 
therefore any changes to the structure and composition of polymer and the solvent, 
which affect this balance will also affect the temperature of the LCST. 
Copolymerisation 
To adapt PNIPAM for various applications it is commonly copolymerised to add 
functionality. Copolymerisation of NIPAM with hydrophobic or hydrophilic monomers 
can decrease or increase the LCST, as the balance between groups able to hydrogen 
bond with water and the hydrophobic effects are shifted196. Linear copolymers of 
PNIPAM containing 8.9 mol% or 16.9 mol% styrene, had a decreased cloud point from 
32 oC to 20 and 9 oC respectively.197 Below the cloud point the NIPAM-styrene 
polymer chains have decreased segmental mobility compared with PNIPAM only, 
indicating the hydrophobic styrene within the polymer may be forming intra-molecular 
aggregates prior to the chain collapse. Copolymers of NIPAM and modified NIPAM, 
where the isopropyl group is replaced with a larger, more hydrophobic alkyl substituent, 
also have a decreased cloud point198. As the size of alkyl substituent and proportion in 
the copolymer increases a decrease occurs in the cloud point. Similarly 
copolymerisation of NIPAM with PHEMA also decreases the cloud point199. 
Hydrophilic monomers N-vinylpyrrolidone (NVP)200 and N,N-dimethylacrylamide 
(DMAA)199 copolymerised with NIPAM, increase the cloud point of the resulting 
polymer. Free radical polymerisation of NIPAM and NVP was carried out at 
temperatures below and above the LCST. Synthesis at 30 oC resulted in a random 
distribution of NVP within the PNIPAM chains whilst synthesis at 60 oC afforded 
polymers with NVP distributed on the end of the chains as the PNIPAM collapsed into 
globules during the synthesis allowing copolymerisation with NVP occur only at the 
exposed chain ends. The cloud points of the two polymers was higher in randomly 
distributed NIPAM-co-NVP polymer, as the hydrophilic groups with the NIPAM chain 
disrupts the hydrophobic-hydrophilic balance and push the chain collapse to higher 
temperatures. These results demonstrate that the effect of copolymerisation on the phase 
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separation temperature is dependent upon both the quantity and size of the co-monomer, 
and its location relative to PNIPAM.  
Polymer Architecture 
From the examples above, it is evident that the distribution of monomers in the polymer 
affects the temperature of the phase transition. In graft and block copolymers the 
segments of each monomer can behave almost independently of one another. Block 
copolymers of NIPAM with poly(lactic acid) (PLA)201 and PEG202 maintain a cloud 
point of 32 oC, whilst random polymers of the same composition are not 
thermoresponsive. Similarly the cloud point of copolymers with a styrene 203,204 or 
acrylic acid205 backbone grafted with PNIPAM macromonomers were similar to 
PNIPAM, whilst random polymers were not. PNIPAM grafts have also been used to 
induce the collapse of non-thermoresponsive poly(dimethylacetamide) (PDMAC) when 
the density and molecular weight of the grafts is high enough203. 
Presence of Salt 
PNIPAM based polymers used for biological studies tend to be maintained in cell 
culture media or solutions designed to mimic the in-vivo physiological salt 
concentrations. The presence of kosmotrophic anions such as MgSO4 and CO3, reduce 
the LCST of thermoresponsive polymers, and the effect of different anions follows the 
Hofmeister series. This is due to the competitive hydrogen bonding between anions and 
the amide of PNIPAM for water molecules, thus weakening the hydrogen bonding 
between water and the NIPAM amide and shifting the LCST to lower 
temperatures206,207. 
1.9.3 Biological applications of PNIPAM 
PNIPAM based polymers have been used for drug delivery, releasing encapsulated 
molecules at the LCST. Block copolymers of PNIPAM, with a hydrophobic monomer, 
such as butyl methacrylate208 and methyl methacrylate209 can form micelles with a 
hydrophobic core and PNIPAM exterior. During the formation of the micelles drug 
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molecules can be trapped within the hydrophobic core. Upon increase in temperature 
the PNIPAM chains on the outside of the micelle, collapse and release the enclosed 
drug. However further modifications are often required to control the mechanism of 
drug release, as the temperature responsive behaviour of PNIPAM often leads to a quick 
burst, rather than prolonged release.  
Traditionally adherent cells grown on TCP are harvested using enzymes such as trypsin. 
However these methods of cell detachment, which non-specifically cleave cell- ECM 
adhesions can affect the cell phenotype. Trypsin is also animal derived and could lead to 
disease transmission, which is not ideal for cellular therapies. Coating TCP with 
PNIPAM chains can be used as an alternative method to detach cells. Furthermore as 
the detachment does not involve the use of any enzymes, cell-cell adhesions are not 
disrupted either, and intact cell sheets can be obtained. Below the phase transition 
temperature, PNIPAM chains grafted to surfaces are extended and hydrated, upon 
heating the chains collapse into globules close to the TCP surface, generating a 
hydrophobic surface (Figure 1-7). Cells can then attach to the PNIPAM chains through 
soluble proteins in the media. When confluent, the cell sheets can be detached by 
increasing the temperature causing the PNIPAM to once again extend and hydrate, 
releasing the cells210–212. This technique can be further modified to create patterned cell 
sheets. Through copolymerising PNIPAM with a hydrophobic monomer and lowering 
the phase transition temperature, TCP surfaces can be modified to contain PNIPAM 
coated regions that can switch between cell adhesive and non-cell adhesive at different 
temperatures. Initially the temperature can be increased to the phase transition of the 
hydrophobically modified PNIPAM, and cells can be attached to these regions, while 
the more hydrophilic PNIPAM chains are still extended and non-cell adhesive. 
Subsequently the temperature can be raised such that the remaining polymer collapses 
and a second cell type can attach to these now cell adhesive regions. Patterned sheets of 
hepatocytes and endothelial cells have been fabricated in this manner, to mimic their 
paracrine cellular interactions within the pancreas and liver213,214. Basic 3D tissues can 
also made by layering the cell sheets obtained from PNIPAM surfaces. Alternating 
sheets of fibroblasts, and endothelial cells patterned in channels, have been layered to 
create primitive vascular networks215. ADSC sheets have also been prepared on 
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PNIPAM surfaces, for repairing scarred myocardium. Delivery of the cells within an 
intact sheet, maintained them at the site of injury. Over 4 weeks the sheet thickened and 
became populated with new blood vessels, reducing the scarring in the damages 
tissue216. 
1.9.4 PNIPAM hydrogels for regenerative medicine 
The thermoresponsive nature of PNIPAM also lends itself to use an injectable scaffold, 
as cells may be suspended in the aqueous polymer solution below the phase transition 
temperature and then injected in-vivo or transferred to moulds and allowed to gel 
encapsulating cells uniformly within the resulting gel217. When linear polymers of 
NIPAM undergo the solution- gel transition they initially form hydrogels the shape and 
volume of the mould and initial polymer solution. However as gelation is mediated by 
the aggregation of polymer globules into a continuous phase, some of the water is 
expelled from the polymer networks, in a process known as syneresis, and the hydrogel 
shrinks218,219. To reduce this syneresis and therefore maintain water content and volume, 
PNIPAM is commonly crosslinked or copolymerised. Mikos et al. synthesised syneresis 
free acrylate functionalised PNIPAM hydrogels. These undergo tamden gelation, 
initially through the phase transistion and then by chemical cross-linking, preventing 
syneresis from occurring217,218.   
PNIPAM hydrogels have been researched for a vast number of applications, using 
multiple cell types and in many combinations with copolymers, therefore this review 
will focus on applications of PNIPAM hydrogels in tissue engineering of connective 
tissues and MSCs. 
Copolymers of PNIPAM and N-acryloxysuccinimide (NASI) have been engineered to 
control the release of growth factors to stimulate osteogenesis. The NASI groups on the 
polymer are able to couple with exposed amine groups on lysine and arginine within 
protein growth factors such as BMP-2. Coupled with the thermoresponsive behaviour of 
PNIPAM, the aim of this copolymer was the delivery of BMP-2 to the site of bone 
repair, by injection, and then retain the BMP-2 within the scaffold at the site of injury 
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for a slow and continued release220. Compared with PNIPAM – BMP-2 mixtures 
without the functionality, PNIPAM-NASI provided prolonged release of BMP-2 in-vivo 
over 14 days.  
The use of PNIPAM-NASI-BMP-2 also had a greater osteoinductive potential 
compared with injections of BMP-2 only221 indicating that thermoresponsive polymers 
can bind and sustain a release of growth factors in-vivo. Further functionality was added 
to the polymer, with the addition of RGD sequences, which promoted adhesion of 
C2C12 cells onto the PNIPAM-NASI-RGD hydrogel. However with improved cell 
adhesion, NIPAM-NASI- BMP-2 stimulated osteogenesis of C2C12s in-vitro was 
comparable to polymers without RGD, and interestingly in the absence of BMP-2 the 
PNIPAM scaffolds were more osteogenic than 2D TCP controls222. These results 
suggest PNIPAM based hydrogels can induce cell differentiation without necessarily 
providing a substrate for cell adhesion, and have osteoinductive properties in the 
absence of soluble factors. PNIPAM hydrogels containing pentaerythritol diacrylate 
monostearate, acrylamide and hydroxyethyl acrylate have been shown to be calcified in 
serum containing media in the absence of cells218. This intrinsic ability of the hydrogels 
to develop bone like matrix could explain the osteoinductive properties of the previous 
polymer in the absence of BMP-2. 
To produce PNIPAM hydrogels that would not exhibit significant syneresis, Healy et al. 
synthesised copolymers and semi-interpenetrating (sIPN) networks of PNIPAM with 
hydrophilic acrylic acid (AAc), which maintained over 90% water from the parent 
solution, upon gelation. These hydrogels also contained peptide crosslinks containing 
matrix metalloprotease -13 (MMP-13) degradable sequences to facilitate remodelling of 
the matrix223. IPNs are a class of polymer containing two or more networks that are 
partially intertwined among each other, but not covalently crosslinked.  They are 
synthesised by crosslinking one of the networks in the presence of the other, and 
therefore cannot be separated from each other without breaking chemical bonds224. A 
sIPN differs from an IPN because the polymers can be separated from each other and 
only penetrate each other on a molecular scale, due to the entanglements of the 
polymers225.  
Introduction 
 
 
 
55 
Below the phase transition temperature, these gels were mechanically weak with 
complex moduli of 1-2 Pa, therefore injectable. This increased to 100- 300 Pa at the 
phase transition, dependent on the crosslinking density, but these are still weak 
gels226,227. Osteoblasts were able to migrate within the sIPN’s, degrading the gel through 
the peptide sequences. Later addition of RGD sequences improved osteoblast adhesion, 
but without RGD it appears the degradable peptides still permitted cell adhesion and 
migration as the cells can create voids in the matrix and produce their own ECM226. In a 
rat femur ablation assay, the degradable sIPNs were implanted within the bone and 
remodelled trabecular like tissue was visible after a 4-week period, no significant 
differences were observed in the remodelling of the sIPNs without RGD. Where sIPNs 
were implanted without degradable sequences the extent of remodelling was reduced227. 
Soft sIPNs (70 Pa) were also suitable substrates for maintaining the pluripotency of 
ESCs. Compared with TCP, the sIPNs allowed ESCs to adhere and retain their 
undifferentiated phenotype, expressing OCT4 and SSEA-4.228  
More recently the sIPNs have been used to deliver BM-MSCs into the heart for the 
repair of heart tissue following myocardial infarction. In-vivo the BM-MSCs were 
proliferative and their adhesion and spreading improved with increasing mechanical 
strength of the hydrogel. Over 6 weeks the heart tissue thickened and the presence of 
the bulk gel was undetected229. Left ventricle function, which gave an indication of the 
success of the therapy, showed no difference between cell laden sIPN and sIPN only 
injections, suggesting that the hydrogel has good cellular infiltration from the 
surrounding tissue as a result of the degradable crosslinks.   
Poly(NIPAM-co-AAc) hydrogels synthesised by another group, have been used to 
maintain the phenotype of chondrocytes in-vitro. Within the hydrogels chondrocytes 
maintained their rounded morphology and synthesised collagen II and aggrecan230,231. 
These results are in contrast to Healy’s hydrogels, however they used a 10 wt% gel, 
rather than 4-5 wt%, resulting in much tougher gels (900 Pa) and these do not contain 
the degradable links Healy et al used. This highlights how variations in crosslinking, 
concentration and polymer architecture but the same chemical composition can generate 
a wide range of hydrogels that are injectable from PNIPAM. PNIPAM hydrogels have 
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also been used to induce chondrogenesis. Several groups have created hydrogels able to 
encapsulate chondrogenic growth factors. From poly(NIPAM-co-AAc) hydrogels 
containing DEX, ascorbate, TGF-β3 and chondrocytes implanted into nude mice, a 
collagen II and GAG rich tissue formed, where the chondrocytes had spherical 
morphologies and appeared within lacunae like structures similar to native cartilage232.   
Tougher hydrogels has been made from combinations of PNIPAM and PEG. PNIPAM 
with PEG grafts of varying length and density, also have reduced syneresis. Equilibrium 
water content increased with the length of the PEG grafts, while the stiffness of the 
hydrogels fell. Variations in PEG resulted in hydrogels with 35 – 71% water content, 
and complex moduli of 205 KPa – 52 KPa233. Therefore these hydrogels were proposed 
as injectable treatments for repairing the nucleus pulposus, a tissue exposed to high 
compressive strains. PNIPAM-PEG copolymers at the other end of the spectrum that 
had high water content, but low mechanical properties, could encapsulate the 
neurotrophic factors, brain-derived neurotrophic factor (BDNF) and neurotrophin-3 
(NT-3) for injectable repair of spinal cord neural tissue. In-vitro the factors were 
released biologically active over 4 weeks. BM-MSCs were also viable within the gels, 
spreading and proliferating over a 21 day culture period234. 
These examples demonstrate the wide variety of applications of PNIPAM based 
hydrogels for regenerative medicine. Using their thermoresponsive nature, the gels can 
be delivered by injection and they are able to release small molecules for regenerative 
medicine therapies to repair defects in bone, cartilage, the heart and the spinal cord. 
Furthermore they can be used as in-vitro systems to maintain the in-vivo phenotype of 
MSCs. 
1.9.5 Overall Research Aims  
As discussed there is huge potential for hydrogels for regenerative medicine, however 
they are not without their limitations. Synthetic polymers are largely non- cell adhesive 
and non-degradable. Where natural materials are highly biocompatible but do not 
possess the mechanical strength or long term survival synthetic materials have. 
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Furthermore each hydrogel is generally only fit for one purpose due to the large 
variation in ECM between different tissue types. Water content, cellularity, elasticity 
and mechanical strength all vary between tissues and organs. Therefore there is a gap in 
the development of hydrogels for a material that can be used for a variety of 
applications, where the properties can be easily varied. Furthermore one of the 
requirements for a material to be commercially viable in the field and to be used 
therapeutically is affordability. This is alongside the ability to reproduce the fabrication 
process, ease of mass production and methods for sterilisation, transport and storage.  
The potential of a single hydrogel for multiple applications, helps to alleviate problems 
with commercial viability. Furthermore if the hydrogels encourage and permit cell 
infiltration it could be used as an off the shelf therapy for multiple patients and would 
require less regulatory hurdles in commercialisation. In the absence of cells the product 
would be considered a medical device rather than a device and cellular therapy 
combination.  
Therefore this thesis explores the development of a bio-synthetic hydrogel composite of 
PNIPAM and collagen I, to exploit the biocompatibility of collagen and the mechanical 
strength and thermoresponsive properties of PNIPAM. Varying the proportions of 
collagen and PNIPAM in the hydrogel will be performed to examine the effect of the 
composition on the material properties of the hydrogel. This thesis describes the 
synthesis and characterisation of the bio-synthetic hydrogel followed by examples of its 
application for two different stem cell applications. Hydrogels with low mechanical 
properties are used for creating an in-vitro model of the lymph node, showing the utility 
of the composite for research applications, while hydrogels with a higher mechanical 
strength are then investigated as potential injectable treatments for cartilage repair.  
Initially the synthesis and characterisation of poly(NIPAM-co-styrene-graft-NVP), and 
the properties of the resulting hydrogel when it is combined with collagen I will be 
presented in Chapter 2. Then two potential applications of the bio-synthetic scaffolds 
are explored in Chapter 3. 
Specifically the aims of this thesis are to; 
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1. Synthesise and characterise Poly(NIPAM-co-styrene-graft-NVP) 
2. Determine the material properties of hybrid gels of collagen I and Poly(NIPAM-
co-styrene-graft-NVP) 
3. Identify how different blends of the hybrid gels may be used for two different 
MSC based tissue engineering application
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 Development of collagen I and Chapter 2
poly(NIPAM-co-styrene-graft-NVP) hybrid gels  
2.1 Introduction  
2.1.1 Bio-synthetic hydrogel systems 
To improve the biomimicry of PNIPAM based hydrogels, bio-synthetic hydrogels 
containing a combination of PNIPAM and natural ECM components have been 
fabricated. Although cell adhesion ligands and protease specific sequences can be 
synthetically incorporated into PNIPAM to improve adhesion, they do not always have 
a significant effect on the bulk hydrogel properties, and the properties they confer are 
not easily tuned without re-synthesising the polymer. Bio-synthetic hydrogels with 
varying combinations of two (or more) synthetic and natural polymer networks, have 
been produced by several research groups to examine their potential as cell scaffolds.  
2.1.2 PEG based biosynthetic gels  
Seliktar at al. have developed composite gels of linear PEG cross linked with fibrinogen 
to improve the tissue remodelling of PEG based gels, as the protease substrate sites 
within fibrinogen permit gel degradation235,236. Fragments of fibrinogen were 
PEGylated by reaction of acrylate functionality at the PEG chain ends with the free 
thiols of fibrinogen. Further PEG-diacrylate (PEG-DA) addition in the presence of UV 
initiation crosslinked the gel together. Several hydrogels were made with varying 
molecular weights of PEG-DA. Interestingly the elasticity of the hydrogels and the in-
vitro degradation rate decreased with increasing PEG molecular weight, potentially due 
to larger pore size. The elastic modulus did however increase with polymer 
concentration. The addition of fibrinogen significantly decreased the mechanical 
properties compared with PEG only gels, due to a reduction in crosslinking between 
adjacent PEG chains235. However fibrinogen improved cell adhesion of endothelial cells 
on the hydrogel surface and the spreading of SMCs within gels compared with PEG 
only gels. When the degree of crosslinking was increased through addition of more 
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PEG, the porosity of the gels reduced, which in turn decreased cell attachment and 
migratory ability of SMCs 236.  
2.1.3 Interpenetrating polymer networks 
Biosynthetic hydrogels have been made in the form of interpenetrating networks (IPN). 
Where the monomers within the IPNs are hydrophilic, hydrogel IPNs can be produced. 
Blends of PVP and gelatine in a 1:1 ratio produced hydrogels with good swelling, 
compressive strength and cell attachment, while PVP only gels were elastic, but not cell 
adhesive237. Similarly with the PEG-fibrinogen gels, inclusion of gelatine decreased the 
compressive strength of the hydrogel whilst improving cell adhesion. Bio-synthetic 
semi-IPNs (sIPN) have also been synthesised from gelatine and acrylamide. The 
greatest tensile strength for the series was observed in sIPNs where only one of the 
polymer networks was crosslinked238. In these gels the crosslinked gels are able to 
maintain structure, whilst the second component could temporarily deform under the 
applied strain. This demonstrates how two polymer networks combined can work 
together to resist strains. The sIPNs were most elastic when the polyacrylamide was 
crosslinked, and gelatine was mobile. A similar behaviour is seen in the ECM matrix of 
cartilage, where aligned collagen fibrils are maintained in a weaker GAG gel. In the 
reverse gel where gelatine was crosslinked, the gel was weaker than crosslinked 
acrylamide only gels, highlighting how effective bio-synthetic hydrogels can be, where 
a synthetic polymer can provide additional strength to a biological hydrogel. PHEMA is 
commonly used as a biomaterial, even though it is non –cell adhesive. Again by 
crosslinking PHEMA into IPNs with gelatine, cell adhesion of fibroblasts was 
improved239. In-vivo the IPNs integrated into the surrounding tissue and were 
remodelled, furthermore the elastic moduli of the IPN, 80 KPa was greater than either 
PHEMA, 56 KPa, or gelatine, 36 KPa, films alone.  
2.1.4 Hyaluronan-NIPAM hydrogels 
To take advantage of the thermoresponsive nature of PNIPAM, several hydrogels have 
been made from natural ECM components grafted with PNIPAM chains. Unmodified 
HA is water-soluble and usually functionalised or crosslinked in order to form gels. 
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Matsuda et al. used grating of PNIPAM chains to HA to produce water insoluble gels, 
and drive the gel formation with temperature240. The phase transition of the gels 
occurred around 34 oC, and decreased slightly with increasing PNIPAM graft length and 
densities. As the gels were not cell-adhesive they were explored as non-tissue adhesive 
coverings for surgical repair. In a rat cecum abrasion model, HA-g-PNIPAM prevented 
adhesion of surrounding tissues to the damaged area241. HA-g-PNIPAM gels have also 
been used for ADSC culture242. Hydrogels were synthesised with 28 and 53 wt% 
PNIPAM, again with increasing PNIPAM concentration, the elasticity increased and 
pore size decreased. The ADSCs were unable to spread and attach to the gel and 
remained in a rounded state. Although the 53 wt% PNIPAM contained more viable 
ADSCs after 28 days cell culture and were less prone to enzymatic degradation, the 
lower PNIPAM may be more biocompatible as ADSCs were able to degrade and 
migrate out from the gel. Peroglio et al. also produced HA grafted with PNIPAM. As 
the molecular weight of the grafts increased, the hydrogels became more prone to 
syneresis, but increased in mechanical strength up to 16 KPa243, demonstrating how the 
composition needs to be carefully tailored to produce the best performing hydrogel. The 
weaker gels were used for ex-vivo implantation of BM-MSCs into a bovine dissected 
spine, as a possible therapy for nuclear pulpous repair. After 1 weeks culture in 
chondrogenic media the implanted cells were producing a collagenous matrix, more 
efficiently than in-vitro pre-differentiation BM-MSCs244. 
Another approach to combine PNIPAM with HA, was through direct mixing of a 
PNIPAM and acrylic acid (AAc) copolymer, PNIPAM-co-AAc, with HA prior to 
gelation. As the gels are not adhesive, they were used for chondrocyte differentiation, 
supplemented with combinations of TGF-β1 and dex and implanted into nude mice. 
Over 8 weeks the factors were slowly released from the gels. Chondrogenesis was 
improved by incorporating HA into the hydrogels compared with just PNIPAM-co-
AAc245, and the most significant differentiation was observed using the combination of 
all factors and HA, due to the prolonged release of TGF-β1 and dex and the biomimetic 
scaffold246,247.  
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2.1.5 Gelatine NIPAM hydrogels 
In contrast to the HA-g-PNIPAM hydrogels, gelatine-g-PNIPAM hydrogels are more 
cell adhesive241,248–251. Hydrogels were formed from solutions of gelatine-g-PNIPAM at 
concentrations over 5 wt %, and as the ratio of PNIPAM to gelatine (P/G) increased the 
minimum gelation concentration fell. The phase transition temperature varied between 
33 – 34 oC, decreasing as the P/G increased. The compressive strength and elastic 
moduli of the gels also followed a similar trend, reaching 222 and 8.7 KPa respectively 
for the 20 wt% gels with the highest PNIPAM content249,250. Cell viability, spreading 
and proliferation of fibroblasts and human umbilical vein endothelial cells (HUVEC) 
increased with P/G as these gels contained a more open network as a result of the large 
hydrophobic aggregates that are formed within the gel249. 
Gelatine-g-PNIPAM showed potential for tissue engineering of cartilage 252. 
Chondrocytes behaved similarly to fibroblasts within the gels, they were rounded with 
minimal spreading, but this is typical of the cell type. They also had the best viability in 
the gels with a high P/G ratio. Over 12 weeks in culture the cells arrested in the G0/G1 
stage and synthesised a cartilaginous matrix of proteoglycans and type II collagen. The 
response of mechanical loading on the gels approached that of native collagen with time 
in culture. Although the gels can form in-situ within native cartilage, the authors pre-
cultured chondrocytes within the gels prior to implantation, as the phase transition 
temperature of the gels was close to 37 oC and there were concerns over gel leakage 
with minimal changes in temperature. The pre-cultured tissue was secured in full 
thickness defects with fibrin glue and sealed with a periosteal flap. Examination of the 
tissue after 5 weeks showed a GAG and collagen II rich matrix, which had the 
histological appearance of native cartilage when pre-cultured in-vitro prior to 
implantation252. Although this use of PNIPAM-HA hybrids was able to regenerate high 
quality cartilage, the technique still required invasive surgery. 
2.1.6 Chitosan-NIPAM hydrogels 
Chitosan grafted with PNIPAM has also been designed for cartilage repair253. 
Compared with hydrogels of PNIPAM, chitosan-g-PNIPAM had larger shear moduli 
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and water content. Chitosan-g-PNIPAM was subsequently grafted onto HA, producing 
gels with similar water content, but they were generally weaker. In-vitro chondrogenic 
differentiation was most successful in HA-g-(chitosan-g-PNIPAM), potentially due to 
the presence of HA in native cartilage, and with 6 weeks differentiation the shear 
moduli of the chondrogenic gels approached 70 KPa. 
2.1.7 Alginate-NIPAM hydrogels 
PNIPAM has been grafted to the surface of porous alginate gels to add a level of 
temperature control to the swelling and deswelling of the gel254. Thermoresponsive 
swelling improves the functionality of alginate gels for stimuli responsive drug release. 
The porosity of the alginate gels, results in fast swelling of only one minute. When 
functionalised with PNIPAM, the gels also quickly de-swell at the phase transition 
temperature. The effect is increased when the PNIPAM is grafted onto the surface of the 
alginate pores, as these are within the gels that are in contact with fluid.  
2.1.8 Collagen PNIPAM scaffolds 
Currently the only scaffolds produced that combine collagen with PNIPAM, are 
fabricated from copolymerisation of PNIPAM and a diethylene glycol diacrylate 
(DEGDA) crosslinker around a pre-formed collagen sponges255. PNIPAM was 
incorporated into the sponges to improve the mechanical properties of collagen for 
tissue engineering applications. Addition of PNIPAM increased the shear moduli of the 
collagen sponge and introduced temperature dependent swelling and deswelling into the 
scaffolds. To date they have not been used in combination with cells. 
2.1.9 Conclusions on bio-synthetic PNIPAM hydrogels 
Although there are numerous examples of bio-synthetic hydrogels based on PNIPAM, 
there are limitations in their applications. Some of the hydrogels discussed above 
require crosslinking with UV or through synthetic routes to form gels. Upon 
crosslinking they form hydrogels with high mechanical strength, however the gelation is 
accompanied with an increase in viscosity and the materials cannot be implanted in-
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vivo. Although gels made from HA-g-PNIPAM gelled with an increase in temperature 
their application in cartilage repair was only shown to be successful when the gels were 
pre-cultured and then implanted. However their thermoresponsive behaviour was 
amenable to cell encapsulation. Many of the gels were non-cell adhesive and therefore 
used as scaffolds for cartilage repair as MSCs and chondrocytes require a rounded 
morphology to commit to a chondrogenic lineage. The mechanical properties of the 
different gels could be varied through changing the composition of the synthetic to 
natural component. Generally, addition of a natural polymer to synthetic, decreased the 
mechanical properties compared with the synthetic polymer alone, however the 
materials were stronger than the natural materials and now contained biological 
functionality. There is however a lack of materials that can be tuned without further 
chemical synthesis, and as many natural gels can gel with increases in temperature, 
there is potential for hydrogels where both the synthetic and natural polymers gel in-situ 
forming physical networks among each other. Lastly the majority of gels are only used 
for engineering of highly mechanically compliant tissues, such as cartilage. The 
addition of a thermoresponsive element to a natural ECM based hydrogel could also 
have many applications in the engineering of softer tissues such as the kidney, liver or 
lymph node. These hydrogels do however show the potential of bio-synthetic PNIPAM 
based hydrogels as they can support cells viability and differentiation in-vitro and in-
vivo and their composition can lead to very varied mechanical properties.  
2.2 Aims and synopsis 
There is currently a range of bio-synthetic hydrogels for tissue engineering, yet there are 
no tuneable materials, as the composition of the hydrogel is pre-determined from the 
synthesis. A technology gap exists for a material that can be tailored for multiple 
applications at the time of use, therefore reducing the need for multiple tissue 
engineering products. At present, there are no other hybrid gel systems composed of 
PNIPAM and collagen, which are not chemically crosslinked together, and gel 
simultaneously among each other. A hybrid gel created by simply mixing a synthetic 
and biological polymer in the desired proportions, has potential as an off the shelf 
scaffold for multiple applications. Presented within this chapter is the synthesis and 
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characterisation of poly(NIPAM-co-styrene-graft-NVP), (which will be referred to as   
NSN for simplicity) and the development of a hybrid gel system which combines NSN 
with collagen I. The effect of the blend of collagen to NSN in the gels, on the resulting 
gel properties will be assessed by mechanical testing, syneresis experiments and SEM 
imaging. 
The aims of this chapter are: 
1. Synthesis of poly(NIPAM-co-styrene-graft-NVP) 
2. Determine the structure, size and thermoresponsive behaviour of poly(NIPAM-
co-styrene-graft-NVP) 
3. Indentify the physical properties of hybrid gels of collagen I and poly(NIPAM-
co-styrene-graft-NVP)  
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2.3 Methods 
2.3.1 Polymer Synthesis  
All glassware was dried in a 60 oC oven prior to use to remove residue water and 
solvents. 
2.3.2 Synthesis of semitelechelic oligo(NVP) 
Oligomers of NVP (ONVP) were prepared as described below. N-vinyl-2-pyrrolidone 
(NVP, Sigma Aldrich) was distilled under reduced pressure and the first fraction kept 
for synthesis. Distilled NVP was stored at – 20 oC prior to use. 2-isopropoxyethanol 
(IPE, Sigma Aldrich) (4.6 eq) was charged to a 3-necked flask equipped with a reflux 
condenser and gas bubbler that was subsequently sealed using a rubber septum. IPE was 
used as both a solvent and chain transfer agent in the polymerization. Prior to the 
addition of further reagents, nitrogen was bubbled into the solution for 15 minutes. 
Azobisisobutyronitrile (AIBN, BDH) (3.5 x 10-3 eq) was dissolved in a minimum 
quantity of IPE and added via syringe into the flask. Nitrogen was bubbled into the 
reaction for another 15 minutes. NVP (1 eq) was then added via syringe and the reaction 
mixture stirred at 60 oC, under nitrogen for 3 hours. The remaining solvent in the 
reaction mixture was removed in vacuo yielding a clear viscous liquid. The polymer 
was then purified by adding the concentrated reaction solution slowly to a rapidly 
stirring excess (20x product volume) of diethyl ether, and the precipitate dried overnight 
in vacuo. The glassy white solid (ONVP) was precipitated again from dichloromethane 
(DCM) into diethyl ether and dried for 24 hours in vacuo. 
2.3.3 Functionalisation of oligo(NVP) 
The hydroxyl end groups of ONVP were functionalised with 4-vinylbenzyl chloride 
(VBC) to give vinylbenzyl functionalized NVP oligomers (ONVP-VB). Sodium 
hydride (17.6 eq, Sigma Aldrich) was washed 3 times in anhydrous diethyl ether under 
nitrogen in a sealed flask and subsequently dissolved in anhydrous dimethylformamide 
(DMF) (10 ml). 4-Vinylbenzyl chloride (VBC, Sigma Aldrich) (40 eq) and nitrobenzene 
(50 µm, Sigma Aldrich ) were diluted in anhydrous DMF (5ml) and added via syringe 
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to the flask. ONVP (1 eq) was dissolved in a minimum of anhydrous DMF and added to 
the flask. The reaction mixture was stirred at room temp for 24 hours in the dark. 
Remaining solvent was removed in vacuo and the resulting viscous liquid added slowly 
to a rapidly stirring excess (20x product volume) of diethyl ether. The precipitate was 
dried overnight in vacuo.  The glassy white solid (ONVP-VB) was precipitated again 
from a minimum quantity of methanol/DCM (1:9) into diethyl ether and dried for 24 
hours in vacuo. 
2.3.4 Synthesis of poly(NIPAM-co-styrene-graft-NVP) 
Prior to use NIPAM (Sigma Aldrich) was recrystallised. Briefly, NIPAM was dissolved 
in a minimum quantity of hexane:toluene (40:60) with gentle heating. The solution was 
cooled at -20 oC for 30 minutes and the recrystallised NIPAM dried in vacuo. NIPAM 
was recrystallised two further times and dried in vacuo for at least 24 hours to remove 
residue solvent. NIPAM (31.45 mmol) and AIBN (0.335 mmol) were dissolved in 1,4-
dioxane (10ml), once dissolved styrene (Sigma Aldrich) was added (3.495 mmol) and 
the solution transferred to a glass ampule. The functionalised NVP oligomer (ONVP-
VB) (0.035mol) was dissolved in a minimum quantity of 1,4-dioxane and added to the 
ampule. The ampule was subjected to 3 freeze- thaw cycles and sealed under vacuum. 
The reaction mixture was heated at 60 oC overnight and the resulting liquid added 
slowly to a rapidly stirring excess (20x product volume) of diethyl ether. The 
glassywhite solid was precipitated again from DCM into diethyl ether and dried for 24 
hours in vacuo. The resulting solid was dissolved in a mixture of ethanol:acetone (3:7) 
and ultra filtered using a ultrafiltration cell (Millipore) and 10,000 Mw cut off cellulose 
filter. The filtrate was precipitated again in diethyl ether. The solid was then dissolved 
in ultra pure water and freeze dried to give a fluffy white solid. The polymer was stored 
under nitrogen at -20 oC due to its hygroscopicity. 
2.3.5 NMR analysis of oligomers and graft polymers 
Hydrogen nuclear magnetic resonance (1H-NMR) spectra were obtained using Bruker 
Avance 400 spectrometre using a 12 ppm sweep width. 25 mg of the sample of interest 
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was dissolved in deuterated solvent and filtered through glass wool to remove any 
insoluble material.  
2.3.6 GPC analysis of oligomers and graft polymers 
Gel permeation chromatography (GPC) was performed using 5 mg of the sample of 
interest dissolved in 2ml of degassed DMF. Each sample was run on PL gel mixed B 
columns (10 mm particle size, 100-10 Å pore size, Polymer Laboratories) equipped 
with an refractive index detector. A flow rate of 1ml/min was used and the samples run 
for 40 minutes in a mobile phase of degassed DMF supplemented with 0.01% MgCl.  
Columns were calibrated using poly(methylmethacrylate) (PMMA) standards. Three 
colour-coded standards were run on the columns, each containing a mixture of five 
monodisperse PMMA polymers. Red vial: 2,000/30,000/300,000/1,500,000 g mol-1, 
yellow vial: 1,000/13,000/130,000/1,000,000 g mol-1 and green vial: 
500/7,000/70,000/500,000 g mol-1. Average molecular weights of samples were 
obtained using Agilent Cirrus GPC software. Mean values of 3 replicates were 
calculated for the number average molecular weight, weight average molecular weight 
and dispersity index. 
2.3.7 MALDI-TOF mass spectroscopy  
Matrix assisted laser desorption time-of-flight spectroscopy (MALDI-ToF) spectra were 
obtained for the ONVP oligomers using a Bruker Reflex III spectrometer operating in 
positive ion reflectron mode. The instrument was calibrated with Angiotensin II and 
Insulin standards. Each sample was dissolved in chloroform (8mg/ml) and combined 
with dithranol matrix (10 mg/ml in chloroform) and sodium iodide (2mg/ml in 
methanol) at a ratio of 2:2:1. 
2.3.8 Turbidity Measurements 
Dilute solutions of NSN were dissolved in either milli Q water or basal cell culture 
media and heated from 0 – 60 oC and then cooled straight away back to 0 oC. The 
absorbance at 500 nm was measured during the heating and cooling runs using a Jasco 
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ETC-505T peltier temperature controlled Jasco V-560 UV-Vis spectrometer. The cloud 
point was determined from the heating run as the point of inflection from the baseline.  
2.3.9 Rheological Measurements 
Rheological measurements were obtained using a TA Instruments Rheology Advantage 
AR-G2 cone and plate rheometre fitted with a 40mm cone. The plate was fitted with a 
peltier control and julabo F24 water bath. 800 µl of each sample was pipetted onto the 
plate, which was held at 0 oC and the cone lowered to zero gap ensuring the sample was 
not overfilled. Any excess sample was removed by pipetting or using a paper towel. 
Samples were held at the starting temperature for 1 minute prior to any experimental 
runs. 
2.3.10 Collagen I extraction from rat tail tendon  
Prior to extraction rat tails were rinsed and thawed in 95% ethanol. The epidermis was 
removed from each tail by making a cut down the length of the tail using a scalpel, 
taking care to not cut into the underlying tendon bundles. Using a haemostat the top of 
the tail was clamped, whilst a second haemostat was used to pull the epidermis away 
from the tail. To remove the tendons, the tail was clamped at the proximal end using a 
haemostat and the tendon bundles immediately proximal to the haemostat were severed 
using a scalpel. Tendons were removed from the tail joint by joint, a second haemostat 
was used to clamp and break the joint at the distal end of the tail. The joint and 
associated tendons were then pulled away from the tail and the tendons cut from the 
joint and stored in sterile water. The process was repeated for each joint in the tail to 
isolate as much of the tendons as possible.  
The isolated tendons were washed three times in dH2O and once in 95% ethanol and 
then dissolved in 0.5 M acetic acid (50ml / 1g of tendon, Sigma Aldrich) for 30 hours 
with gentle stirring at 4 oC. The dissolved tendon solution was then centrifuged for 1 
hour at 20,000g at 4 oC and the supernatant maintained to remove any un-dissolved 
proteins. The supernatant was freeze dried in aliquots to obtain solid collagen I. As the 
tendons contain other ECM proteins these may also be solubilised during the extraction. 
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In order to maintain reproducibility in extractions, dissolution time in acetic acid was 
kept constant in each extraction as well as the volume of acetic acid the tendons were 
dissolved in.   
2.3.11 Collagen I gel formation  
All collagen solution preparation was performed on ice. Freeze dried collagen I was 
dissolved in 0.02M acetic acid at concentrations between 3.33 – 6.66 mg/ml. To 
produce a working solution the collagen I stock was diluted with 10X DMEM (1 part 
DMEM to 9 parts collagen) and gently mixed to prevent the formation of air bubbles. 
The working stock was neutralised with 1M NaOH until the pH reached 7.5 (verified 
using pH testing strips and phenol red indicator). To create moulds for the gels, a metal 
ring was adhered to a glass coated Petri dish (MatTek) using vacuum grease for imaging 
applications, or within a 24 well plate for other applications. Prior to gel formation the 
metal rings and Petri dishes were washed in 95% ethanol and coated with 1wt % 
polyethyleneimine for 10 minutes (PEI, Sigma Aldrich). The PEI was washed away 
with 95 % ethanol and the ring and dishes left to air dry. 1 wt% glutaraldehyde (Sigma 
Aldrich) was coated onto the PEI surface and left for 30 minutes, and washed well with 
dH2O. 30ul of the neutralised collagen was pipetted into the ring taking care not to 
introduce air bubbles into the solution, and the gel was allowed to set at 15 oC for 30 
minutes. The gels were then covered in basal cell culture media and transferred to a 
tissue culture incubator. 
2.3.12 Formation of hydrogels 
NSN was dissolved in basal cell culture media at concentrations between 0.25 – 10 wt 
% to create a working stock. To improve dissolution the solutions were kept at 4 oC on a 
rocker for up to 48 hours, until all the solid had dissolved. 30ul of the hydrogel stock 
was transferred into metal ring moulds (6mm diameter, 1mm depth) and the gels 
allowed to set for 30 minutes at 37 oC in a tissue culture incubator. After 30 minutes the 
gels were coated in cell culture media, taking care not to damage the gel during 
pipetting. Hybrid gels of NSN and collagen I were created by mixing the two solutions 
together at the appropriate concentration on ice prior to setting the gels in the metal ring 
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moulds. The hybrid gels are set at 37 oC for 30 minutes and then coated in cell culture 
media. The gels are denoted NSNx for NSN only gels or Col-NSNx, where x is the final 
concentration of the NSN gel by %weight/volume. For all gels the final collagen 
concentration is 0.3 wt%.  
2.3.13 Syneresis Measurements 
A series of hybrid gels were mixed and gelled within metal ring moulds in replicates of 
3 and incubated at 37 oC. The gels were photographed using an upright Zeiss stereo-
microscope equipped with a Zeiss Axiocam MRc5 camera, over 51 hours. Syneresis 
was calculated by measuring the surface area of each gel using Fuji (Image J) software. 
The syneresis index was calculated as Areat  /Areai, where Areat is the area of the gel at 
a given time point and Areai is the initial volume. 
2.3.14 SEM imaging 
Preformed hybrid gels were removed carefully from molds using fine tipped forceps 
and quickly flash frozen in liquid nitrogen on copper grids. The bulk of the gel was 
broken off of the grid to expose the internal structure of the gel. Each gel was freeze-
dried and sputter coated in gold. SEM images were obtained on a JOEL JSM -7600 F 
field emission scanning electron microscope, operating at 3 kV. Fiber diameters were 
calculated by measuring random selection of each image. Each micrograph was divided 
into a numbered 6x7 grid and 10 boxes chosen at random. At least 10 fiber diameter 
measurements were taken from each box using Image J. The average fiber diameter and 
SEM was calculated for each sample.  
2.4 Results 
2.4.1 Synthesis of oligo(N-vinylpyrrolidone) macromonomers 
The graft copolymer, poly(NIPAM-co-styrene-graft-NVP) (NSN) was prepared via a 3-
step synthesis as described in section 2.3.1 (Figure 2-1). Graft copolymers, or 
brush/comb polymers have a linear backbone, from which pendant chains, grafts or 
brushes are attached. The synthesis of a graft copolymer is typically performed by the 
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addition of a reactive monomer within the polymer backbone where grafts can later be 
attached. Subsequently a second polymerisation can be initiated from the reactive 
monomer or an already synthesised polymer chain can be bonded to the reactive 
position. NSN was prepared using a third approach, where macromonomers of NVP 
were synthesised with a polymerisable end group in the α – position. The  
macromonomers were subsequently grafted to the polymer backbone in a second 
polymerisation step as the backbone of the polymer formed. Initially the pendant NVP 
grafts were synthesised via chain transfer to solvent, which produced oligomers 
containing the repeating NVP unit, functionalised at the α- position with 2-
isopropoxyethanol (ONVP-OH) (1). To enable addition of the NVP grafts to the 
NIPAM and styrene backbone the α chain end of ONVP-OH was functionalised with 2-
vinylbenzyl chloride to give ONVP-VB (2). Lastly monomers of NIPAM, styrene and 
the ONVP-VB underwent free radical polymerisation to afford a graft copolymer with a 
NIPAM and styrene backbone and pendant NVP chains (3). 
 1H-NMR, GPC and MALDI-ToF were used to confirm the expected products of each 
reaction step. ONVP-OH elutes from the GPC column as one broad peak, which has a 
number average molecular weight (Mn) of 13500 g mol-1, with an elution time of 19– 26 
minutes (Table 2-1). The polydispersity index (PDI), the ratio of Mn to the weight 
average molecular weight (Mw) indicates how broad the molecular weight distribution 
of a polymer is. ONVP-OH has a PDI of 2.56, typical of a polymer synthesised by free 
radical polymerisation. The molecular weight distribution is bell shaped, with a slight 
skew of higher weight fractions at higher molecular (Figure 2-2). 
 Molecular weight (g mol-1)  
Mn Mw PDI 
ONVP-OH 13500 34300 2.56 
ONVP-VB 14500 29000 2.01 
NSN 30400 91500 3.01 
Table 2-1 Molecular weight averages of NVP oligomers and NSN. 
As determined by GPC. 
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Figure 2-1 Synthetic route to poly(NIPAM-co-styrene-graft-NVP)   
Initially NVP oligomers are synthesised by chain transfer to solvent (ONVP-OH), and subsequently 
functionalised with vinylbenzy chloride to give polymerisable ONVP-VB. Finally the grafts and 
backbone of the polymer are formed in-situ. 
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Figure 2-2 Molecular weight distributions of NVP oligomers and NSN.  
ONVP-OH (solid line), ONVP-VB (dotted line) and NSN (dashed line) 
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Figure 2-3 1H-NMR spectra of NVP oligomers. 
 ONVP-OH(A) and ONVP-VB (B) in CDCl3 
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The chemical shifts of the 1H-NMR of ONVP-OH are detailed below. 1H-NMR 
spectrum for ONVP-OH confirms polymerisation has occurred, as the chemical shifts 
are broad rather than narrow, which would be seen if the monomer was present. The 
presence of the isoproproxy end group cannot be confirmed by the NMR as the 
chemical shifts of the repeating NVP unit overlap with their expected shifts (Figure 
2-3A). The end group peaks will also be significantly smaller by NMR, as each polymer 
has an average number of 121 NVP monomers (Mn / 111.14) per each isopropoxy 
ethanol end group. The presence of the end group can however be confirmed through 
MALDI-ToF analysis as discussed later. The 1H-NMR spectrum is consistent with 
results published by Liu et al 256 and Lapworth et al257. 
ONVP-OH (3) 1H-NMR (400 MHz, CDCl3) δ/ppm: 4.1 -3.5 (t/m, br, CH2-(N)CH-
CH2-, backbone), 3.69 (s, possible -OH) 3.5 – 3.0 (m, br, -N-CH2-CH2-, pyrollidoneM), 
2.5 – 1.9 (m, br, C(O)-CH2-CH2-, pyrrolidone and (N)CH-CH2-, backbone), 1.9 -1.3 
(m, br,–CH2-CH2-CH2-, pyrollidone) 1.24 (s, -CH3-C-CH3-, end group) 
The functionalised ONVP-OH, ONVP-VB was characterised in the same manner. 1H-
NMR shows functionalisation of ONVP-OH by the appearance of well resolved peaks 
in the downfield region of the spectrum (6-8 ppm) corresponding to the aromatic ring 
and alkene end groups introduced by vinyl benzyl functionalization (Figure 2-3B). 
These peaks do not appear broad as each polymer chain only contains one functional 
unit, and the chemical shifts do not overlap. The Mn of the ONVP-VB is similar to 
ONVP-OH, as only the end group has been altered, the overall size in the polymer 
chains is not effected (Figure 2-2, Table 2-1).However slight changes should be 
expected due to changes in average polymer size following purification when smaller 
chains may be removed.  
ONVP-VB (2) 1H-NMR (400 MHz, CDCl3) δ/ppm: 7.59- 7.44 (dd, aryl protons), 6.77-
6.68 (m, CH2=CH-), 5.88- 5.71 (d, CH2-CH-), 5.42-5.45 (d, CH2-CH-), 4.95 (s, -
CH2(O)-CH2-, backbone), 4.1 -3.5 (t/m, br, CH2-(N)CH-CH2-, backbone), 3.69 (s, -
OH) 3.5 – 3.0 (m, br, -N-CH2-CH2-, pyrollidone ), 2.5 – 1.9 (m, br, C(O)-CH2-CH2-, 
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pyrrolidone), 1.9 -1.3 (m, br, overlapping peaks of –CH2-CH2-CH2-, pyrollidone and 
(N)CH-CH2-, backbone) 1.24 (s, -CH3-C-CH3-, end group) 
To demonstrate that the synthesis of ONVP-OH proceeded by chain transfer to solvent 
and to deduce what proportion of ONVP-OH was successfully functionalised to ONVP-
VB, MALDI-ToF mass spectroscopy analysis was employed. As MALDI-ToF uses a 
matrix-assisted approach in ionization, large molecules can be analysed without 
fragmentation. The MALDI-ToF mass spectrum of ONVP-OH shows a series of 
repeating mass peaks, where the signals in each series of repeats corresponds to an 
oligomer with the same number of repeating monomer units and a differing end group. 
Each series is separated by the mass of the NVP monomer, 111.14 g mol-1 (Figure 
2-4A).  
For each NVP oligomer to contain the functional 2-isopropoxyethanol end group, the 
polymerisation must have proceeded by transfer to solvent (Figure 2-5 scheme 3), rather 
than direct initiation by AIBN (Figure 2-5 scheme 4). The degree of initiation by chain 
transfer to solvent can hence be determined by comparison of the peak heights of 2-
isopropoxyethanol and AIBN functionalised oligomers. Although initiation by chain 
transfer is the dominant initiation in the initial synthesis of the oligomer, direct initiation 
does occur. The expected mass of each end group was calculated using chemdraw, and 
these were correlated with the appropriate MALDI-ToF peak (Figure 2-4A, Table 2-2). 
There are two prominent peaks in the ONVP-OH MALDI-ToF spectrum, where the 
larger of the two, peak A, corresponds to an oligomer with α-isopropoxyethanol, ω-H 
end functionality (Figure 2-4C). This is the result of chain transfer initiation and 
hydrogen abstraction termination to give a mass/charge ration (m/z) of (104.08 + 1 + 
23) + n(111.14). Where the mass of a proton is included for the termination end group 
and the mass of a sodium cation from the MALDI ionization. The smaller series of 
peaks, peak B, corresponds to an oligomer with a cyano end group from initiation by 
AIBN, and termination by hydrogen abstraction, m/z= (69.06 + 1 + 23) + n(111.14). 
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Figure 2-4 MALDI-ToF spectra of NVP oligomers. 
ONVP-OH (A) and ONVP-VB (B), and expanded regions of spectra A (C) and B (D). 
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Figure 2-5 Possible initiation mechanisms during ONVP-OH.  
Heat treatment causes AIBN to decompose into 2-cyanoprop-2-yl radicals (1). 2-cyanoprop-2-yl 
radicals initiate 2-isopropoxyethanol radicals (2) or directly initiate NVP polymerisation (4) 
Radicals derived from 2-isopropoxyethanol initiate NVP polymerisation (3).  
  
(1) 
(2) 
(3) 
(4) 
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The proportion of each end group was calculated as shown below (Equation 2.1) and the 
equation modified as required for OH and AIBN end groups (Table 2-2). Peaks with 
low resolution at low and high molecular weights, were excluded from calculations, as 
well as those that could not be distinguished above baseline noise. Where an isotope 
pattern has been resolved the most abundant isotope peak was used for the calculation. 
Chain transfer was the dominant initiation resulting in 61.08% of the product, whilst 
38.92% of the resulting product was initiated by AIBN. 
%𝐸𝐺 =    ℎ!"ℎ!" +   ℎ!"   +   ℎ!"#$  ×  100 
Equation 2.1 
 
where,  ℎ!"    : height of ONVP-VB end group peak 
  ℎ!"    : height of ONVP-OH end group peak 
  ℎ!"#$  : height of ONVP-AIBN end group peak 
The functionalised oligomer, ONVP-VB, should show a repeating series of three peaks, 
however only two of the peaks are clearly resolved (Figure 2-4D). The larger of the two 
peaks is functionalised ONVP-OH, giving rise to an m/z of 220.15 + 1+ 23 + n(111.14) 
(peak C) and has α-vinyl benzyl and ω-H end functionality. The smaller series of peaks 
correspond to the remaining AIBN initiated oligomer (peak E). The third peak that 
should be apparent would be from any remaining ONVP-OH that has not been 
functionalised (peak D). However this is not clearly resolved, is of low intensity and 
hidden beneath the non-isotopically resolved ONVP-VB peak C. Where an ONVP-OH 
end group could be resolved this was included in calculation for proportion of 
functionalised end groups. This low abundance indicates most of the ONVP-OH 
starting material has been functionalised with vinylbenzyl chloride. As expected the 
highest proportion of oligomers are the vinyl benzyl functionalised product, at 81.67%. 
Which shows a 20% increase in proportion compared with the 61.08% of ONVP-OH 
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starting material that was present. Which indicates that the samples were not uniform in 
composition or that some ONVP-OH was lost in precipitation steps.  
Table 2-2 Expected products of macromonomer synthesis and functionalisation 
 
2.4.2 Synthesis of Poly(NIPAM-co-styrene-graft-NVP) 
As the ONVP graft content within NSN will affect the properties of the resulting 
hydrogel, including the phase transition temperature and the water content, the 
proportion of reagents in the NSN polymerisation was calculated to produce a polymer 
with 10 mol% NVP.  As only 81.67 % of the ONVP-VB product was functionalised as 
shown by MALDI-ToF, this was accounted for in reaction quantities.  As with the 
 Peak Adduct 
End 
group 
mass  
(g mol-1) 
% End 
group 
ONVP-OH 
A 
 
104.08 61.1 
B 
 
69.06 38.9 
ONVP-VB 
C 
 
220.15 81.6 
D 
 
104.08 6.0 
E 
 
69.06 16.9 
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oligomers the polymerisation of the NSN polymer was confirmed by 1H-NMR (Figure 
2-7). A large peak is visible at 1 ppm arising from the NIPAM isopropyl group, and the 
aromatic region is now broad rather then well defined as it contains peaks 
corresponding to the styrene aromatic ring as well as the benzyl groups in each ONVP 
oligomer. The 1H-NMR profile of ONVP is still visible, however the peaks are smaller 
as only 10 mol% of the total NSN polymer is ONVP. By GPC analysis NIPAM-S-NVP 
has an Mn of 30400 g mol-1 (Figure 2-2).  
NSN (3) 1H-NMR (400 MHz, CDCl3) δ/ppm: 7.51-6.51 (m, br, aryl protons 
overlapping with -NH-CH-(CH3)2), 4.00 -3.52 (br, s, -CH-(CH3)2), 4.00-1.20 (br, m, 
overlapping signals of PVP), 1.20-0.80 (-CH-(CH3)2) 
2.4.3 Poly(NIPAM-co-styrene-graft-NVP) is thermoresponsive at physiological 
temperatures 
Poly(NIPAM-co-styrene-graft-NVP) dissolved in cell culture media and heated to 37 oC 
resulted in a self-supporting gel. When cooled at 4 oC the hydrogel liquefied and was a 
viscous flowing liquid (). To assess the thermoresponsive properties of poly(NIPAM-
co-styrene-graft-NVP) in more detail cloud point/turbidity and rheological methods 
were performed. The two techniques complement each other as they determine the 
phase transition temperature based on different properties. By using UV-Vis 
spectroscopy the phase transition temperature is determined from the cloud point. 
During the sol-gel phase transition of PNIPAM, the polymer chains collapse from an 
extended coil to a globule and precipitate out of solution, causing the solution to 
become cloudy and turbid. The onset of the precipitation is measured by a change in 
absorbance and the temperature where this occurs is defined as the cloud point. Dilute 
solutions of polymer are used for turbidity measurements to prevent complete 
aggregation of the polymer and gelation, and in order for the absorbance to remain low 
(<1-2). The phase transition temperature as determined by the cloud point /turbidity 
method for NSN in pure water occurred at 26– 28 oC (Table 2-3). Varying the heating 
rate from 1 oC/min to 0.3 oC/min had a small effect on the cloud point increasing it by a 
degree for a 0.1 wt% solution in water (Figure 2-8). Varying the concentration of the 
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polymer in water to 0.05 wt% but maintaining the heating rate of 0.3 oC/min had no 
effect on the cloud point.  
The behaviour of NSN in water upon cooling was also examined. The cooling curves of 
all solutions regardless of the rate of temperature change did not mirror the heating 
curves, as the gel-sol transition occurred at lower temperatures than the sol-gel 
transition. However the slopes of the cooling and heating curves are similar, suggesting 
that once the transition begins the rate of the transition is the same in both directions. 
 
Figure 2-6: Gelation of NSN at physiological temperature. 
At 37 oC, 5 wt% NSN forms a self-supporting gel. When cooled to 4 oC the gel liquefies. 
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Figure 2-7 1H-NMR spectrum of NSN in MeOH 
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Figure 2-8 Effect of temperature on turbidity of NSN solutions. 
0.1 wt% in water, heated/cooled 1 oC/min (A) and 0.3 oC/min (B). 0.05 wt% NSN, heated/cooled 0.3 
oC/min (C). 0.1 wt% (D) and 0.05 wt% NSN (E) in DMEM heated/cooled 0.3 oC/min. Solid lines 
represent heating of solutions and dashed lines represent cooling.  
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Turbidity Rheology 
Sample Heating 
rate 
Cloud 
Point(oC) 
Sample Crossover 
(oC) 
2nd transistion 
(oC) 
3rd transistion 
(oC) 
NSN0.1 
H2O 
1 
oC/min 
28.5 NSN10 
DMEM 
8.1 23.5 33.5 
NSN0.1 
H2O 
0.3 
oC/min 
26.9 NSN5 
DMEM 
9.3 24.0 34.3 
NSN0.05 
H2O 
0.3 
oC/min 
27.0     
NSN0.1 
DMEM 
0.3 
oC/min 
26.7     
NSN0.05 
DMEM 
0.3 
oC/min 
26.9     
Table 2-3 Phase transition temperatures as determined by turbidity(cloud point) and rheology (gel 
point)  
Subscript numbers represent NSN concentrations. 
 
Turbidity was not ideal for determining the phase transition temperature of NSN 
dissolved in cell culture media (DMEM). During the sol-gel transition of 0.1 wt% 
solutions in DMEM, the polymer aggregated together, the solution was no longer 
homeogenous and the absorbance could not be measured (Figure 2-8D). The cloud point 
could still be determined from the heating curve, as the aggregation occurred after the 
onset of turbidity. The cloud point was similar to 0.1 wt% NSN in water, 27 oC. To 
avoid or reduce the aggregation of the polymer, 0.05 wt% solutions of NSN in DMEM 
were also tested. Although less aggregation occured, solutions of 0.05 wt% NSN in 
DMEM did not plateau during the heating runs (Figure 2-8E). These solutions also had 
cloud points of 27 oC. The cooling runs of NSN in DMEM also behaved differently 
compared with the same heating rate and concentrations as the water solutions. The 
turbidity continued to increase during the cooling run therefore these results has not 
been included. 
The phase transition temperature was also determined from dynamic mechanical 
analysis (DMA), specifically rheology. Rheology is the study of how a material flows. 
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The technique can be used to look at the deformation of a material under an applied 
shear force. As hydrogels are viscoelastic materials and can behave like an elastic solid 
and a viscous liquid I looked at the rheological response in terms of the storage (G’) and 
loss modulus (G’’), which characterise the contribution of the solid and liquid 
components of the material respectively. When G’ > G’’ the material is in a solid state, 
and when G’< G’’ the material is liquid.258 We define the temperature when G’ exceeds 
the value of G” and gelation occurs as the gel point, as an alternative measurement of 
the phase transition temperature. As the technique determines the phase transition 
temperature based on gelation, NSN solutions were used where the concentration was 
greater than the minimum gelation concentration. The ratio of G’ to G’’ otherwise 
known as the loss tangent, tan δ, can also be used to assess the state of the polymer. 
When tan δ = 1, the viscous and elastic properties of a polymer are equal, when tand δ is 
below 1 the polymer is more elastic and solid like. 
In order to make accurate measurements, appropriate testing parameters were chosen 
where the gels behave in a viscoelastic region. A suitable percentage strain was 
determined by varying the % strain applied on the gel between 0 – 100 % and 
maintaining the oscillating frequency constant at 0.5 Hz. At a given % strain a 
viscoelastic gel will stop deforming elastically and become permanently deformed, 
therefore a % strain for future measurements is chosen where deformation will not be 
permanent. Likewise an appropriate oscillating frequency was chosen for further 
rheological testing by performing a frequency sweep between 0.01 – 10 Hz. Subsequent 
experiments to determine the gel point involved temperature ramps, therefore the 
viscoelastic region was identified for NSN5 gel in DMEM at 0 oC and 37 oC (Figure 
2-9).  
At 0 oC, below 1% strain, the moduli of the NSN solution was noisy due to the low 
mechanical strength of the dissolved polymer and low applied strain (Figure 2-9A). 
Above 1% strain a viscoelastic response was observed, even at high % strains. Whilst in 
a liquid state the NSN solution is able to flow and resist deformation. At 37 oC the 
opposite effect is seen. At low % strains the gel can resist deformation, but above 3%  
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Figure 2-9 Determination of accurate rheology % strain rates and frequency NSN5 at 0 and 37 oC.  
% Strain sweeps performed between 0.01 and 100 % strain (A) and frequency sweeps of 0.01 to 10 
Hz (B). Red and black lines represent G’ and G’’ respectively. The effect of frequency on Tan δ (C). 
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strain the complex modulus decreases and the material begins to deform plastically. 
Therefore a 2% strain was used for all subsequent experiments. At 0 oC when the 
polymer remains in a dissolved state, the moduli are dependent on frequency, slowly 
increasing as the polymer has newtoninan like behaviour (Figure 2-9B). The same is 
observed for tan δ, which increases with frequency up until 2 Hz. At 37 oC the moduli 
steadily increase with frequency, however between 0.5 – 1 Hz they appear dependent of 
frequency. Tan δ decreases slightly during the frequency sweep at 37 oC, but compared 
to the 0 oC sweep it is relatively independent of frequency, indicative NSN was in a gel 
state (Figure 2-9C). Therefore 0.5 Hz was chosen for further rheology experiments.  
Temperature sweeps between 0 – 40 oC, at a heating rate of 1 oC/min, were carried out 
using NSN10. The G’-G’’ crossover gel point occurred at temperatures lower than 
expected compared to the turbidity results (Figure 2-10) this was also observed for 
NSN5. From the curves of the storage and loss moduli, NSN appears to go through three 
transitions upon an increase in temperature, which can be more clearly seen within tan δ 
values. Below 5 oC both the storage and loss moduli are low where G’ is greater in 
value, both values begin to increase above 5 oC and crossover around 10 oC. Above the 
gelation temperature both moduli continue to increase and linearly with changes in 
gradient around 23-24 oC and again at 35 oC. Although the G’-G’’ crossover occurs 
lower than expected the moduli undergo a sharp increase at 23-24 oC, close to the 
temperature suggested for the phase transition temperature by turbidity. At 23-24 oC the 
value of tan δ also begins to increase suggesting the gel is becoming less elastic and 
more viscous. This could be an effect of water expulsion from the gels as the polymer 
chains form globules, in agreement with the turbidity results, which suggest the coil-
gobule transition occurs around this temperature. 
2.4.4 Fabrication of NSN and collagen I hybrid gels 
Hybrid gels were created by gently mixing NSN with solubilised collagen I on ice and 
allowing the solutions to gel in the presence of each other. The collagen concentration 
was 0.3 wt% in all gels, and NSN concentrations were 2.5, 1.25, 0.5 and 0.25 wt%. 5 
wt% NSN gels and 0.3 wt% collagen gels were used as controls in each experiment.  
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Figure 2-10 Determination of NSN10 gel point by rheology. 
Effect of temperature on G’ (solid line) G’’ (dashed line) and Tan δ (dotted line) of NSN10 (A) and 
NSN5 (B). Asterisks on the curves represent a sudden change in gel properties. 
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Solutions below 2.5 wt% NSN were unable to gel into self –supporting gels, whilst gels 
did form from NSN concentrations lower than 2.5 wt%, when blended with collagen.  
In order to create reproducibly sized gels with a flat upper surface, metal washer moulds 
were used. The rings produced gels 6mm in diameter with a 1 mm depth. Gels that had 
been cast within 96 well plates, were not uniform the dimensions, as the gels formed a 
meniscus with the sides of the well. 
2.4.5 Collagen I reduces syneresis in Poly(NIPAM-co-styrene-graft-NVP) gels 
The syneresis was most significant in the hydrogel only gel, NSN5, whilst no shrinking 
was observed in acellular collagen only gels (Figure 2-11). The syneresis in the NSN 
only gel continued for at least 36 hours after the initial gelation had occurred. However 
within the hybrid gels where the concentration of collagen was similar to the 
concentration of NSN very little syneresis occurred. The syneresis of the gels was 
quantified by a syneresis index equal to the surface area of the gel at a given timepoint 
(Areat) divided by the initial gel surface area (Areai). The least syneresis was observed 
for Col-NSN0.25, with an index of 0.953. The indices for Col-NSN0.5 and Col-NSN1.25 
were similar to Col-NSN0.25, 0.92 and 0.93 respectively. As the NSN concentration 
increased the index decreased, where the index for Col-NSN2.5 is 0.56 approaching the 
index for a pure NSN5 gel of 0.31. 
2.4.6 Mechanical strength of hybrid gels vary with NSN content 
The shear mechanical properties of the hybrid gels were investigated using rheology, 
using the % strain and frequency previously determined in section 2.4.3. This analysis 
was carried out at 37 oC only, as the hybrid gels may ultimately be used as an injectable 
and therefore would gel at body temperature, unless the gelation temperature was 
otherwise controlled in-vivo. Constant % strain and frequency was applied to each gel 
for 30 minutes. Time sweeps of collagen were only performed for 20 minutes as G’ and 
G” had plateaued within this period. Solubilised collagen gelled within the initial 1 
minute temperature equilibration of the rheometre heat plate prior to the run, with G’ 
remaining higher G’’ for the entire 20 minute run (Figure 2-12A). Within the first 10  
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Figure 2-11 Syneresis index of NSN, collagen and hybrid gels.  
Gels maintained at 37 oC for 51 hours (A) and representative images of gels used for measurements 
(B) Results are mean ±SEM (n=3). 
  
0 
hr
 
51
 h
rs
 
NSN5 Col-NSN2.5 Col-NSN1.25  
  
Col-NSN0.5 Col-NSN0.25 Collagen 
0 2 4 6 8 10 30 40 50 60
0.0
0.2
0.4
0.6
0.8
1.0
Hours
Ar
ea
t /
 A
re
a i
NSN5
Collagen
Col-NSN2.5
Col-NSN1.25
Col-NSN0.5
Col-NSN0.25
A
B
Development of collagen I and NSN hybrid gels 
 
 
 
93 
 
Figure 2-12 Behaviour of hybrid gels under shear forces 
Evolution of G’ (solid circles) and G” (open circles) during 30 minute dynamic time sweeps at 37 
oC. Collagen (A), NSN10 (B), NSN5 (C), Col-NSN5 (D), NSN2.5 (E), Col-NSN2.5 (F), Col-NSN1.25 (G), 
Col-NSN0.5 (H) and Col-NSN0.25 (I). %strain and frequency were maintained at 2% and 0.5 Hz 
throughout. 
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minutes both G’ and G’’ increased sharply and then began to plateau. During the second 
half of the run the moduli continued to increase slowly to a maximum of 160 Pa. 
Sample G’peak(Pa) G’’peak (Pa) G’final (Pa) G’’final (Pa) 
NSN10 30817 23326 29253 21054 
NSN5 10652 8457 2401 1569 
NSN2.5 2692 2006 33 30 
Col-NSN5 11282 8641 3965 2311 
Col-NSN2.5 1410 1044 2 1 
Col-NSN1.25 426 270 13 8 
Col-NSN0.5 124 15 124 15 
Col-NSN0.25 79 9 79 9 
Collagen 160 40 160 40 
Table 2-4 Shear mechanical properties of NSN and Col –NSN gels 
 
Compared with the collagen results, the runs for NSN5 and the hybrids display a 
different trend (Figure 2-12B-G). Gelation occurred during the initial rise in 
temperature of the plate to 37 oC and G’ remained larger than G’’ through out the runs, 
similarly to collagen. However in contrast to the collagen gels which reach a peak in the 
storage and loss moduli and plateau or slowly continue to increase displaying strain-
stiffening, the hybrid gels reach a peak in their storage and loss moduli and then rapidly 
fall and begin the plateau. The rate at which the moduli fall is roughly proportional to 
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the concentration of NSN within the gel where the lower concentration of NSN within 
the gel, the faster the rate of decrease in the moduli. When the NSN concentration is 
similar to collagen (Col-NSN0.5 and Col-NSN0.25), the gels are able to maintain their 
mechanical strength. There is also evidence of strain stiffening in these gels.  
To assess the shear moduli of the hybrid gels, an average value for both the storage and 
loss moduli was calculated for the peak moduli (G’peak and G’’peak) and final moduli 
(G’final and G’’final) after a 30 minutes time sweep at constant temperature, % strain and 
frequency (Table 2-4). The values were averages of 10 measurements of the moduli at 
the peak and the end of the run (n=3). In the case of some hybrids where the NSN 
concentration was similar to the collagen concentration the final moduli values were 
also the peak values, as the collagen was undergoing strain-stiffening and responsible 
for the bulk mechanical properties of the hybrid gel. Although there was an initial very 
sharp peak this was excluded from calculations.  
The initial stiffness of Col-NSN gels during the runs, defined by G’peak and G’’peak, 
increased with the NSN concentration, where the effect of NSN on the moduli of the 
hybrid gel’s was most substantial in the Col-NSN5, Col-NSN2.5 and Col-NSN1.25 (Table 
2-4). NSN concentrations lower than 1.25 wt% had little effect on increasing the 
mechanical strength of the gel compared to collagen alone. The stiffness of NSN gels 
was also determined in the same way. Again increasing the concentration of NSN 
increased the mechanical strength, but the relationship was not directly proportional. 
The stiffness of the Col-NSN5 hybrid gel was roughly equal to the sum of the individual 
NSN5 and collagen gels, however this was not a trend for all blends, the peak moduli of 
Col-NSN2.5 was half the value of NSN2.5 alone.  
2.4.7 Internal structure of hybrid gels varies with NSN concentration 
To assess the structure of the hybrid gels, how it varies between the blends, and to infer 
how the structure of the hybrids may affect the mechanical properties, SEM microscopy  
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Figure 2-13 SEM micrographs of collagen and hybrid gels.  
Scale bars are 10 µm in the upper row and 1 µm in the bottom.  
  
Development of collagen I and NSN hybrid gels 
 
 
 
97 
 
Figure 2-14 Fibre diameters measurements of collagen and NSN fibres in hybrid gels 
 
was performed. Collagen gels contain a network of thin, delicate fibrils, uniform in 
diameter along their length (Figure 2-13) In some areas aligned, parallel fibrils can be 
observed forming into thicker fibres. To assess changes in the collagen network upon 
inclusion of NSN fibril diameter measurements were carried out using Image J analysis 
software. At least 10 fibril diameter measurements were taken from 20 random areas of 
each micrograph. The collagen fibrils ranged between 100 – 300 nm in diameter (Figure 
2-14). 
Inclusion of NSN within the gels altered the gel microstructure. Col-NSN0.25 has a 
similar fibrillar network to collagen gels, the variation in the fibril diameter within 
thenetwork was not significantly different from collagen gels, but the gel also contained 
rounded aggregates randomly attached to the fibrils. At the higher NSN concentrations, 
the fine collagen network is less obvious in the SEM images. The collagen network is 
less dense and there are larger voids within fibrils, as the entire network appears to be 
coated with the globular NSN particles. The fibril diameters within the hybrid varied 
from 100 nm, where collagen fibrils were exposed up to 3 µm, in regions where NSN 
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appeared to be aggregated on to the collagen. The number of the thicker collagen-NSN 
fibril aggregated increased with NSN concentration. Inclusion of NSN within the 
hydrogels resulted in more diffuse and porous structures compared with collagen alone.  
2.5 Discussion 
2.5.1 Synthesis of poly(NIPAM-co-styrene-graft-NVP) 
Synthesis of ONVP-OH, ONVP-VB and poly(NIPAM-co-styrene-graft-NVP) gave the 
same results as previously published257. There are similarities in molecular weight 
distributions of ONVP-OH, ONVP-VB and NSN within this thesis and the 1H-NMR 
spectra of each product also matches the results of the previously published values. 
As the ONVP-VB synthesis proceeds via chain transfer to solvent, the initiation of the 
polymerisation can proceed by direct initiation from the AIBN derived primary radical 
(Figure 2-5 scheme 4) or chain transfer from the solvent (Figure 2-5 scheme 1-3). This 
method of oligomer synthesis, yielding functionalised chain ends has been previously 
shown to occur through several initiation reactions, including direct initiation from the 
primary radical, 2-cyanoprop-2-yl radical, however chain transfer to solvent was the 
dominant reaction259. When 3-methylbutan-2-one and AIBN were used to generate NVP 
oligomers with methyl ketone end groups, chain transfer to solvent was also the 
dominant initiation, and in comparison with the above, results in a small proportion of 
NVP oligomers that had been initiated by the 2-cyanoprop-2-yl radical 256. Various 
solvents have also been used as chain transfer agents in order to generate NVP 
oligomers including ethyl L-lactate 260 methyl isobutyrate, methyl propionate, diethyl 
malonate and diethyl-2-methylmalonate 261. This route of synthesis results in low 
molecular weight polymers, suitable for peptide functionalization and graft synthesis. 
MALDI-ToF was employed to determine the proportion of NVP oligomers, which had 
the iso-propoxy end group. 81% of ONVP-OH was functionalised from a hydroxyl end 
group to 4-vinyl benzyl, in agreement with the previous study. 257  
At high molecular weights and high polydispersity the sensitivity of MALDI-ToF 
decreases, therefore only well resolved peaks were included in analysis. To obtain 
Development of collagen I and NSN hybrid gels 
 
 
 
99 
‘cleaner’ MALDI-TOF spectra and reduce the PDI of the ONVP-OH oligomers, 
fractionation techniques could be adopted during the precipitation stages and confirmed 
by GPC.  
2.5.2 Thermoresponsive behaviour of NSN 
Determination of the phase transition temperature of NSN by turbidity and rheology, 
gave different values, 26-28 oC and 8-9 oC respectively. The variation seen in these 
values could be attributed to the technique used for the analysis, as each method 
measure the transition through different properties. Rheological methods define the 
phase transition temperature at the gel point, when the storage modulus, G’ is equal to 
the loss modulus, G’’, and the elastic properties of the polymer exceed the viscosity. 
Whilst turbidity measurements determine the cloud point of PNIPAM, the temperature 
when PNIPAM becomes insoluble, forms aggregates and precipitates, causing clouding 
of the solution. This is measured by changes in absorbance. A third technique that is 
commonly used to determine the phase transition temperature thermodynamically is 
differential scanning calorimetry (DSC) which measures the endotherm produces as the 
hydrogen bonding network between the polymer and water is disrupted when PNIPAM 
phase separates.  
One possible explanation for the discrepancies in the techniques could be the effect of 
polymer concentration on cloud point measurements. A true LCST value can only be 
determining from a phase diagram examining polymers at a range of concentartions, as 
the phase transition temperature will vary. Boutris et al. saw a 10 oC decrease in cloud 
point measurements whilst varying the concentration from 0.5 – 22 wt% for low 
molecular weight PNIPAM (Mn = 9000 g mol-1)262. They also observed the values 
calculated for the phase transition temperature for 1 wt% PNIPAM were 5 oC lower 
when determined by DSC compared with turbidity measurements, indicating cloud 
points from turbidity are higher in temperature than the phase transition temperature. 
Lower concentrations were not analysed in their study, and the effect on the cloud point 
could be more extreme at even lower concentrations. However both Winnik187 and 
Fulishige263 have shown at higher molecular weights, < 1700000 g mol-1, and using 
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fractionated samples with polymer concentrations down to 0.005 wt% the cloud points 
are not effected by concentration. The molecular weight of NSN (Table 2-1) falls 
between the molecular weights studied in these experiments and therefore the low 
concentration of NSN (0.05 – 0.1 wt%) used in these turbidity studies could result in an 
cloud point higher than the gel point value of the phase transition temperature.  
The high cloud points from turbidity measurements could also be explained with respect 
to the mechanism involved during the phase transition. The compacting of the PNIPAM 
coil prior to globule formation and aggregation are events that cannot be distinguished 
from each other by turbidity measurements. As a result of the low concentrations and 
molecular weight of the polymer used for the turbidity measurements, the cloud point 
may appear higher than the LCST as only the globule aggregation stage may produce 
enough turbidity in the solution to change the absorbance at 500 nm.  
While the turbidity measurements were performed on 0.1 and 0.05 wt%, the polymer 
solutions for rheological experiments were significantly higher, 5 and 10 wt%, and this 
difference in concentration could also explain the difference in results. Most light 
scattering and fluorescence studies on single chain behaviour at the phase transition 
temperature to determine the mechanism of PNIPAM collapse, used polymers with a 
low polydispersity <1.05 index and high molecular weight Mw > 106, in order to 
produce meaningful results, and reduce any intermolecular interactions190–192,264. The 
situation may be quite different for concentrated solutions. Although the polymer chains 
will collapse and aggregate, inter-chain entanglements may occur below the LCST, 
resulting in experimental values lower than the LCST. Rheology time sweeps showed 
that G’=G’’ at 8.1 oC for 10 wt% NSN and 9.3 oC for 5 wt% NSN. However the effect 
of temperature on both G’ and G’’ changed for a 2nd (23.5 -24 oC) and 3rd (33.5 -34 oC) 
transition, that is not seen in turbidity studies. The values for the 2nd transition are 
consistent with turbidity measurements, assuming the cloud points occur at a 
temperature 2-3 oC higher than expected due to low concentration. The temperature of 
the 2nd transition is also associated with a minimum value in the loss tangent, where the 
polymer is behaving most elastically and gel like. The decrease in the G’-G’’ gel point 
temperature with increasing concentration is also indicative that high concentrations of 
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NSN may result in increased entanglements and viscosity in the polymer solution and 
therefore a lower gel point than the actual LCST value. 
Based on these results, it is likely the true LCST occurs around 25 oC for NSN, where 
the 2nd rheology transition occurs and a few degrees lower than the cloud point. The 
turbidity measurements use dilute solutions and therefore may only show the turbidity 
once full polymer collapse and aggregation has occurred. Whilst the concentrated 
solutions used for rheology measurements show gel like behaviour at lower 
temperatures due to chain entanglements.  
Another important point in the LCST characterisation is the solvent NSN was dissolved 
in. Turbidity measurements were carried out in both water and DMEM, whilst the 
rheological measurements were only performed in DMEM. DMEM used for the 
rheological studies contains MgSO4 among other inorganic salts to support cell growth 
in-vitro, and may be contributing to the change in the phase transition temperature of 
PNIPAM as seen by rheology. Although the variation in the cloud point values was less 
than 1 oC between water and DMEM (Table 2-3), the effect may be greater in the more 
concentrated solutions used for rheology. This could be justified by investigating the gel 
point of NSN in pure water at the same concentrations. Furthermore a value of 25 oC for 
the LCST is typical of PNIPAM copolymerised with a hydrophobic monomer. 
Considering the decrease in the LCST upon copolymerisation with styrene from 
previously published results, and the effect of hydrophilic monomers increasing the 
LCST the combination of styrene in the PNIPAM backbone and NVP grafts may cancel 
each other. The fact the LCST is lower than 32 oC indicates the styrene has a bigger 
effect than NVP, which would be expected as the NVP within the polymer is separated 
from the collapsible PNIPAM chain, and the two chains can behave relatively 
independent of each other.   
Zhao et al. synthesised NVP-g-NIPAM and linear NVP-co-NIPAM polymers 
containing 20 wt% NIPAM and 80 wt% NVP. The graft copolymer has a LCST of 35.5 
oC, whilst the linear polymer did not exhibit a phase transition. The high hydrophilic 
content of NVP directly bonded to NIPAM prevents the chain collapse. In the graft 
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polymer the hydrophilic NVP backbone only increases the LCST by a few degrees, 
even though the proportion of NVP in the polymer is 4 times greater than NIPAM, as 
the distribution of the two monomers are separated from each other. This provides 
further evidence that the presence of hydrophilic or hydrophobic monomers do not 
greatly affect the LCST unless they exist in the same part of the polymer as PNIPAM, 
otherwise the PNIPAM can still collapse into globules. 
Solutions of NSN exhibit a degree of hysteresis when cooled down, as shown by 
turbidity. During heating, the solutions begin to go turbid around 26 oC, however when 
the solutions are cooled back down the turbidity begins to decrease around the LCST 
but the dramatic drop occurs in the region of 23 – 20 oC. This could be a result of intra-
chain interactions within NSN, although the globule aggregates may have separated 
above 23 oC, the chains are still crumpled coils. Wu et al. have shown that the crumpled 
coils formed in the first stage of the phase transition are stable for at least 44 hours, and 
therefore the balance between the hydrophobic effects of aggregations dominates over 
and hydrogen bonding between water until lower temperatures. Wu has also shown 
intra-chain hydrogen bonding in crumpled coils is maintained until lower temperatures 
than the LCST 264. Other groups have also observed hysteresis between the heating and 
cooling turbidity, but to a larger extent, where the hysteresis was 11 oC. 257 The 
temperature difference was a lot smaller in my results, as the full extent of intra-chain 
collapse may not have be observed in turbidity, and below a certain size the polymer 
chains would not have been observed. Alternatively the presence of NVP grafts could 
contribute to less stable crumpled coils compared with linear PNIPAM, due to less 
intra-chain hydrogen bonding.      
2.5.3 Conclusions on the LCST of NSN 
From the above results it is obvious that behaviour of NSN at the temperature when the 
phase transistion occurs is complex, and values can vary between experimental 
conditions and samples. There are a wealth of theories that offer explanations based on 
the data, however to fully understand the behaviour further work needs to be carried out 
on NSN. Accurate determination of the LCST requires an integrated use of techniques. 
Development of collagen I and NSN hybrid gels 
 
 
 
103 
DSC measurements, as well as NSN concentrations, to confirm the LCST of 24oC is 
accurate. Static and dynamic light scattering experiments on dilute solutions of NSN 
would allow determination of the mechanism involved in the phase transition. Whilst 
fluorescence probes within the backbone and the NVP grafts could show how the 
different chains in the polymer behave at the LCST. Rheology studies using NSN gels 
right down to the minimum gelation concentration would also be useful in exploring 
whether the high concentrations are causing the low temperature G’ and G” crossover. 
A phase transition temperature of 24 oC is suitable for a tissue engineering scaffold as 
the polymer will gelate at physiological temperature. The small degree of hysteresis in 
the cooling of the polymer is also advantageous, as it will allow the scaffolds to be 
manipulated during in-vitro experiments without collapse.  
2.5.4 NSN-collagen hybrid gel properties with blend 
The potential of the NSN-collagen hybrid gels as tuneable tissue engineering scaffolds, 
requires the properties of the gels to be easily altered by varying the composition. 
Syneresis measurements, mechanical testing and SEM imaging clearly show the 
composition does affect the properties of the resulting gels. Below 2.5 wt% NSN 
solutions are unable to form self-supporting gels, and are therefore unsuitable as cell 
scaffolds. By blending lower NSN concentrations with collagen, gels could be formed. 
Therefore blending the two materials is advantageous as a self-supporting gel can still 
be formed, that contains a low NSN concentration, as some cell scaffold applications 
may not be favourable to a high synthetic content, but still require its presence for its 
mechanical strength.  
The extent of syneresis in the gels is a result of the mechanism of gel formation. 
PNIPAM based hydrogels form by the aggregation of polymer globules held together 
by physical forces, including Van de Waals and hydrophobic effects. In the process of 
aggregation, water is expelled from the solutions and therefore the gel does not maintain 
the volume of the initial solution. Collagen gels however, are formed by the 
polymerisation of collagen molecules into fibrils and maintain their initial size in the 
absence of any cells. Yoshioka et al. synthesised bio-synthetic copolymers of NIPAM 
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and gelatine (43:57% respectively) that were not prone to syneresis when crosslinked. 
But when solutions of 2.2 wt% gelatine and 2.8 wt% PNIPAM were just mixed 
together, the opposite occurred265. Depending upon the blend, our hybrids of collagen 
and NSN display reduced syneresis compared with NSN alone, or no syneresis at all. 
However without crosslinking, gelatine is water soluble, and does not form gels in the 
same manner collagen solutions do, therefore Yoshioka’s results are not altogether 
surprising. Equilibrium of the NSN gels was not a fast process, the syneresis of NSN5 
gels continued for a period of 36 hours. Wu et al. demonstrated by measurements of the 
hydrodynamic radii of linear PNIPAM, that globule aggregation is slow at the LCST. 
Although globules formed quickly, shown by an initial decrease in Rh, the aggregation 
continued for at least the 3.4 hour period studied. Similarily Zhang et al. showed 
PNIPAM microgels are prone to syneresis during a 25 hour period 266,267.  
Blending NSN5 with 0.3 wt% collagen decreased the syneresis of the gel, where the 
effect increased with decreasing NSN concentration, and was almost entirely inhibited 
in Col-NSN0.25 gels. At low concentrations NSN cannot form gels, as the concentration 
of NSN globules is not high enough to sufficiently aggregate together. With a decrease 
in aggregation of the polymer globules, you would also expect a decrease in syneresis as 
the media is not being excluded from a continuous polymer gel phase. Furthermore 
when the concentrations of collagen and NSN are similar, the collagen fibrils within the 
gel may dominate the gelation process preventing the polymer globules from 
aggregating or even collapsing. The syneresis behaviour of Col-NSN2.5 and Col-NSN1.25 
compared with NSN suggests the presence of collagen may prevent the polymer chains 
from collapsing to the same extent as within NSN5. This behaviour was observed in 
other bio-synthetic gels, where the presence of biological polymers also reduced 
syneresis.  PNIPAM grafted HA hydrogels by Mortinsen et al. were less prone to 
syneresis when the PNIPAM grafts were smaller compared with larger grafts. They 
proposed less syneresis occurred in the hydrogels with small grafts, as ‘transient gels’ 
formed with minimal entanglements between PNIPAM chains. With larger grafts the 
hydrogels had more stability from a high number of entanglements243.  
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The effect of collagen during the phase transition of NSN can also be seen in 
rheological studies.  During time sweeps of the hybrid gels at 37 oC, both G’ and G’’ 
initially increase quickly in magnitude after the onset of gelation but then decrease. 
Where the decrease occurs quicker and more sharply in the hybrids with a lower NSN 
concentration. Whilst the shear measurements were performed the aggregating NSN and 
collagen separate from some of the water in the sample. Once the gel is no longer one 
continuous phase the measurements recorded by the rheometre are no longer 
representative of just the hybrid gel. In the hybrid gels with a lower concentration of 
NSN, the aggregation of the globules may occur faster as there are less entanglements 
with neighbouring chains, therefore a faster drop in the moduli of the gels. When the 
NSN concentration was similar to collagen, the hybrid gels behaved more like collagen, 
again suggesting that collagen gel can dominate over the NSN globule behaviour. The 
shear moduli of Col-NSN0.5 and Col-NSN0.25 did not decrease like the other hybrid 
blends, and the initial solution volume was maintained. Furthermore the moduli 
continued to steadily increase for the length of the run as the collagen exhibited strain-
stiffening behaviour268,269. Therefore if hybrid gels are made from higher concentrations 
of collagen, which match the NSN concentration, it may be possible to produce 
syneresis free gels with even larger shear moduli. 
Although the phase separation prevents accurate determination of the elastic properties 
of the gels, the overall effect of the blend on the mechanical properties can still be 
observed. In most bio-synthetic gels, the mechanical strength increases with inclusion of 
a synthetic polymer, and continues to increase with the proportion of the synthetic 
component235,249,250,270, but the hybrid gels are weaker than gels made purely from the 
synthetic polymer. Our results support these findings; there is a very obvious trend in 
the peak moduli values of the hybrid gels at the beginning of each run, when gelation 
first occurs. The stiffest gels contain the highest concentration of NSN, whilst hybrid 
gels of collagen and NSN have lower moduli than NSN only gels, but are stiffer than 
collagen only gels. At higher concentrations of NSN, there are more globules 
aggregating together, leading to a stiffer gel. From syneresis measurements, it is clear 
that the NSN globules would have continued to aggregate after the 30 minute 
measurement period, and the resulting gel would have contained a denser polymer 
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phase and therefore likely to have shear moduli at equilibrium even higher then the peak 
moduli values. This conclusion could be confirmed by performing shear, compression 
and tensile testing of the hybrids gels once they have fully formed and equilibrated. In 
contrast to these results are the mechanical properties of bio-synthetic IPN’s, which tend 
to be higher than the equivalent synthetic polymer network238,239, however these gels are 
pre-formed before use and therefore not injectable. Any cells encapsulated during 
crosslinking would not remain viable due to the harsh chemical environment. The bio-
synthetic collagen NSN gel is held together by physical crosslinks, crosslinking the 
collagen with gluteraldehyde could improve mechanical properties to greater than 
PNIPAM alone but this would limit the use of the gel. 
SEM microscopy offered further information on how the different hybrids formed gels 
dependent on NSN concentration. At the higher concentrations, the collagen fibrillar 
network was more open and porous compared with collagen alone, as the NSN 
aggregation is probably the dominant process in gelation, where the aggregation may 
interfere with the fibril formation of collagen. The collagen fibrils appear thickened, 
which is likely a result of NSN globules aggregating with them. In agreement with the 
syneresis experiments and rheology data, when the concentration of collagen and NSN 
are similar, the gel properties were dominated by collagen, and therefore the structure of 
the gel was similar to collagen only gels. Col-NSN0.5 and Col-NSN0.25 gels were 
composed of thinner fibrils and had less clumping of aggregates on the fibres, as shown 
by the SEM micrographs and fibre diametre measurements.  
These results imply the collagen fibrils and NSN globules in the hybrid gel are able to 
interact with one another. Collagen gels are hydrophilic, whilst the styrene monomers 
and isopropyl group of PNIPAM are hydrophobic and therefore unlikely to interact. 
However any exposed amides of the NIPAM monomer and the NVP graft chains are 
hydrophilic and can hydrogen bond with the collagen. This must be occurring to some 
degree, as by eye the gels appear homogenous in texture and SEM images do not appear 
to have two separate phases. Similarly, in bio-synthetic scaffolds made from 
polymerisation of PNIPAM in the presence of a collagen sponge, PNIPAM seemed coat 
and aggregate on the collagen fibrils. When the PNIPAM concentration was increased 
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the collagen network was less visible and the scaffold structure was dominated by 
PNIPAM.255. Fibronectin has also been shown to coat PNIPAM coated surfaces above 
the LCST271.  
Taking together the results from SEM, syneresis and rheology it appears the gel 
formation mechanisms and resulting properties of NSN and collagen hybrid gels are 
dominated by the concentration of NSN, but the aggregation of NSN globules can be 
hindered by the presence of collagen fibrils (Figure 2-15). Gelation of NSN occurs 
through chain collapse and aggregation, with significant reductions in volume. With 
low concentrations of NSN, the collagen network hinders aggregation and there is no 
change in gel volume. At higher concentrations of NSN, a collagen fibril network forms 
within the hydrogel, but the degree of syneresis increases with increasing NSN content. 
When the NSN concentration is below 1.25 wt% it appears the fibrillar collagen 
network that forms in the hybrids is similar to a collagen only gel, and the fibrillation 
mechanism of gel formation dominates over NSN aggregation. Whilst increasing the 
concentration of NSN has a big effect on the mechanical properties of the gels.  
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Figure 2-15 Mechanisms of gel formation in different hydrogel blends.  
Dotted lines represent initial solution volume. 
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2.6 Conclusion 
Hybrid gels of NSN and collagen have the potential to be used for a range of 
applications. At low NSN concentrations, below 1.25 wt%, the gels have low 
mechanical properties, but the syneresis is reduced and a range of porosities are 
observed. These gels are also more likely to be more cell adhesive as more of the 
collagen fibrils are exposed. These materials could be useful for soft tissue applications. 
Whilst the higher NSN concentration gels are tough, and potentially less cell adhesive 
and have potential as scaffolds for harder tissues such as bone and cartilage. Although 
other groups have demonstrated bio-synthetic gels which have variable mechanical 
properties based on the ratio of synthetic to natural polymer, these require chemical 
synthesis to amend the composition.  
The following chapter explores the use of these hybrid gels with low (col-NSN0.5) and 
high concentrations of NSN (col-NSN5) for two different tissue engineering challenges, 
to demonstrate the versatility of this hybrid system as a tissue scaffold for multiple 
applications.
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 Tissue Engineering Applications of Chapter 3
collagen I – NSN gels 
3.1 Introduction 
Tissue engineering of bone, skin and cartilage has already been well studied with 
commercial products and treatments available or undergoing clinical trials159. Although 
tissue engineering as a means to produce organs is also being explored for the kidney272, 
liver273 and pancreas, successes are often limited to the use of decellularised tissues274, 
or the transplant of donor tissue to make neo-organs, where the latter technique is 
commonly used to replace the bladder with sections from the bowel. The small number 
of tissue engineered products in use is largely due to the complex structure of organs 
and the need for a vascular supply for tissue survival, however research is well 
underway with solutions using 3D printing to create patterned tissues and microfluidics 
to introduce primitive vascular networks275,276. Many basic organ models have been 
developed for use as in-vitro research models to further our understanding of biological 
mechanisms of development and disease and as alternatives for toxicity screens277,278.  
Tissue engineered approaches have recently been used by a small number of research 
groups to develop artificial human lymph nodes (aLN) to study LN organogenesis and 
organ function during immune responses279,280. Although the initial events in embryonic 
development of the LN are well studied, the later events in the maturation of the dense 
stromal network and development of the compartmentalised structure are less well 
understood. Knock out mice models have been used to examine the role of signalling 
pathways and cytokines in organogenesis, but these often result in an absence of lymph 
nodes (LN) and secondary lymphoid tissues. An alternative approach to understand the 
maturation of the LN, is to develop in-vitro organ models and then examine the role of 
gene deficiency using knock out cell lines. ALN models could reduce the number of 
mice used in research. Furthermore an in-vitro model could be used to examine the 
formation of ectopic lymphoid tissue that occurs in many autoimmune diseases. For this 
tissue engineering challenge, hybrid gels with low NSN content will be used as 
scaffolds for developing an aLN. 
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In addition as cartilage repair has been a major goal in tissue engineering, the tougher 
hybrid blends that contain higher concentrations of NSN will also be investigated here, 
as potential injectable scaffolds for cartilage engineering, to demonstrate the versatility 
of the hybrid gels. The high mechanical properties of the high NSN gels lend 
themselves to this application, as the articulating surfaces in the hip and knee are under 
high mechanical strains. 
3.1.1 Lymph node function and structure 
In the peripheral tissue, immature dendritic cells, macrophages and neutrophils, survey 
for pathogens. Upon encounter with foreign material they become activated and mature 
into antigen presenting cells (APCs), migrating via the afferent lymphatics to the 
regional LNs, where they interact with B and T lymphocytes to initiate the adaptive 
immune response281,282. Due to the specificity of lymphocytes for a particular antigen, 
the probability of this interaction within the body is low; therefore the LN has a highly 
specialised structure to efficiently aid in the antigen presentation (Figure 3-1). From the 
afferent lymphatics, lymph passes into the sub-capsular sinuses that surround the 
lobules of the organ, and deeper in the centre of LN through transverse and medullary 
sinuses. Naive lymphocytes enter the LN through high endothelial vessels (HEV), 
specialised blood vessels, unique to lymphoid organs. Non-haematopoietic, stromal 
cells provide architecture and structural support within the LN, compartmentalising the 
lobules into B-cell follicles around the periphery of the organ and T-cell zones within 
the cortex. Fibroblastic reticular cells (FRCs) and follicular dendritic cells (FDCs) are 
two well-studied sub-sets, which define the follicles and the cortex respectively. Within 
the follicle, FDCs form an interconnected network, and within the cortex FRCs 
assemble around ECM fibrils creating conduit channels283–285. Initially the role of the 
stromal cells in the organ were largely ignored, the cells were believed to simply 
provide a structural framework within the LN.  
However this is not the case, the stromal networks provide a substratum for lymphocyte 
migration and directionality and produce gradients of soluble factors to guide the 
migration286. Chemokines CCL19 and CCL21, produced by FRCs guide the migration 
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Figure 3-1 Schematic of lymph node structure.  
The lymph node is divided up into distinct lobules (A), which are compartmentalised into B-cell 
follicles (B220 staining, green) (B) in the cortex and T-cell zones (CD3 staining, red) (C) within the 
medulla, by the underlying stromal networks. The lymphatic networks (Lyve1 staining, red) 
transport lymph into the organ, whilst naïve lymphocytes enter via the high endothelial venues 
(Meca79 staining, green) (C).  Networks of fibroblastic reticular cells are situated in the medulla 
supporting T-cell function and migration whilst follicular dendritic cells are located in the follicles. 
Around the periphery of the lobules, is a third stromal subset, the marginal reticular cells. The 
lymph node contains a network of collagen fibres (second harmonic generation, blue) (D) and is 
encased within a collagen capsule (E). Histology images courtesy of Anne Thuery and Amy Sawtell.  
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 of CCR7 expressing T-cells with APCs within the T-cell zone, whilst FDCs release 
CXCL13 to mediate the migration of CXCR5 B-cells into, and within the follicles287–
289. The survival and proliferation of naïve B and T cells are also regulated by FRCs and 
FDCs, which produce IL-7289 and BAFF290. As well as stimulating migration through 
chemotaxis, lymphocytes directly adhere and migrate along the stromal cell network. 
FRCs surrounding the HEVs have been demonstrated to control the entry of naïve 
lymphocytes into the LN and provide a substratum for both T and B-cell migration 
within the paracortex, through direct cell-cell adhesion291 mediated by FRC expression 
of VCAM-1 and ICAM-1292,293. At the follicle boundaries FRCs may also prevent naïve 
T-cell access. Similarly FDCs also express ICAM-1 and VCAM-1, and direct B-cell 
migration within the follicles291.  
Additionally to supporting lymphocyte survival the stromal networks contribute to 
antigen presentation. FDCs are involved in antigen presentation to naïve B-cells294,295, 
whilst FRCs can induce T-cell tolerance through presentation of peripheral tissue 
antigens296. The FRC conduit system of the LN283–285, carries low molecular weight 
molecules into the central cortex297, where dendritic cells associated with the conduits, 
extend thin processes into the channels and probe for soluble antigens within the 
lymph298. The LN contains relatively little ECM, most is enclosed within the FRC 
conduits282,297. Collagen I and III fibrils and collagen VI are enclosed as reticular fibres, 
covered with basement membrane proteins and FRCs104. The entire LN is enclosed in a 
collagen I and elastin capsule, from which several collagen III trabeculae extend into 
the organ.  
3.1.2 Development of lymphoid organs 
Through experiments using knock-out mice, deficient in key genes involved in 
secondary lymphoid tissue organogenesis, mechanisms involved in the development of 
the LN have been identified. Interactions between haematopoietic lymphoid tissue 
inducer cells (LTi), and stromal lymphoid tissue organiser cells (LTo) are fundamental 
for development299,300. LTi cells are derived from the fetal liver, whilst LTos are belived 
to be mesenchymal in origin as they express high levels of adhesion molecules, ICAM-
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1, VCAM-1 and MadCAM-1 and receptors PDGFR-α and -β301. The FDC networks of 
the LN are also derived from mesenchyme, as they express Mfge8 and PDGFRβ, and in 
the absence of PDGFRβ+, Peyer’s patches (PP), another secondary lymphoid tissue, do 
not contain FDC networks302. The developmental origins of FRCs are currently 
unknown, like FDCs it is expected they are derived from surrounding mesenchymal 
tissue. Research in mice has shown that LNs develop around embryonic day 10.5, via 
budding of endothelial cells from larger veins. Connective tissue then enters the sacs 
forming the earliest structure reminiscent of the organ. Initially retinoic acid from 
nearby developing nerve fibres is believed to stimulate the expression of CXCL13 on 
mesenchymal cells, recruiting pre- LTi to the site of the developing LN299. Signalling 
between LTis and mesenchymal cells through LTα1β2 and its receptor LTβR on the 
mesenchymal cells, results in maturation of the mesenchymal cells to LTo cells and a 
continual loop of adhesion molecule and chemokine expression by the LTos.  This 
consequently leads to further recruitment of LTi cells and increased LTα1β2 
signalling299,303. Chemokines CXCL13, CCL19 and CCL21 and adhesion molecules 
ICAM-1, VCAM-1 and MadCAM-1 aid in the recruitment and retention of infiltrating 
haematopoietic cells and the LN anlagen increases in size. This process is similar in all 
secondary lymphoid organs299,303.  
3.1.3 Maturation of FDC and FRC stromal networks 
As well as being involved in the development of secondary lymphoid organs, LT and 
another inflammatory cytokine, tumour necrosis factor (TNF) signalling are also 
important in the maturation and maintenance of the resulting stromal architecture. The 
initial mesenchymal cells present at the site of the developing LN express intermediate 
levels of ICAM-1 and VCAM-1. Without further LT signalling and the presence of LTi 
cells, the mesenchymal cells are unable to mature into ICAM-1high/VCAM-1high cells304. 
In LTβ or LTα knock out mice, where most LNs are absent, mesenteric LN can still 
found in some animals, but the structures of the resulting LTβ deficient LNs lack FDC 
networks305. Disruption of signalling through TNFR1, also results in LNs lacking 
FDCs305,306. In contrast to PPs, where FDC network maturation is dependent upon B-
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cell sources of LT and TNF, Expression of TNF from both B and T cells complement 
each other in the development of FDC networks in the LN307–309.  
Isolation of FRCs from LNs has been useful in determining the development of FRC 
based reticular networks. When cultured in-vitro, isolated murine FRCs co-cultured 
with the non-adherent cell fraction of the LN, can assemble into connected networks, 
with increasing expression of the FRC marker ER-TR7310. Similarly to FDC 
development, the FRC network formation is stimulated through TNF and LT signalling, 
where combined stimulation of TNFα and anti-LTβR produced the most extensive in-
vitro FRC network310. In contrast to experiments by Fletcher et al. who demonstrated 
LN FRC networks formed in the absence of B and T-cells311, the in-vitro FRC network 
formation could also be stimulated by co-culture with T-cells. However in the absence 
of B and T-cells during in-vivo FRC development, LT and TNF signalling from LTis 
and other cells can stimulate network formation. Ngo et al. also reported normal FRC 
development in the absence of B-cells312, and Coles et al. demonstrated natural killer 
cells are able promote stromal network formation in the absence of lymphocytes313. 
Taken together this indicates that although B and T-cells are a source of LT and TNF in 
murine LN development, unlike FDC development, their expression from a specific cell 
type in not necessary to form FRC networks. 
3.1.4 Current developments in modelling LN 
Modelling the LN has currently been explored by two approaches, which both use 
collagen based scaffolds seeded with murine stromal cell lines. Currently there have 
been no developments using human stromal cells. Suematsu et al. developed aLNs 
containing FRC stromal networks, distinct B and T cell zones and HEV like blood 
vessels by seeding the thymus derived stromal cell line TEL-2 into collagen sponges279. 
However these were not true in-vitro models, the collagen sponges were implanted in-
vivo, where stromal networks formed and lymphocytes migrated into the tissues. This 
does however highlight that a stroma – collagen system has potential to develop into 
lymphoid-like tissue given the right cues. A second aLN has been designed by seeding 
immortalised murine FRCs into a polyurethane - collagen scaffold. Within the 3D 
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scaffold the FRCs organised into a network, and expressed CCL21. Upon exposure to 
small fluid flows the network formation and CCL21 production increased280. Although 
these examples show progress is being made in producing models of the LN, only one is 
an in-vitro model that reduces the use of mice. Furthermore both models use 
immortalised cell lines, which may not fully recapitulate the behaviour of LN stromal 
networks.   
3.1.5 Articular Cartilage 
Articular cartilage, or hyaline cartilage is a smooth anisotropic connective tissue, found 
on the surface of articulating bones, which acts as a shock absorber and to reduce 
friction and wear whilst transferring loads over joints during movement. Lesions can 
form in cartilage following trauma, often caused by sporting injuries or through diseases 
of the joint. Without treatment the lesions can increase in size and progress towards 
osteoarthritis (OA). Osteoarthritis is most commonly found in joints that undergo high 
levels of articulation in everyday life, including but not limited to, the knee, hip, hands, 
feet and the back. It is the common joint disorder in the USA, effecting 10% of men and 
13% of women over the age of sixty in 2010314, with the incidence expected to increase 
as the population lives longer. When the protective cartilage layer of the joint is 
damaged, surrounding healthy cartilage can be worn away, the underlying bone 
becomes exposed and thickens and the surrounding tissues adapt to compensate for the 
instability caused. The joint becomes swollen, painful and inflamed. When the disease 
is severe, the inflammation and swelling can prevent motility in the joint and often the 
only route of treatment is through highly invasive total joint replacement (TJR). 
Treatment of cartilage lesions at an early stage could help to prevent the disease 
progression, and improve the quality of life for a patient.  
3.1.6 Structure and composition of articular cartilage 
Articular cartilage is an avascular tissue, with a low cell density, mainly composed of 
collagen II and proteoglycans (Figure 3-2). The structure of the ECM and cellular 
composition varies from the superficial zone at the cartilage surface, to the deep 
calcified regions at the bone surface, to aid the tissue function (Figure 3-3). In contrast 
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to most connective tissues cartilage contains collagen II, another fibril forming collagen 
with a similar structure to collagen I. Owing to its fibrilliar nature, collagen II is strong 
in tension, where the exact arrangement of the collagen II fibres within cartilage, 
confers the function of the tissue.  
The fibrils are thin, roughly 20 nm in diameter, and run parallel with the surface of the 
tissue within the superficial zone, therefore this region of the tissue has the highest 
tensile strength, which is necessary at the articulating surface315,316. In the middle zone 
collagen fibrils are wider in diameter and orientated in multiple directions to resist 
loading. Whilst in the deep zone, fibrils are at their widest, between 70 – 120 nm in 
diameter, to strengthen the integration into the bone317. In contrast to collagen I, 
collagen II has a higher content of hydroxyl lysine residues to aid in electrostatic 
interactions with the highly negatively charged proteoglycans also present in 
cartilage318. The collagen fibrils in cartilage are approximately 80-90% collagen II, but 
also contain collagen IX and XI319–321, which are believed to limit the size of fibrils 
during their assembly321. Proteoglycans are also present within cartilage, these are 
mechanically weak compared with collagen II; where their function within cartilage is 
to maintain a high water content. Aggrecan is a large 225-250 kDa proteoglycan, 
specific to cartilage. It contains GAG side chains, specifically chondroitin and keratan 
sulphate, bound to a HA core. The GAG side chains are organised into a bottle-brush 
arrangement around HA, caused by the repulsion of adjacent negative charges from 
carboxyl and phosphate functionality322,323. Each GAG side chain typically contains 100 
negatively charged groups, creating a large osmotic swelling pressure, and maintaining 
water within the tissue324.  
Compared with other connective tissues, cartilage has a very small population of cells. 
Chondrocytes are found singly or within aggregates or columns surrounded by a 
pericellular matrix (PCM), unique from the bulk ECM of cartilage, which may provide 
a protective environment for the cells, when the tissue is subjected to mechanical 
strains325. The PCM is predominately formed of collagen VI, and also contains decorin, 
aggrecan, HA and collagens type II and IX326. Like the ECM, the morphology and 
distribution of chondrocytes varies with tissue depth. In the superficial region, the cells  
Tissue engineering applications of hybrid gels 
 
 
118 
 
 
Figure 3-2 Distribution of chondrocytes and collagen within articular cartilage.  
Within the superficial zone at the articulating surface, chondrocytes are flattened and surrounded 
by thin, highly aligned collagen II fibrils. In the middle and deep zones, collagen II fibrils run in all 
directions to provide high compressive strength and aid the integration into the bone in the 
calcified region, which contains hypertrophic chondrocytes. Adapted from320,327     
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Figure 3-3 Extracellular matrix of articular cartilage. 
Predominately composed of collagen II fibrils, where the fibril diameter size is controlled by 
collagen IX and collagen XI (not shown) within the fibrils. Large aggregates of the cartilage specific 
GAG, Aggrecan, which is bound to hyaluronic acid maintain high volumes of water within the 
tissue. Adapted from320   
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are flattened and disc like, in the middle zone chondrocytes adopt a rounder 
morphology, and in the deep region, where cartilage integrates into the underlying bone, 
the chondrocytes are terminally differentiate and become hypertrophic, producing a 
collagen X rich matrix. Additionally they produce high levels of osteonectin, a matrix 
protein associated with calcification in bone formation328. 
3.1.7 Cartilage repair strategies 
Only small defects in cartilage, which extend down into the subchondral bone are able 
to undergo spontaneous healing. When the underlying bone is fractured a blood clot 
forms and is accompanied by the release of growth factors and migration of MSCs into 
the clot, which produce new ECM. However the newly formed cartilage is generally 
scar tissue, with characteristics of hyaline cartilage, that is much weaker than articular 
cartilage329. Current treatments for cartilage damage either focus upon providing pain 
relief through administration of non-steroidal anti-inflammatory drugs, COX2 inhibitors 
or debridement of the area to remove the damaged cartilage and surgical techniques to 
repair the damaged area. Micro-fracture into the underlying bone can promote MSC 
migration into the damaged area to restore the cartilage, but like the spontaneous repair 
seen in deep defects the cartilage formed is often weaker and does not provide long-
term repair. Autologous chondrocyte implantation (ACI) is also used to repair cartilage 
lesions and can be used for large and full thickness defects23,330. A small biopsy of 
healthy cartilage is taken from a non-weight bearing surface and the cells are expanded 
in culture. The expanded cells are then implanted into the defect and held in place with 
a sutured membrane, which is either synthetic (chondroguide) or harvested from healthy 
tibia periosteum from the individual. However the success of this technique to produce 
high quality hyaline cartilage is disputed, where the technique might be improved by 
combining chondrocytes or MSCs with a chondro-inductive cell scaffold.  
However given all the advances in cartilage repair therapies, over 70000 total knee 
replacements (TKR) are still carried out in England and Wales each year and the 
number is rising331. The distal end of the femur and proximal end of the tibia are cut and 
the articulating surface is replaced with metal and ultra high molecular poly-ethylene 
Tissue engineering applications of hybrid gels 
 
 
121 
(UHMWPE). The surgical procedure is very invasive, with high post-operative pain and 
long re-habitation periods. TKRs are expensive and can often require revision 
surgery332. The wear of the synthetic components is also linked to immune responses 
and loosening of the implanted components within the bone7. A new cartilage repair 
therapy would ideally aim to regenerative cartilage at the early stages of the disease to a 
similar strength as native hyaline cartilage and reduce the need for TKRs. Reducing the 
pain and discomfort to the patient as well as the direct and indirect economic costs. 
3.1.8 Tissue engineering cartilage  
In embryonic development, in-vivo culturing of MSCs in diffusion chambers, in-vivo 
cartilage repair from underlying bone and in-vitro chondrogenesis in cell pellets, 
cartilage development occurs by the condensation of MSCs into a dense structure and 
their differentiation into chondrocytes, characterised by the production of a 
cartilaginous matrix predominately containing collagen II and aggrecan26,44,48,329. In 
each situation, chondrogenic precursors maintain a rounded morphology making few 
cell-ECM and many cell – cell interactions. The compact arrangement of cells also 
results in a decrease in oxygen concentration. In-vitro differentiation experiments have 
demonstrated the importance of these factors upon chondrogenesis. When cultured in 
2D monolayers, isolated chondrocytes spread and attach, losing their in-vivo spherical 
morphology and they downregulate chondrocyte specific markers153. The in-vivo 
phenotype can however be recovered when the cell are encapsulated within non-
adhesive agarose gels that prevent cell spreading122. MSCs also favour chondrogenic 
differentiation when maintained in a rounded morphology as cell pellets or suspended in 
agarose gels, highlighting that although cell-cell contacts may play a role in the 
differentiation, given the appropriate biochemical cues and cell shape isolated MSCs 
can also undergo chondrogenesis333. In-vitro MSCs require the addition of TGF- β3 
alongside condensation to differentiate towards cartilage tissue48. With TGF-β3 
treatment, cell shape also effects the differential capacity of MSCs. MSCs allowed to 
spread out on large fibronectin coated surfaces produce early markers of myogenic 
differentiation, whilst MSCs cultured on small fibronectin islands, with little substrate 
attachment, remaining rounded, express chondrogenic markers334. Furthermore 
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disruption of the actin cytoskeleton of MSCs and chondrocytes leads to cells with a 
more rounded morphology in both 2D and 3D and an increase in GAG deposition and 
SOX9 expression335.   
The chondrogenic potential of MSCs in 3D also varies with the properties of the 
scaffold that is used. ADSCs encapsulated in alginate gels exhibit a rounded 
morphology, while within gelatine they can spread and proliferate. In gelatine, agarose 
and alginate, ADSCs are able to synthesise a cartilaginous matrix, but the matrix formed 
in gelatine is fibrocartilage like, whereas the matrix that ADSCs produce in alginate and 
agarose gels that did not allow cell attachment, more closely resembled native 
cartilage336. Hypoxia also plays a role in chondrogenesis. Within dense pellets of cells, 
the oxygen gradient is reduced and therefore this effect will also contribute to the 
differentiation of the cells. Compared with normoxia (20% oxygen), MSCs cultured in 
hypoxic conditions (1% oxygen) increase expression of collagen II, aggrecan and SOX9 
and produce a richer GAG matrix129,130.   
From the above it is clear that like MSC differentiation towards other cell types, 
chondrogenesis involves a complex interplay of physical and biochemical factors. 
Although condensation of precursors is essential in-vivo and in-vitro in cell pellets, it is 
not clear whether the direct cell- cell interactions or simply just the shape the cell adapts 
are crucial for the differentiation. As hypoxia also contributes, the condensation may 
also just serve to reduce the oxygen gradient. Therefore potential biomaterial based 
cartilage repair strategies could explore the chondrogenesis of isolated MSCs forced 
into rounded morphologies. The scaffold would need to contain minimal sites for cell 
adhesion and have good mechanical properties to withstand the high compressive and 
tensile forces in the articulating joint, hence a synthetic material could be favourable. 
Furthermore synthetic materials can be designed with controllable degradation rates. 
The quality of tissue engineered cartilage may be improved where the scaffold used 
degrades slowly, altering the ECM produced by MSCs or chondrocytes during 
remodelling.  
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3.2 Aims and synopsis 
Presented within this chapter are two possible applications of MSCs for tissue 
engineering and the potential of the collagen – NSN hybrid gels as MSC supporting 
tissue scaffolds.  
To model the entire LN is a major challenge and it is clear that the organogenesis of the 
LN is a complicated process. Therefore to reduce the complexity of the organ, 
haematopoetic cells are removed from this model. The model will focus upon the 
development of lymphoid stromal cell networks by differentiating MSCs with the 
soluble cues stromal cells receive from LTis during development. An in-vitro stromal 
cell type has been previously developed from ADSCs in 2D (unpublished data, B 
Glaysher). To move this into 3D, ADSCs will be encapsulated within the hybrid gels 
with inflammatory cytokines to develop a model of lymphoid mesenchyme. Low NSN 
content hydrogels will be used for this application, to achieve cell adhesion and 
spreading, whilst mimicking the mechanical properties of the organ. The reversibility of 
the lymphoid mesenchyme phenotype will also be examined, by performing MSC 
differentiation assays following cytokine induction. 
In contrast to the LN model, BM-MSCs will be used to investigate the potential of the 
hybrid gels for cartilage repair. BM-MSCs are an appropriate choice, as they may have 
improved chondrogenic potential compared with other MSC sources. Furthermore as 
they will be situated in close proximity to the damaged cartilage, they may be migrate 
into the gel and contribute to the tissue remodelling. High NSN content gels will be 
used for this application as they have higher bulk mechanical strength which will be 
essential for supporting the developing tissue under the forces of the knee joint. 
The aims of this chapter are: 
1. Characterisation of a lymphoid mesenchyme cell line derived from ADSCs, 
assessing the cell phenotype and reversibility 
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2. Translate a 2D model of lymphoid mesenchyme into 3D using low NSN content 
hybrid gels and spheroid models  
3. Investigate the chondrogenic capacity of BM-MSCs within high NSN content 
hybrid gels. 
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3.3 Methods 
3.3.1 Cell Culture 
ADSCs. Human ADSCs were purchased from Invitrogen (Stem Pro Human ADSCs). 
The cells had been sourced from lipoaspirate tissue and had been previously expanded 
for one passage prior to cryopreservation and shipping. ADSCs were expanded in 
culture in MesenPRO RS Medium (Invitrogen) for one passage and then cultured in 
basal media (DMEM supplemented with 10% FBS, 2mM L-glutamine and 1% p/s) for 
at least one passage prior to experimental use. Cells were passaged when they reached 
80-90% confluency, first washed in 1x PBS and incubated with TrypLE Express 
(Invitrogen) to detach cells, and re-seeded at 5000/cm2.  All experiments were carried 
out with cells between passage 3-5. Flow cytometry analysis performed by Invitrogen 
confirmed these cells were positive for CD29, CD44, CD73, CD90, CD105 and CD166 
and negative for CD14, CD31, CD45 and Lin1. 
BM-MSCs. Human BM-MSCs were isolated from the tibia plateau of the knee, 
obtained from arthroplasty procedures under ethics guidelines. The bone was broken up 
roughly into 2 cm2 pieces and cultured bone marrow side down in a 10 cm2 petri dish, 
covered with basal media (DMEM supplemented with 15% batch-tested FBS, 2mM L-
glutamine and 1% p/s). Cells were left to evade from the bone marrow for 7 days, after 
which the medium and bones were removed and 10 ml of fresh media was added. BM-
MSCs preferentially adhered to the treated TCP whilst contaminating red blood cells 
and lymphocytes were removed through washing and passaging. Cells were passaged 
(1:3) when 80-90% confluent and tested for mycoplasma. Cells from each donor were 
identified as kneeXXX, where XXX is a unique number given to each donor knee. All 
experiments were carried out with cells between passage 3-5. Basal media for all further 
cell culture consisted of DMEM supplemented with 10% batch-tested FBS, 2mM L-
glutamine and 1% p/s 
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3.3.2 Mycoplasma testing 
Cells for testing were seeded at a density of 5000/cm2 into a 24 well plate in basal 
media and left to adhere. Once the cells were spread the cell culture medium was 
removed and the cells were gently rinsed in 1x PBS. Adherent cells were fixed and 
permeabilised in methanol (200 µl/well) for 5 minutes and then rinsed three times in 1x 
PBS. The cells were incubated in DAPI (200 µl/well) for 5 minutes in the dark and then 
rinsed three times in 1x PBS. DAPI stained cells were viewed under UV illumination to 
assess for mycoplasma infection. Infected cells were discarded. 
3.3.3 Induction of lymphoid mesenchyme phenotype in ADSCs 
Basal media was supplemented with recombinant human interleukin-4 (IL-4) (50 ng/ml, 
Peprotech), recombinant murine tumour necrosis factor –α (TNF-α) (10 ng/ml) and anti-
human lymphotoxin-β receptor (anti-huLTβR) (100 ng/ml, Biogen IDEC, Inc ) for at 
least 2 days. Supplemented media was changed every 2-3 days. 
3.3.4 Flow cytometry 
Cell were detached as above, washed twice in FACS buffer (1x PBS containing 1% 
bovine serum albumin (BSA) and 5 mM ethylenediaminetetracetic acid (EDTA, 
Invitrogen) and then re-suspended 5– 20 x104 cells/well in a 96 welled V-bottomed 
plate (Fisher). 100 µl of FACS buffer containing primary antibodies (see Table 3-1) was 
added to each well, and the cells were incubated for 30 minutes at 4 oC. A further 100 µl 
of FACS buffer was added to each well and the plate centrifuged for 5 minutes at 450 
rpm. The plate was quickly flicked to remove the FACS buffer and the cells were 
washed a further two times in 200 µl FACS buffer. Secondary or conjugated antibodies 
were diluted in 100 µl of FACS buffer and incubated with cells for 30 minutes at 4 oC in 
the dark (Table 3-2). The cells were washed as before and suspended in 300 µl of FACS 
buffer in micro test tubes (Biorad) on ice and kept in the dark prior to analysis. Samples 
were analysed using a Cyan, flow cytometre, using unstained cells as controls, 
collecting at least 1 x105 events where possible. Data was analysed using Summit 
(Beckman Coulter) and FlowJo (Tree Star). 
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Antigen Conjugate Clone Supplier Dilution 
Hu ICAM-1 PE HA58 
 
Ebioscience 1/200 
Hu VCAM-1 biotin 1G11B1 
 
Abcam 1/200 
Hu Podoplanin purified D2-40 
 
Covance 1/200 
Hu CD11b FITC ICRF44 Ebioscience 1/200 
Hu CD14 FITC M5E2 BD Bioscience 1/200 
Hu CD29 purified HUTS-21 BD bioscience 1/200 
Hu CD31 FITC WM-59 Ebioscience 1/200 
Hu CD34 647 4H11 Ebioscience 1/200 
Hu CD44 FITC IM7 Ebioscience 1/200 
Hu CD45 PB H130 Ebioscience 1/200 
Hu CD73 purified AD2 BD Bioscience 1/200 
Hu CD90 PE-Cy5 ebio5E10 Ebioscience 1/200 
Hu CD105 purified 8N6 Ebioscience 1/200 
Hu CD106 purified STA Ebioscience 1/200 
Table 3-1 Primary Antibodies 
 
 
 
Specificity Conjugate Supplier Dilution 
Ms IgG (H+L) 488 Invitrogen 1/500 
Ms IgG (H+L) 594 Invitrogen 1/500 
Streptavidin 647 Invitrogen 1/500 
Table 3-2 Secondary Antibodies 
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3.3.5 Adipogenic differentiation 
Cells for differentiation were seeded confluent in 96-well plates (20000/cm2) in basal 
cell culture media and left to attach overnight. The following day the media was 
replaced with either adipogenic media (basal cell culture media supplemented with 1µM 
dexamethasone (Sigma Aldrich), 500µM 3-isobutyl-1-methylxanthine (IBMX, Sigma 
Aldrich), 1µg/ml insulin (Sigma Aldrich) and 100µM indomethacin (Sigma Aldrich)) or 
basal cell culture media for non-adipogenic controls. Media was replaced every 2-3 
days. 
3.3.6 Osteogenic differentiation 
Cells for differentiation were seeded confluent in 96-well plates (for pNPP and pico 
green assays) and 48-well plates (for staining) (20000/cm2) in basal cell culture media 
and left to attach overnight. The following day the media was replaced with either 
osteogenic media (basal cell culture media supplemented with 50µg/ml L-ascorbic acid-
2-phosphate (Sigma Aldrich), 5mM β-glycerophosphate (Sigma Aldrich) and 10nM 
dexamethasone) or basal cell culture media for non-osteogenic controls. Media was 
replaced every 2-3 days. 
3.3.7 Chondrogenic differentiation 
MSCs obtained from knees were centrifuged at 450 rpm for 5 minutes in universal tubes 
or 15ml Falcon tubes with basal media, to form pellets (240000 cells/pellet). The 
following day the media was replaced with either chondrogenic media (DMEM 
supplemented with 1% p/s, 2mM L-glut, 1% ITS+ liquid media supplement (Sigma 
Aldrich), 50µg/ml L-ascorbic acid-2-phosphate, 100nM dexamethasone, 40µg/ml L-
proline (Sigma Aldrich), and 10 ng/ml transforming growth factor-β3 (TGF-β3, 
Peprotech)) or basal chondrogenic media (DMEM supplemented with 1% p/s, 2mM L-
glut, 1% ITS+, 50µg/ml L-ascorbic acid-2-phosphate, 100nM dexamethasone and 
40µg/ml L-proline) for non-chondrogenic controls. Media was replaced every 2-3 days. 
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3.3.8 Oil Red O staining  
Media was removed from cells, which were then washed once in 1x PBS and fixed in 
4% PFA for 10 minutes for staining on days 1, 7,14 and 21 of adipogenic 
differentiation. Fixed cells were then washed once in dH2O and incubated for 5 minutes 
in 60% isopropanol (IPA). The cells were then stained in oil red O (0.3 % oil red O w/v 
in 60 ml 99% IPA and 40 ml dH2O, filtered before use, Sigma Aldrich) for 10 minutes 
and washed three times in dH2O. The cells were kept moist and imaged immediately to 
prevent lipids from bursting. The stain was eluted from the cells by incubating with 50 
µl of 99% IPA for 10 minutes and measuring the absorbance at 490 nm on a plate reader 
(Dynex Technologies MRX II). 
3.3.9 Alizarin Red staining 
Cells were washed once in 1x PBS and fixed in 4% PFA for 20 minutes for staining on 
days 1, 7,14 and 21 of osteogenic differentiation. Fixed cells were washed three times in 
PBS and stained in 40 mM alizarin red (in dH2O, pH 4.2, filtered before use, Sigma 
Aldrich) for 20 minutes. The cells were then washed in PBS three times and in tap water 
to remove non-specific staining. The plates were then air dried prior to imaging. 
3.3.10 Alkaline Phosphatase staining 
Cells were washed twice in PBS and incubated at room temperature for 2 minutes with 
alkaline phosphatase (ALP) reagent. (0.2 mg/ml naphtol AS-MX (Sigma Aldrich) 
dissolved in 1% N,N-dimethylformamide (DMF) and diluted in 0.1 M Tris(base) (pH 
9.2, Sigma Aldrich) containing 1 mg/ml Fast Red TR (Santa Cruz Biotechnology) 
sterile filtered before use). The ALP reagent was removed, and the cells then fixed in 
4% PFA for 5 minutes. Fixed cells were washed in PBS and dH2O and incubated in 1% 
silver nitrate solution on a light box for 30 minutes. Cells were washed three times in 
dH2O and incubated in 2.5% sodium thiosulphate (pH 9.2, Sigma Aldrich) for 5 
minutes. Prior to imaging the cells were washed twice in dH2O and stored in 20% 
glycerol (Sigma Aldrich).  
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3.3.11 pNPP and pico green assays 
Cells were washed in 0.2M carbonate buffer (2:1 v/v solution of 0.2M sodium 
carbonate (Sigma Aldrich) to 0.2M sodium bicarbonate (Sigma Aldrich), pH 10.2) and 
lysed with 150 µl triton lysis buffer (0.1% Triton-X (Fisher) in 0.2M carbonate buffer) 
accompanied by 3 freeze/thaw cycles (-80oC/21oC). Upon the last thaw the contents of 
the wells were pipetted up and down to fully lyse the cells and 50 µl of the lysate was 
transferred to either a 96-well plate for the para-Nitrophenylphosphate (pNPP) assay 
and to a black 96-well plate for the pico green assay. 
pNPP standards (0.5, 0.3, 0.2, 0.1, 0.05, 0.025, 0.0125 and 0 µM/ml in 0.2M carbonate 
buffer) were prepared by diluting pNPP stock solution (10mM, Sigma Aldrich). pNPP 
stock substrate (1 mg/ml pNPP (Sigma Aldrich) in 9ml 0.2 M carbonate buffer and 1ml 
100 mM magnesium chloride (Sigma Aldrich)) was diluted 1:2 v/v with dH2O and 50 µl 
was added to each sample well. Samples were incubated at 37 oC for up to 1 hour. The 
absorbance of each sample and standards was measured at 405 nm on a plate reader.  
Pico green standards (8, 4, 2, 1,0.5, 0.25 and 0 µg/ml in triton lysis buffer) were 
prepared from salmon sperm DNA stock (100 µg/ml in triton lysis buffer). 50 µl of pico 
green reagent (1:50 dilution of pico green (Invitrogen) in TE buffer (10mM tris 
(Invitrogen) and 1mM EDTA, pH 7.5)) was added to the standards and samples and the 
plates were incubated at room temperature in the dark for 5 minutes. The fluorescence 
was read on a plate reader (BMG Polarstar Optima for absorbance, fluorescence and 
luminescence) at 485 nm excitation and 538 nm emission. 
3.3.12 Culturing MSCs within hybrid gels 
Hybrid gels were prepared as previously described in section 2.3.12. MSCs were 
suspended within the gel on ice, prior to gelation. The cell suspension was pipetted with 
pre-chilled tips into either PEI coated metal rings, adhered to glass bottomed Petri 
dishes or into 96 well v-bottomed plates. 30 µl of gel-cell suspension was used for both 
molds. ADSCs were used in the aLN experiments and BM-MSCs were used for 
cartilage engineering. 
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3.3.13 ADSC Spheroids 
2% methylcellulose was prepared by autoclaving 6 g methylcellulose (4000 centipoises, 
Sigma Aldrich) in a Schott bottle, which was subsequently dissolved in 150 ml of pre-
warmed DMEM (60 oC) at room temperature. A further 100 ml of DMEM was added to 
solution, which was stirred for a further 2-3 hours until clear. The methylcellulose stock 
was centrifuged at 3600g for 2 hours to remove any insoluble particulate. The clear 
supernatant was stored at 4 oC until required. Spheroids of 6 x105 cells were formed by 
suspending ADSCs at 4 x 105/ml in 0.25 % methyl cellulose solution (diluted in basal 
media, from the 2% stock). 150 µl aliquots of the cell suspension were transferred into a 
non-adherent 96 well U-bottomed plate (Fisher). Overnight the cells aggregated into 
spheroids.  
3.3.14 ADSC viability in low NIPAM content gels 
Cells cultured within the hybrid gels were labelled using LIVE/DEAD 
viability/cytotoxity kit (Molecular probes). Each gel was covered in 2ml of live/dead 
staining solution (4uM Ethidium homodimer 1 and 2uM Calcein AM in sterile PBS) 
and incubated at 37 oC for 30 mins. 200ul of fresh staining solution was then added to 
each gel and the labelled cells were visualised by confocal microscopy. A dead cell 
control was created by treating a gel in 70% methanol prior to staining with the 
live/dead reagent. 
To release cells from collagen gels, the gels were carefully transferred to 1.5 ml 
eppendorfs using forceps and ground using a disposable pestle followed by incubation 
on a shaker at 37 oC in 0.4 mg/ml liberase RT (Roche) until the collagen had been 
digested (3 - 10 minutes). In hybrid gels, the liberase digestion was combined with 
cooling on ice and pipetting to break up the polymer. The isolated cells were 
centrifuged at 450 rpm for 5 minutes and washed twice in PBS, then resuspended in 
basal media in 6-well plates. 
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3.3.15 Imaging 
Cryosectioning. Hydrogels, spheroids and chondrogenic pellets for sectioning were 
first washed in 1x PBS, embedded in Optimal cutting temperature compound (OCT, 
TissueTek) and subsequently flash frozen in liquid nitrogen. Samples were stored at -20 
oC prior to sectioning. 10 µm sections were cut using a cryostat (Bright Instruments, 
OCT5000) at -20 oC and collected on poly-L-Lysine slides (Thermoscientific).     
Immunofluorescent staining of sections. Slides were left to defrost for a few minutes 
prior to fixing. All washing steps were in 1x PBS for 5 minutes, repeated 3 times. 
Sections were then fixed in 4% PFA for 10 minutes at room temperature then washed in 
1x PBS. For intracellular staining, the sections were the incubated with 0.1% Triton-X 
(in PBS) for 10 minutes and washed in PBS. Sections were blocked with blocking 
buffer (0.1% BSA in PBS with 10% serum (species secondary antibody raised in)) for 
30 minutes and then stained with primary or conjugated antibodies, diluted in blocking 
buffer overnight at 4 oC. Sections were then washed in PBS and incubated with 
secondary antibodies and DAPI diluted in blocking buffer (if required) for 1 hour at 
room temperature in the dark. Secondary antibody was washed from the sections with 
PBS. The sections were mounted with 5 µl of prolong gold (Life Technologies), No.1.5 
cover slips (Fisherbrand) and sealed with nail polish. 
For collagen II staining, antigen retrieval was performed prior to blocking. The sections 
were incubated with Proteinase K solution at 37 oC for 20 min, followed by a 10 minute 
incubation at room temperature. The sections were then washed as previously described.  
Proteinase K stock 20x : 16 mg proteinase K (5-15U/mg, Sigma Aldrich) in 10 ml TE 
buffer and 10 ml glycerol. TE buffer: 50 mM TrisBase, 1 mM EDTA, 0.5% Triton-X.   
Immunofluorescent staining of whole collagen gels. All wash steps were in 1x PBS to 
immerse the gel on a rocker, where the PBS was replaced every 10 minutes 3 times. 
Gels were fixed by removing culture media and incubating with 4% PFA at room 
temperature for 30 minutes, the gels were then washed in PBS. The cells were 
permeabilised with 0.1% Triton-X, where the Triton was replaced 4 times over an hour 
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and the gels were subsequently washed in PBS. Gels were then blocked and stained 
using the protocol for sections, with the secondary antibody incubations increased to 2 
hours. Following staining the gels were immersed in 2ml of 1x PBS to prevent drying. 
Slides and gels were imaged using a LSM710 invert confocal microscope (Zeiss). 
Hematoxylin and Eosin staining. Prior to cryosectioning whole gels were fixed in 
PFA as in the above method and then incubated in 15% sucrose solution for 3 hours and 
30% sucrose overnight. Gels were then sectioned as before. Slides were mounted in a 
staining rack and sequentially stained. 
1. Harris hematoxylin for 3-5 minutes 
2. Rinse in running water for 5 minutes 
3. Dip in 0.5% eosin 12 times (1.5g eosin in 95% ethanol) 
4. Dip in water until stain no longer streaks 
5. 10 dips in 50% ethanol 
6. 10 dips in 70% ethanol 
7. Submerge in 95% ethanol of 30 seconds 
8. Submerge in 100% ethanol for 1 minute 
Sections were then mounted with DPX mountant.  
3.3.16 cDNA synthesis and qPCR 
RNA extraction. RNA was extracted using the RNeasy Mini kit (Qiagen). For cells 
grown in a 2D monolayer 350 µl of RLT lysis buffer was added directly to cells.  
Spheroids were transferred using cut pipette tips to 1.5 ml eppendorfs and washed once 
in PBS. 150 µl of RLT lysis buffer was added to the tube and the spheroids 
disaggregated using a hand held motorised pestle. A further 200 µl of RLT lysis buffer 
was then added to the tube. For cell-laden hydrogels, cells were isolated as described in 
section 3.3.14. The isolated cells were centrifuged at 450 rpm for 5 minutes and washed 
twice in PBS. 350 µl of RLT lysis buffer was added to the cells.  
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For all culture methods the lysate was then pipetted up and down and transferred to a 
QIAshredder column (Qiagen) to homogenise. 350 µl of 70% ethanol was added to the 
homogenised lysate and mixed well by pipetting. The ethanol/lysate solution was 
transferred to a RNeasy spin column and centrifuged to load the RNA on the column. 
The column was washed in RW1 and RPE buffers and eluted using 30 µl of RNase free 
H2O. RNA concentration was measured using a nanodrop (Thermo Scientific. RNA was 
stored at – 80 oC until required. 
cDNA synthesis. Extracted RNA was used for cDNA synthesis using an EZ-First 
Strand cDNA synthesis kit (Geneflow). Each RNA sample was mixed with 1 µl 10x 
Oligo(dT) primer and DEPC treated water to a total volume of 10 µl and heated at 70 oC 
for 10 minutes to anneal primers. 2 µl Dithiothreitol (DTT) and 8 µl 2.5x RT reaction 
mix was added to each RNA sample and the solution mixed well. The samples were 
incubated on a thermal cycler (Labcycler, SensoQuest) for 60 minutes at 42 oC to 
synthesise the cDNA and for 15 minutes at 70 oC to stop the reaction. The newly 
synthesised cDNA was diluted to 100 µl and stored at -20 oC prior to polymerase chain 
reactions (PCR). cDNA was stored at -20 oC until required. 
Primer Design. Primers were previously designed using NCBI primer blast software 
(National centre for biotechnology, http://www.ncbi.nlm.nih.gov/). They were designed 
to span exon-exon boundaries and give products between 200-300 bp in size.  
Tissue engineering applications of hybrid gels 
 
 
135 
 
Gene Primer Sequence 
Hu GAPDH 
fwd TGCACCACCAACTGCTTAGC 
rev GGCATGGACTGTGGTCATGAG 
Hu ICAM-1 
fwd ATGGGCAGTCAACAGCTA 
rev GCAGCGTAGGGTAAGGTT 
Hu VCAM-1 
fwd GTCTCCAATCTGAGCAGCAA 
rev TGGGAAAAACAGAAAAGAGGTG 
Hu IL-4 R 
fwd TGAGTGGAGCCCCAGCACCAA 
rev ACAGGCAGACGGCCAGGATGA 
Table 3-3 Primer sequences 
 
qPCR. Real time PCR was performed on an ABI17300 prism system (Applied 
Biosystems) using a 96 well format. A master mix for each primer pair was made Table 
3-3), and each well contained 4 µl cDNA (or nuclease free H2O for controls), 12.5 µl 
sybr green PCR master mix (Applied Biosystems), 6.5 µl nuclease free water and 1 µl 
each of forward and reverse primer (Sigma Aldrich). For each gene of interest 3 
technical replicates were carried out. The plate was centrifuged for 2 minutes at 3600 
rpm prior to reaction. The qPCR thermal cycling programme consisted of 50 oC for 2 
minutes followed by 95 oC for 10 minutes, and 40 cycles of 95 oC for 15 seconds, 60 oC 
for 1 minute and 72 oC for 30 seconds, and then 72 oC for 5 minutes. The plate was then 
Tissue engineering applications of hybrid gels 
 
 
136 
held at 4 oC until removed from the cycler. The data was analysed using ABI17000 
software and normalised against GAPDH for changes in the cycle threshold.  
3.3.17 MTT viability assay 
Cells were seeded at the desired density within 30 µl hydrogels. 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma Aldrich) was dissolved in 1x PBS 
(5mg/ml) and sterile filtered. Spent medium was removed from cell-laden hydrogels 
and replaced with 100 µl of fresh basal medium and 25 µl of MTT solution. Samples 
were incubated for 4 hours at 37 oC. MTT containing medium was then removed from 
each well and replaced with 100 µl of cell lysis solution (0.1M HCl in 2-propanol) and 
the cells/cell-laden hydrogels were incubated at 4 oC until the scaffolds became 
translucent and did not contain any remaining purple formazan product. 50 µl of lysis 
solution from each well was transferred to a fresh 96-well plate and the absorbance of 
each was measured at 570 nm using an ELISA plate reader. Alternatively after 4 hours 
of incubation with MTT, the cell-laden hydrogels were flash frozen in liquid N2 in 
OCT, sectioned and immediately imaged to assess the distribution of formazan 
throughout the hydrogels.  
3.3.18 Alcian blue staining 
Sections were fixed as previously described in section 3.3.15, and briefly washed twice 
in dH2O. The sections were then incubated in 1% alcian blue stain (8GX alcian blue in 
dH2O, Sigma Aldrich) for 30 minutes. Excess stain was removed by brief washes in 
dH2O, and the slides were mounted with 20% glycerol. 
3.3.19 Statistics 
Significance was calculated using Kruskal-Wallis non-parametric analysis and Dunn’s 
post-test comparison of all pairs of samples. P values were calculated using GraphPad 
Prism software where, p > 0.05 = not significant, 0.01 – 0.05 = significant *, 0.001 – 
0.01 = very significant ** and  p <0.001 = extremely significant ***.   
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3.4 Results: In-vitro modelling of lymphoid mesenchyme 
3.4.1 Cytokine treatment induces a lymphoid mesenchyme phenotype in 2D 
ADSCs 
The supporting backbone of the LN is a series of stromal networks that are derived from 
the mesenchyme. To engineer the stromal networks of the LN I used a previously 
developed a protocol using inflammatory cytokines to induce a lymphoid phenotype in 
2D ADSCs (unpublished results, B Glaysher). Treatment of ADSCs with the cytokines 
IL-4, TNF-α and an agonistic antibody specific for the lymphotoxin β receptor, resulted 
in the upregulation of markers of lymphoid stroma, specifically adhesion molecules 
ICAM-1, VCAM-1 and podoplanin Figure 3-4). Anti- LTβR was used in place of 
LTα1β2 to provide signalling through LTβR, as it improved induction of the lymphoid 
mesenchyme phenotype (unpublished data). In ADSCs without the cytokine treatment 
34% of ASDC express ICAM-1, while less than 1% express VCAM-1 (Figure 3-4B), 
compared with 97% of post-treated ADSCs expressing ICAM-1, and 84% expressing 
both ICAM-1 and VCAM-1 Figure 3-4C). Podoplanin expression on the ADSCs varied 
among the population, but a large shift is observed in the MFI of the untreated ADSCs, 
which increases from 6.78 up to 32.05 when the ADSCs received cytokine induction 
Figure 3-4D). Treated only with IL-4, ADSCs upregulated VCAM-1, while the 
combination of TNF-α and anti-LTβR upregulated both ICAM-1 and VCAM-1 
expression, where over 99% of cells expressed ICAM-1, highlighting the combined 
treatment of all three factors is necessary for lymphoid mesenchyme induction Figure 
3-4E).  
3.4.2 Lymphoid mesenchyme induction reduces the differential capacity of 2D 
ADSCs  
ADSCs are able to differentiate into fat, bone and cartilage tissue when cultured in basal 
media supplemented with soluble factors. Following the cytokine induction of 2D 
ADSCs into lymphoid mesenchyme, the tri-lineage differential capacity of the cells may 
be reduced, therefore the effect of the cytokine treatment on ADSC adipogenesis and 
osteogenesis was examined. ADSCs were cultured for 21 days in adipogenic (AM), 
osteogenic (OM) or basal media (BM) supplemented with the lymphoid inducing  
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Figure 3-4: 2D ADSCs can be induced into a lymphoid mesenchyme phenotype upon 
induction with cytokines, as characterised by marker expression. 
ICAM-1 and VCAM-1 expression on unstained ADSCs (A), ADSCs without cytokine 
Induction express intermediate levels of lymphoid mesenchyme marker ICAM-1, whilst VCAM-1 
expression is negligible (B), When treated with IL-4, TNF-α and anti-LTβ R, ADSCs express high 
levels of both ICAM-1 and VCAM-1, indicating induction into a lymphoid mesenchyme phenotype. 
(C). Additionally with the cytokine treatment podoplanin expression also increases 
on ADSCs (D). Numbers indicate MFI of unstained ADSCs (red), untreated ADSCs (green) and 
cytokine treated ADSCs (blue). When treated with either IL-4 (E) or TNF- α and anti-LTβR (F) the 
induction of the phenotype shown by ICAM-1 and VCAM-1 expression is reduced, indicating all 3 
factors are required for efficient induction. 
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cytokines. ADSCs without cytokine treatment were able to differentiate into adipocytes, 
shown by Oil Red O (ORO) staining of lipids forming in the cells (Figure 3-5A). There 
was no spontaneous differentiation of untreated or cytokine treated ADSCs cultured in 
BM. Adipogenesis was inhibited in ADSCs treated with cytokines. The effect was 
quantified by measuring the ORO stain eluted from the lipids with iso-propyl alcohol. 
In the presence of cytokines, adipogenesis was significantly reduced after 14 days of 
differentiation, compared with adipogenic controls, the ORO concentration was roughly 
equal to, or lower than ADSCs cultured in basal media (Figure 3-5). Alkaline 
phosphatase (ALP), an enzyme produced by osteo-progenitors, was measured to 
quantify osteogenesis of the ADSCs. In the presence of ALP, pNPP is hydrolysed to 
pNP, a coloured substrate that can be quantified spectrophotometrically. By measuring 
the DNA content with pico green, the pNP concentration is then normalised against the 
cell number. Control ADSCs in OM, underwent osteogenesis as expected, with 
significantly high levels of ALP activity, and cell proliferation compared with control 
ADSCs in BM (Figure 3-6). ADSCs in BM supplemented with cytokines, had no 
significant difference in pNP concentration or cell number compared with control 
ADSCs in BM. In osteogenic conditions, ADSCs treated with cytokines displayed low 
ALP activity over the entire 21 day period, which was comparable to basal conditions. 
However, in OM the cytokine treated ADSCs did undergo an increase in cell number 
comparable to control ADSCs in OM. When normalised to DNA content, ALP was 
significantly reduced in cytokine treated ADSCs compared with controls.  
 As ADSCs have previously been shown to have reduced adipogenic capacity when 
supplemented with TNF-α and anti-LTβR337, the effect of IL-4 alone on adipogenesis 
and osteogenesis was also examined. Supplemented only with IL-4, ADSCs were able 
to differentiate towards an adipogenic lineage comparable to untreated ADSCs. Both 
treated and untreated ADSCs followed a similar differentiation process, with small 
lipids forming within a few cells after 7 days of treatment, then an increase in lipid 
density at day 14 and again at day 21 (Figure 3-7A). By day 21 the entire cell 
population of treated and untreated ADSCs positively stained for ORO. Mature 
adipocytes are also observed in both cultures at day 21, characterised by the presence of 
cells with a single large lipid rather than multiple smaller ones. Elution of ORO stain 
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Figure 3-5 Lymphoid mesenchyme induction inhibits 2D ADSC adiogenesis. 
ADSCs cultured within basal media (BM) or adipogenic media (AM) with or without cytokine 
induction over 21 days. ADSCs treated with cytokines were unable to differentiate towards 
adipocytes, shown by an absence of Oil Red O staining of lipids (scale bars are 200 µm) (A). Total 
Oil Red O stain was eluted from adipogenic cultures with IPA for quantification (n=6) (B).  
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Figure 3-6: Lymphoid mesenchyme induction inhibits 2D ADSC osteogenesis. 
ADSCs cultured within basal media (BM) or osteogenic media (OM) with or without cytokine 
induction over 21 days. ADSCs treated with cytokines also had reduced osteogenic potential as 
shown by alkaline phosphatase expression, however proliferation was unaffected. Quantified by 
pNPP hydrolysis to pNP by alkaline phosphatase (A), Pico green DNA quantification (B) and pNP 
normalised to DNA content (C). Results are mean ± SEM (n=6) 
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Figure 3-7: IL-4 lymphoid mesenchyme induction of 2D ADSCs does not affect adipogenesis 
ADSCs cultured within basal media (BM) or  adipogenic media (AM) with or without IL-4 
treatment over 21 days. The adipogenic capacity of ADSCs treated with IL-4 was unaffected by IL-
4 as shown by Oil Red O staining. (scale bars are 200 µm) (A). Total Oil Red O stain was eluted 
from adipogenic cultures with IPA for quantification (n=6) (B).  
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Figure 3-8: IL-4 lymphoid mesenchyme induction of 2D ADSCs does not affect mineralisation 
ADSCs cultured within basal media or osteogenic media with or without IL-4 treatment over 21 
days. The osteogenic capacity of the ADSCs was unaffected by Il-4 treatment, as shown by Alizarin 
red staining of mineralization (scale bars are 200 µm).  
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Figure 3-9: IL-4 lymphoid mesenchyme induction of 2D ADSCs affects ALP activity but not cell 
proliferation 
ADSCs cultured within basal media (BM) or osteogenic media (OM) with or without IL-4 
treatment over 21 days.  ADSCs treated with IL-4 had reduced alkaline phosphatase expression, 
but proliferation was unaffected. Quantified by pNPP hydrolysis to pNP by alkaline phosphatase 
(A), Pico green DNA quantification (B) and pNP normalised to DNA content (C). Results are mean 
± SEM (n=6). 
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showed no significant difference between adipogenesis of the treated and untreated 
ADSCs at any time point (Figure 3-7B).  
Similarly to full cytokine treatment, 2D ADSCs in OM, supplemented with IL-4, had 
basal levels of ALP expression over the 21 day differentiation period, but displayed a 
similar rate of  proliferation as untreated ADSCs in OM. DNA content increased up to 
day 14 and began to fall at day 21 in the osteogenic conditions (Figure 3-9).To further 
explore the effect of the IL-4 treatment on differentiation, calcium deposition in the 
ECM of the osteogenically differentiating ADSCs was examined by staining with 
Alizarin red. In OM, ADSCs without treatment produced a calcium rich matrix 
following 14 days of differentiation, which further intensifies by day 21 (Figure 3-8). 
ADSCs in BM have low levels of staining, which is similar between days 7 – 21. As a 
result of the high cell density used in the experiment, the confluent monolayer of 
ADSCs in BM detached and contracted at the later time points. Alizarin red staining of 
IL-4 treated ADSCs in OM is similar to untreated ADSCs in OM at each time point, 
where the staining also intensified with time in culture.  
3.4.3 The lymphoid mesenchyme phenotype is reversible 
To examine the reversibility and longevity of the cytokine treatment on 2D ADSC 
lymphoid mesenchyme induction, the cells were pre-treated with IL-4, TNF-α and anti-
LTβR, or IL-4, TNF-α and anti-LTβR and then supplemented with AM or OM with or 
without continued treatment for 14 days (Figure 3-10A). ADSCs cultured in AM or OM 
where the cytokine treatment was removed at the beginning of the 14 days of 
differentiation, were able to differentiate comparably to untreated controls (Figure 
3-10,Figure 3-11). ADSCs which continued to receive cytokine treatment during 
differentiation, differentiated into lipid filled cells, when only treated with IL-4 
similarly to the previous experiment, whilst adipogenesis was inhibited in TNF-α and 
anti-LTβR, and IL-4, TNF-α and anti-LTβR treated ADSCs (Figure 3-10B). In the 
osteogenic samples, alizarin red staining was replaced with alkaline phosphatase and 
von Kossa staining, to examine both ALP activity and mineralisation simultaneously.  
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Figure 3-10: Priming of 2D ADSCs with lymphoid mesenchyme inducing cytokines does not affect 
adipogenesis. 
Experimental scheme of ADSCs differentiation following pretreatment with cytokines (A). ADSCs 
were initially primed for 5 days with or without cytokine treatment, and subsequently seeded 
confluent for differentiation. Cytokine treatment was stopped prior to differentiation or continued 
throughout. The lymphoid mesenchyme phenotype is reversible as shown by adipogenically 
differentiating ADSCs, following removal of cytokines.  Oil Red O staining of ADSCs after 14 days 
differentiation (scale bars are 200 µm) (B).  
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Following 14 days of differentiation in OM, ALP activity, as measured by pNP, was not 
significantly different between ADSCs where cytokine treatment was discontinued prior 
to differentiation and untreated ADSCs (Figure 3-11A). Cells that received continued 
cytokine treatment during osteogenic differentiation had reduced ALP activity, although 
this was not significant after 14 days. Surprisingly, when treatment was continued with 
the combined treatment of all three factors, ALP activity was comparable to control 
ADSCs in OM. Positive alkaline phosphatase staining was observed in all ADSC 
conditions in OM, when cytokine treatment was removed at the start of differentiation 
(Figure 3-11B). In the continued presence of cytokines, staining decreased in the 
presence of IL-4 or TNF-α/anti-LTβR, but was absent when all three were used. In 
comparison with the previous osteogenic results and the ALP staining in this 
experiment, where ALP decreases when all three cytokines are used, the increase seen 
in ALP activity by pNP when treatment was continued in this experiment may be an 
anomaly and requires a repeat experiment to confirm. A small number of von Kossa 
stained mineralised nodules were however present in all osteogenic conditions, 
including the continued treatment of ADSCs with IL-4, TNF-α and anti-LTβR. In OM, 
cell proliferation was similar between control ADSCs and ADSCs without continued 
cytokine treatment. ADSCs that received continued cytokine treatment were less 
proliferative than control ADSCs and ADSCs with continued treatment, but the 
difference was not significant and proliferation remained higher than ADSCs in BM. 
To further examine the induced lymphoid mesenchyme phenotype of ADSCs following 
cytokine treatment and differentiation, flow cytometry analysis of the stromal markers 
ICAM-1 and VCAM-1 was performed on ADSCs with and without continued 
treatment. Compared with ADSCs maintained in BM, adipogenically differentiated 
ADSCs appeared as two populations when gated on side scatter (SS) and forward 
scatter (FS) (Figure 3-12A). Both populations contained cells of a similar size, but a 
second population of ADSCs with a larger SS was present in the adipogenically 
differentiated cells. These populations are referred to as SSmid and SShigh, making up 79 
and 21% of the gated cells respectively. When the cytokine treatment is removed a 
similar profile is seen in the cell population, indicating the cells are differentiating, 
however in the continued presence of TNF-α/anti-LTβR or all 3 factors during  
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Figure 3-11 Priming of 2D ADSCs with lymphoid mesenchyme inducing cytokines does not affect 
osteogenesis. 
ADSCs were initially primed for 5 days with or without cytokine treatment, and subsequently 
seeded confluent for differentiation. Cytokine treatment was stopped prior to differentiation or 
continued throughout. The lymphoid mesenchyme phenotype is reversible as shown by 
osteogenically differentiating ADSCs, following removal of cytokines. Alkaline phosphatase 
expression of ADSCs following 14 days differentiation (A), pNP production by alkaline 
phosphatase, Pico green DNA quantification and pNP normalised to DNA content. Results are 
mean ± SEM (n=6). Reversal of the phenotype also confirmed through alkaline phosphatase and 
Von Kossa stain of control ADSCs and ADSCs in OM with and without continued treatment (scale 
bars are 200 µm) (B).  
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Figure 3-12 Expression of lymphoid mesenchyme markers ICAM-1 and VCAM-1 decreases in 
adipogenic 2D ADSCs  
Expression of stromal markers ICAM-1 and VCAM-1 in control ADSCs (A) A second SShigh 
population of cells was present in cells differentiated in adipogenic media (AM). Following 
adipogenic differentiation (in the absence of cytokines) ICAM-1 and VCAM-1 expression was lower 
in AM compared with ADSCs cultured in basal media (BM). Analysis of ICAM-1 and VCAM-1 
expression in adipogenically differentiating cells with or without continued cytokine induction 
following 5 days of priming (B).  Following the removal of cytokines SSmid and SShigh populations of 
ADSCs were present with low ICAM-1 and VCAM-1 expression indicating reversal of the 
lymphoid phenotype. Where cytokine treatment continued, the SShigh population was low, and 
ADSCs expressed ICAM-1 and VCAM-1 as expected based on the cytokine induction mix used.   
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adipogenesis, the SShigh population decreased to 9 %. In un-supplemented BM, ADSCs 
express low levels of ICAM-1 (8.36%) and VCAM-1  (13.3%), which fall to 0.24% and 
10.29% respectively in AM and show little variation between SSmid and SShigh 
populations (Figure 3-12B). ADSCs in AM with removed cytokines also have 
negligible ICAM-1 expression. VCAM-1 expression is higher than the control ADSCs, 
and is higher in the SShigh population. In the continued presence of cytokines, the 
proportion of double positive ICAM-1+ VCAM-1+ expressing cells approaches that of 
treated cells in BM. Supplemented only with IL-4, ADSCs express low levels of ICAM-
1, and intermediate levels of VCAM-1, where the VCAM-1 expression is lower in the 
more adipogenic SShigh cells. In the presence of TNF-α/anti-LTβR there is an increase in 
double positive cells, and a large increase in ICAM-1 expressing cells in both SS 
populations. Again the combined effect of IL-4, TNF-α and anti-LTβR is highlighted, as 
the ADSCs supplemented with all three factors have the highest proportion of double 
positive cells at 66.49% for SSmid and 84.25% and for SShigh.     
3.4.4 Development of 3D models of lymphoid stroma 
To move the lymphoid stromal model into 3D, ADSCs were encapsulated within 
collagen or hybrid gels. Collagen containing a suspension of ADSCs, prior to its 
gelation, forms gels with a uniform distribution of cells, and takes the shape of the 
parent solution. Over 24 hours ADSCs within the gel spread out and attach to the 
collagen matrix, forming a 3D network of cells (Figure 3-13A). The rings used as 
moulds were coated with a combination of polyethylene imine and glutaraldehyde prior 
to adding the collagen solution; to promote crosslinking of the gel to the mould and to 
reduce any cell mediated contraction. Following 5 days of culture the ADSC containing 
gels were fixed and stained with phalloidin, to identify the actin cytoskeleton and 
morphology of the cells and DAPI. Gels were imaged used a confocal microscope, 
where different planes throughout the gel could be visualised. Collagen gels seeded with 
a high density of ADSCs (5x106 cells/ml) were noticeably pulled apart by the cells 
(Figure 3-13B). An optimal seeding density of 2x106 cells/ml was chosen for creating 
stromal models, as cellular networks formed at this density, and there was minimal cell 
contraction. The top surface of the gels consistently contained a higher density of cells  
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Figure 3-13 Development of 3D ADSC stromal networks in collagen gels.  
ADSCs were suspended in liquid collagen and moulded into PEI-glutaldehyde coated washers. 
Overnight the cells spread out and attach to the gel forming networks (A). Immunofluorescent 
imaging was obtained using a confocal microscope, where images were taken at different depths 
throughout the gel (B). 2D plane showing collagen contraction by high densities of ADSCs (C) scale 
bars are 170 µm. ADSC networks (2 mil cell/ ml) in collagen gels with and without cytokines 
treatments (D). 3D projections are overlays of combined Z-plane images. Representative images of 
2D Z-planes at the gel surface and within the bulk of the gel.  3D projections, scale 100 µm and 2D 
planes, scale bars are 80 µm. 
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compared with the distribution of cells in the centre (Figure 3-13C), which is probably 
the result of increased cell proliferation at the gel/media interface where there is 
increased nutrient and oxygen concentration in comparison to the bulk of the gels. To 
induce the stromal phenotype in 3D, the collagen gels containing ADSCs were covered 
in BM or BM supplemented with IL-4, TNF-alpha and anti-LTβR and cultured for 5 
days. Each gel was briefly washed in PBS prior to and after fixing. Over a 30 min wash, 
the gels turned from pink to white as the media was exchanged with PBS, indicating the 
gels are media permeable. In both treated and untreated conditions the ADSCs spread 
out within the gels to form networks. The morphology of the ADSCs varied in 3D, 
where untreated cells were wider and had fibroblastic and cuboidal morphologies, 
containing organised actin stress fibres running perpendicularly with the widest part of 
the cell, while the treated cells were very thin and elongated compared with untreated 
cells. They contained several processes at their extremities, and also had aligned actin 
fibres within the extensions. In both the treated and untreated samples, the ADSCs 
seemed to have a finer and elongated morphology in the surfaces of the gels. 
 At the seeding density of 2 x106 cells/ml, over 5 days of culture, the collagen gels were 
still prone to contraction. Therefore the collagen - NSN gels with mechanical properties 
at the lower end of the spectrum were examined as an alternative to collagen. Four 
different blends were examined, which each contained 0.3 wt% collagen while the NSN 
concentration varied between 0.25 – 1.25 wt %. The addition of NSN to the collagen 
gels resulted in an increase in opacity, however at these lower concentrations at least 
100 µm depth of the gels could be imaged by confocal microscopy. To initially 
demonstrate the potential of the hybrid gels as cell scaffolds, their biocompatibility was 
examined by looking at cell viability. In all four blends of the hybrid gels, ADSCs were 
able to spread out within the gels and form networks. Live-dead staining showed few 
dead cells, and viable cells with fibroblastic-like morphologies in all gels after 5 days of 
culture (Figure 3-14). Following 5 days culture in 3D, the ADSCs could also be 
released from the gels and cultured back in 2D on TCP (Figure 3-15). The cells were 
released using a combination of liberase enzyme digestion at 37 oC, to break up the 
collagen fibrils and cooling and disruption of the gels by pipetting to break up the 
aggregated hydrogel particles. A larger number of cells were released from the collagen  
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Figure 3-14 ADSCs encapsulated within col-NSN hydrogels are viable. 
Live-dead staining of ADSCs in collagen and col-NSN gels. Representative 2D images taken in the 
bulk of the gels. Calcien-am live cells (green) and ethidium homodimer-1 dead cell (red). Cells were 
treated with MeOH as a negative control. 
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Figure 3-15: ADSCs cultured within the hybrid gels can be released and re-plated as 2D 
monolayers. 
Hybrid gels digested enzymatically with liberase and cooled on ice to release cells. Scale bars are 
200 µm. 
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Figure 3-16: Hybrid gels do not release cytotoxic products into cell culture media.  
ADSC outgrowth from collagen and hybrid gels into TCP regions surrounding the gels . Scale bars 
are 100 µm. 
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only gels, as the hybrids could not be fully disaggregated. However cells could be 
removed from the hybrids and adhere and grow in 2D culture in the same manner. After 
overnight culture of the cells released from the hybrids in 2D, there were no obvious 
dead cells floating within the media, indicating the lower number of cells was due to 
problems in cell release rather than cell death caused by the hybrid scaffold. ADSCs can 
also be seen growing out of the hybrid gels onto the surrounding TCP from the hybrid 
gels, indicating the hydrogels are not releasing anything cytotoxic into the media 
(Figure 3-16). To visualise the ADSC network within the hybrid gels in more detail, the 
gels were fixed in PFA, subjected to sucrose gradient and cryo-sectioned. ADSCs 
within collagen gels had spread out and had fibroblastic morphologies, appearing to 
align with collagen fibrils to form a dense tissue (Figure 3-17). In col-NSN1.25, the 
ADSC density appeared reduced compared with collagen and the cells were fine and 
spread with an array of morphologies from fibroblastic to stellate. While in col-NSN0.5 
the cells populated the gel, almost as well as collagen and had similar fine and delicate 
morphologies, with several processes extended from the main cell body, similarly to the 
cytokine induced ADSCs in collagen. 
To assess whether ADSCs were able to migrate within the gels, and the effect of the 
NSN content on cell migration, different blends of gels were cast on top of a transwell 
membrane. GFP expressing HT1080 cells were then seeded onto the surface of the gels. 
HT1080s are a human cell line, derived from fibrosarcoma, they were used as they are a 
robust and proliferative cell type and therefore their migratory capacity would be more 
profound compared with the ADSCs. The media within the bottom of the well 
contained 20% FBS as a chemo-attractant whilst the media within the transwell did not 
contain any serum. The gels were left for 7 days and then imaged throughout using two-
photon imaging to examine how well the cells could migrate into each blend. Images of 
the cells in random z-planes of each the gel were then measured using velocity software 
to determine the average cell depth in each gel (Figure 3-18A). Images from the surface 
of each gel show that as the concentration of NSN within each gel increases, the cell 
distribution is less uniform across the gel surface. This difference could be due to cell 
proliferation. In the collagen gels and hybrids with low NSN concentration, the cells 
may be more proliferative due to the increased adhesion to the scaffold and 2D like  
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Figure 3-17 ADSC networks and cell morphologies in hybrid gels are affected by gel composition.   
Hematoxylin and eosin stained sections of ADSCs encapsulated within collagen, col-NSN1.25 and 
col-NSN0.5 hybrid gels. In collagen gels ADSCs form a dense layer at the surface of the gel (thick 
arrow). Within col-NSN0.5 the cells adopt a range of morphologies due to the accessible collagen 
fibrils for adhesion. Both stellate, with multiple processes (marked s) and fibrblastic (marker f). 
This is also observed in the col-NSN1.25 gels. Thin arrows indicate the presence of thin, elongated 
processes from the cells. Top row scale 200 µm, bottom row 50 µm. 
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Figure 3-18 HT1080s invasion into collagen and hybrid gels is affected by hydrogel composition. 
HT1080s are able to migrate within all hybrid gels comparably to collagen, however the depth of 
invasion is reduced in col-NSN1.25 gels.  Combined Z-plane images of GFP HT1080s on the surface 
and within collagen and.. HT1080s were seeded within gels on top of transwell membranes, the 
bottom well contained 20% FBS as a chemoattractant (A) scale bars are 100 µm. Side view of 
HT1080s invading into gels, red line indicates the transwell membrane. Measured invasion depths 
of ADSCs in different gels (B). Results are mean ± SEM (n=3 gels, where at least 10 depth profiles 
were measured). 
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adhesions compared with the higher NSN gels. The depth profiles of the cells into each 
gels, was similar for the collagen gels, col-NSN0.5 and col-NSN0.25, which again is 
probably a factor of increased cell attachment to collagen when there is less NSN 
present (Figure 3-18B). The migratory capacity of the cells in col-NSN1.25 was 
significantly lower than the collagen control. Together these results show ADSC 
networks can be formed in 3D in collagen and collagen – NSN blends, where the 
presence of NSN within the scaffold alters cellular morphology and migratory capacity 
as its concentration increases. This may be the result of a reduction of exposed cell 
adhesion ligands on the collagen fibrils, as they become coated with NSN globules, as 
well as the NSN globules forcing the collagen fibrils into a more open network and 
increasing the spacing between cell adhesive ligands.  
3.4.5 Effect of 3D environment upon lymphoid mesenchyme phenotype 
As 3D engineered tissues are more representative of natural tissues than 2D cell culture, 
the effect of the cytokine induction of ADSCs into lymphoid mesenchyme may vary 
between ADSCs maintained in 2D and 3D. As well as using the hybrid gels as a 
scaffold to develop 3D models of lymphoid mesenchyme, cell spheroids were also 
explored as an alternative 3D model of lymphoid mesenchyme. Using both models 
allowed for comparison of a dense scaffold free 3D environment with the open ADSC 
networks formed in the hybrid gels. 3D ADSC were formed from 60,000 ADSCs 
suspended in methyl cellulose in non-adherent U-bottomed plates. Over 24 hours the 
cells formed a single multi-cell aggregate at the bottom of the well (Figure 3-19B). Over 
2-3 days the aggregates compacted and became more spheroidal, with tightly packed 
cells. At the time of spheroid formation the methyl cellulose BM was either 
supplemented with cytokines to induce differentiation of the cells into lymphoid 
mesenchyme or left untreated.  
After 5 days of culture the spheroids were washed in PBS and disaggregated using a 
motorised pestle and RNA was extracted to examine the change in ICAM-1 and 
VCAM-1 expression upon lymphoid mesenchyme induction in 3D. ADSCs treated with  
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Figure 3-19 Analysis of spheroids as 3D models of lymphoid stroma. 
Example MSC spheroid formed in methyl cellulose media (Image courtesy of Julia Marshall) (A). 
ADSC morphology and distribution in 60,000 cell spheroids, scale bars are 80 µm (B). qPCR 
analysis of ICAM-1 and VCAM-1 expression following cytokine induction in 2D monolayers 
compared with spheroids, results show mean ± SEM, n=3. Where ADSCs were treated with 
cytokines at the time of spheroid formation (C) or primed in 2D for 5 days prior to spheroid 
formation (D).  
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Figure 3-20 Lymphoid mesenchyme induction in 3D is lower than 2D  
Following cytokine induction, ICAM-1 and VCAM-1 expression is lower than 2D monolayer 
controls. The same result is observed when ADSCs are primed in 2D prior to spheroid formation. 
qPCR analysis of ICAM-1 and VCAM-1 expression in ADSC spheroids (A) and ADSCs 
encapsulated in col-NSN0.5 (B). Results show mean ± SEM, n=3. 
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Table 3-4: Summary of cytokine induced lymphoid mesenchyme experiments 
For  FACS results, + 1-10%, ++ 10-50%, +++ 50%+. Differentiation results indicate positive Oil 
Red O stain for adipogenic assays and ALP activity as determined by pNPP assay. For qPCR data 
+ up to100 fold increase in expression, ++ up to 100 fold increase in expression and +++ <100 fold 
increase in expression.  
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the lymphoid inducing cytokines in 2D monolayers and within 3D spheroids 
upregulated stromal markers ICAM-1 and VCAM-1 (Figure 3-19C). In both 2D and 3D 
culture, VCAM-1 was more strongly upregulated than ICAM-1, in agreement with the 
previous 2D FACS results (Figure 3-4).   
Interestingly, the expression levels of ICAM-1 and VCAM-1 in the untreated 3D 
spheroids were higher than in 2D untreated cells, however the overall cytokine induced 
increase in ICAM-1 and VCAM-1 expression was much lower in 3D compared with 
2D. As the cells were treated with cytokines at the same time as forming the cell 
spheroids, the induction efficiency may have been reduced.  
Therefore ADSCs were also primed with the cytokines in 2D prior to generation of 3D 
spheroids to assess whether the tightly packed conformation of the cells in the spheroids 
was affecting the induction of the lymphoid mesenchyme phenotype as defined by 
ICAM-1 and VCAM-1 expression (Figure 3-19D). Even with five days of priming in 
2D first, the upregulation of ICAM-1 and VCAM-1 expression in ADSCs in 3D 
spheroids was still lower than in 2D monolayers. To directly compare  the effects of the 
of priming, ADSCs were cultured in 2D with or without cytokines, prior to spheroid 
formation for 5 days, treatment was then continued in 3D spheroids for 5 days. 
Surprisingly ADSCs that were primed in 2D expressed lower levels of ICAM-1 and 
VCAM-1 than ADSCs without 2D pre-treatment. Again VCAM-1 was more strongly 
upregulated than ICAM-1, and the overall increase in adhesion molecules was lower in 
3D compared with 2D (Figure 3-20A).  
Alongside the spheroid study, ADSCs from the same batch were encapsulated in col-
NSN0.5 gels and the cytokine induction study was performed in parallel. Col-NSN0.5 
blends were chosen for this experiment, as ADSCs within this blend had good viability, 
and were able to spread and migrate within the gels similarly to collagen controls. Col-
NSN0.5 gels had bulk mechanical properties similar to the LN and also prevented NSN 
and cell mediated contraction. After 5 days the gels were treated with liberase and 
cooling cycles to release as many cells as possible for RNA extraction. In order to 
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extract high levels of uncontaminated RNA, the cells were washed several times in PBS 
and the digestion times optimised. 
In the col-NSN0.5 gels, cytokine treatment of the ADSCs was similar to the spheroid 
model, with induction in 2D resulting in a higher upregulation of  ICAM-1 and VCAM-
1 compared with the 3D cell networks in the hydrogel (Figure 3-20B). In summary the 
induction of the lymphoid mesenchyme, as quantified by ICAM-1 and VCAM-1 
expression, was reduced in 3D compared with 2D, in both highly compact cell only 
models and open networks within col-NSN0.5 hybrid gels. Table 3-4 summaries the 
lymphoid mesenchyme induction experiments in the 2D and 3D systems.  
3.5 Results: Cartilage engineering using high NSN content gels 
3.5.1 Isolation and characterisation of BM-MSCs for cartilage therapies 
To examine the potential of hybrid gels with high concentrations of NSN for cartilage 
engineering, they were used in combination with BM-MSCs. BM-MSCs were used 
rather than ADSCs as they are found in subchondral bone underlying damaged cartilage 
and therefore are one of the likely cell types which may migrate into the hybrid gel 
scaffold in-vivo. BM-MSCs were isolated from the bone marrow of tibia plateau of the 
knee. Bones were broken up into small pieces (1-2cm2) and cultured for a week, 
allowing BM-MSCs to evade. BM-MSCs were purified by plastic adhereance, where 
contaminating red blood cells and lymphocytes were removed in washing and 
passaging.  BM-MSCs were characterised by analysis of MSC markers by flow 
cytometry and their capacity to differentiate towards bone, fat and cartilage. BM-MSCs 
were isolated from 3 donors and representative cell surface marker profiles and 
differentiation assays are summarised in Figure 3-21A. BM-MSCs from all donors 
expressed cell surface markers CD73, CD90, CD105, CD29 and CD44. CD106 
(VCAM-1) expression varied between donors, and was generally expressed at low 
levels. All donors had negligible expression of CD11b, CD14, CD31 and CD45 markers 
of macrophage, neutrophils, endothelial cells and leucocytes respectively, indicating 
any contaminating cells derived from the bone marrow had not been isolated or were 
lost in culture and passaging of the cells (Figure 3-21A). 
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Isolated BM-MSCs were able to differentiate towards fat under adipogenic conditions. 
ORO stained lipids appeared after 7 days of differentiation, and continued to increase to 
day 14, however the staining was not present across all cells, and the number and size of 
lipids varied between cells (Figure 3-21B). Elution of the stain could not be quantified 
due to low levels of staining. Osteogenic differentiation of the BM-MSCs was more 
successful. After 14 days of culture in OM the differentiated osteoblasts had produced a 
calcium rich ECM and had significantly higher levels of ALP activity compared with 
undifferentiated BM-MSCs (Figure 3-21C). ALP activity was accompanied by 
increased proliferation between days 14 to 21 (Figure 3-21D). Normalised with DNA 
content, ALP activity increased and peaked at day 14 before falling at between days 14 
– 21, characteristic of early stage osteogenic differentiation.  
For chondrogenesis BM-MSCs were centrifuged into high-density pellets to produce the 
cell condensation required differentiation. The pellets were cultured in basal 
chondrogenic media (BM) consisting of DMEM, supplemented with ITS+, 
dexamethasone and L-proline or chondrogenic media (CM), which additionally 
contained TGF-β3. At each time point the pellets were flash frozen and cryo-sectioned 
to examine the ECM production by the differentiating BM-MSCs. Alcian blue and 
collagen II staining, showed the cells synthesised a dense chondrogenic matrix at the 
periphery of the pellets, which surrounded rounded BM-MSCs. Deposition of a GAG 
rich matrix, shown by Alcian Blue staining, occurred and steadily increased from 7 days 
of chondrogenesis (Figure 3-22), while low levels of collagen II matrix were present 
from day 7, but limited to the exterior of the cell pellet (Figure 3-23).  
3.5.2 NSN-collagen hybrid gels for cartilage repair 
To examine the potential of high NSN content hybrid gels for cartilage repair an in-vitro 
assay was performed by suspending 8x106 cells/ml of BM-MSCs within col-NSN5. Col-
NSN5 was used for these experiments as it had the highest mechanical properties of any 
of the gels examined, and most likely to withstand the forces in the knee. The 
suspension was prepared on ice and pipetted into v-bottomed plates as a representative 
mould for a small cartilage defect.  
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Figure 3-21 Characterisation of cell surface markers and differential capacity of BM-MSCs. 
FACS analysis of common MSC cell surface markers, where negative controls are unstained cells 
(A). Oil Red O staining of adipogenic differentiation of BM-MSCs over 21 days, scale bars are 200 
µm (B). Alizarin red staining of osteogenic differentiation of BM-MSCs over 21 days (C). ALP 
activity in osteogenically differentiated BM-MSCs, pNP normalised to DNA content (D).     
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Figure 3-22 GAG expression in BM-MSCs cell pellets following chondrogenic differentiation . 
Cryo-sections of BM-MSCs pellets following 21 days culture in basal media (BM) or differentiation 
in chondrogenic media (CM). The GAG rich cartilage matrix is stained in the sections with Alcian 
Blue, top row scale 500 µm, bottom row 100 µm. At Day 0 low levels of GAG staining is observed. 
BM-MSCs in CM produce a dense GAG rich matrix at the periphery of the pellets, where cells are 
contained in the lacunae like voids within the matrix. 
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Figure 3-23: Collagen II expression in BM-MSCs cell pellets following chondrogenic 
differentiation. 
Cryo-sections of BM-MSCs pellets following 21 days culture in basal media (BM) or differentiation 
in chondrogenic media (CM). Immunofluorescent staining of collagen II matrix in BM-MSC 
sections. Collagen II expression is absent in pellets cultured in BM and early time points of CM. 
Similarly to GAG expression, at the later time points, day 14 and 21 a collagen II rich matrix is 
found at the periphery of pellets differentiated in CM. Scale bars are 270 µm and 33 µm in 
enlarged sections.    
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As the gels are significantly denser than col-NSN1.25 – col-NSN0.25, and the hydrogel 
will contain the cells for a prolonged period of time during in-vitro chondrogenesis 
assays or cartilage repair in-vivo, the viability of BM-MSCs was examined over 3 
weeks, rather than 5 days. Live-dead staining could not be used, as the gels were very 
opaque, and cell membranes may be damaged during sectioning, and may create false 
negative results (Figure 3-24A). Therefore the gels were incubated with MTT to 
identify metabolically active cells within the gels. MTT is reduced to formazan by 
NAD(P)H-dependent cellular oxidoreductase enzymes produced by metabolically active 
cells. Elution of formazan did not produce reliable results therefore gels were 
immediately sectioned and imaged, to examine the distribution of formazan and 
therefore metabolically active cells throughout the gels (Figure 3-24B). One day after 
gelation, metabolically active cells were found throughout the gel, with the highest 
staining seen on the outermost section, where cells were at the gel-media interface. A 
similar distribution of MTT staining was apparent at day 7, however this decreased with 
time in culture. By day 14 high densities of viable cells were present at the gel surface, 
while within the gel staining was clustered in specific areas. This was also observed by 
day 21. MTT staining was not visible in blank gels without cells. 
When cultured in chondrogenic conditions with col-NSN5 for 3 weeks, the BM-MSCs 
began to synthesise a GAG matrix throughout the gel (Figure 3-25). The alcian blue 
staining was not as strong as within the BM-MSC pellets, but intensified in CM at day 
14 and day 21. By day 21, a rich GAG matrix was present as the periphery of the gel, 
similar to the pellet culture. Collagen II staining was not observed during the 3 week 
period (Figure 3-26). Immuno-fluorescent staining of the high synthetic sections proved 
very difficult due to their opacity and fragility during staining.  
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Figure 3-24 Viability of BM-MSCs with col-NSN5 hydrogels.  
Representative image of a whole col-NSN5 hydrogel (A). Col-NSN5 gels containing BM-MSCs were 
incubated with MTT for 4 hours and then sectioned to examine formazan distribution, indicating 
metabolically active cells (B). The assay was performed on gels cultured in BM at regular time 
points up to 21 days. Acellular gels were included as controls for endogenous formazan reduction. 
Scale bars are 200 µm.   
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Figure 3-25 GAG expression in BM-MSCs containing col-NSN5 hydrogels following chondrogenic 
differentiation . 
Cryo-sections of col-NSN5 hydrogels containing BM-MSCs 21 days culture in basal media (BM) or 
differentiation in chondrogenic media (CM). The GAG rich cartilage matrix is stained in the 
sections with Alcian Blue, top row scale 500 µm, bottom row 100 µm. Prior to differentiation (day 
0) the hydrogels contain low levels of GAG matrix. A deeper blue GAG stain is observed in the 
hydrogels maintained in CM.  
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Figure 3-26: Collagen II expression in BM-MSCs containing col-NSN5 hydrogels following 
chondrogenic differentiation. 
Cryo-sections of col-NSN5 hydrogels containing BM-MSCs 21 days culture in basal media (BM) or 
differentiation in chondrogenic media (CM). Collagen II matrix is stained in the sections with 
Alcian Blue, top row scale 500 µm, bottom row 100 µm. Prior to differentiation (day 0) the 
hydrogels contain low levels of GAG matrix. A deeper blue GAG stain is observed in the hydrogels 
maintained in CM.  
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3.6 Discussion 
When modelling/engineering tissues and organs it is important to consider the cell type 
being used. Primary cells can lose their phenotype during in-vitro expansion, while 
transformed cells may have altered gene expression, resulting in changes in cell 
proliferation and they could be potentially malignant. MSCs are however an attractive 
cell type, due to their multipotency, and their role in-vivo in tissue repair and 
homestasis. MSCs are viable in varying blends of the collagen and NSN hydrogels, 
which have NSN concentrations from 0.5 – 5 wt %. This chapter examines the potential 
of collagen -NSN for two very different MSC tissue engineering applications.      
3.6.1 Adipose derived stem cells for modelling lymphoid mesenchyme 
ADSCs are an appropriate choice for modelling the stromal networks of the LN, as the 
stroma has previously been shown to be mesenchymal in origin and the anlagen of the 
LN develops close to adipose tissue299,337. Furthermore a population of adipocyte 
progenitor cells has been recently found in the developing inguinal LNs of mice, which 
closely associate with surrounding adipose tissue337. As ADSCs are easily isolated from 
routine lipoaspirates, they also offer a plentiful supply of cells for modelling a human 
LN. The ADSCs were treated with TNF-α and an antibody against LTβR, to mimic the 
action of LT binding, as these factors are involved in the development and maturation of 
the stromal networks within lymphoid tissues305–312. In screens of other factors, which 
may influence induction of the stromal phenotype of ADSCs, IL-4 in combination with 
TNF-α and anti-LTβR was found to further the expression of lymphoid markers in 
ADSCs (unpublished results). Therefore the combination of the three factors was used 
to induce ADSCs into lymphoid stroma in 2D. Similarly it has been shown in in-vitro 
assays of FRC network formation, treatment with both TNF-α and anti-LTβR were 
more effective than either alone, in stimulating cells to produce a ER-TR7 rich FRC 
network310.  
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3.6.2 Induction of a reversible lymphoid mesenchyme phenotype in 2D ADSCs 
Prior to extending the model into 3D, the degree of cytokine induction on ADSCs into a 
stromal mesenchymal phenotype was examined. This focused on how committed the 
ADSCs were following the cytokine treatment and whether the induction was reversible 
through examining the adipogenic and osteogenic potential of the treated ADSCs. In the 
presence of the lymphoid mesenchyme inducing cytokines, the adipogenic and 
osteogenic differentiation capacity of ADSCs was reduced. Adipogenesis of the ADSCs 
could be inhibited by the combination of TNF-α and anti-LTβR aswell as all three 
factors. It has been previously shown that TNF- α inhibits adipogenic differentiation338, 
therefore this result is not surprising. In studies by Benezech at al. the adipocyte 
precursors found in the developing LNs, which are thought to differentiate into the 
lymphoid stroma, also had blocked adipogenesis when treated with TNF-α, LTβR or the 
combination of both337. In their study only adipogenesis was examined. In osteogenesis 
assays, cytokine treatment with IL-4 only, TNF-α and anti-LTβR or the combination of 
all three factors were all able to reduce ALP activity to basal levels, however cell 
proliferation and deposition of a calcium matrix still occurred.  
Osteogenic differentiation of MSCs precedes initially through cell proliferation and 
collagen I expression, followed by differentiation to committed osteo-progenitors, 
marked by down regulation of collagen I, and an increase in ALP activity. Lastly ALP 
expression is downregulated and osteonectin (ON), osteocalcin (OC) and osteopontin 
(OP) are upregulated as the MSCs differentiate into mature osteoblasts accompanied 
with matrix maturation339,340. The reduction in ALP activity of the ADSCs in OM, 
suggests the cytokine treatment either commits the ADSCs to a phenotype unable to 
undergo the later stages of osteogenic differentiation or the presence of the cytokines 
inhibits the signalling pathways involved in the switch from proliferation to terminal 
differentiation. Although alizarin red staining shows the formation of a calcium matrix, 
this may not be indicative of a mature osteogenic ECM and terminal differentiation, 
furthermore von Kossa staining of mineralised nodules is low in the cytokine treated 
cells. As there is a reduction in ALP activity the ADSCs are unlikely to be 
differentiating towards committed osteo-progenitors, and matrix maturation would not 
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be expected. To make further conclusions on the extent of osteogenic differentiation 
following cytokine induction of ADSCs, analysis of late stage osteogenesis markers 
ON, OC and OP should be investigated. TNF-α has also been previously implicated as a 
negative regulator of osteogenesis. Low physiological concentrations (0.01 ng/ml) may 
be required for osteogenesis to occur, but at concentrations greater than 0.1 ng/ml, TNF-
α has been associated with reduction in ALP activity, osteocalcin expression and 
mineralisation341–343, which agrees with the results presented in this chapter. The effect 
of TNF-α on osteogenesis has been shown to occur through the NF-κB signalling 
pathway, and therefore LT signalling may also inhibit osteogenesis by a similar 
mechanism. The effect of IL-4 on osteogenesis has also been studied to a lesser extent, 
where it has been reported that IL-4 can induce osteoporosis in mice and inhibit ALP 
activity in-vitro in osteoblasts344,345. 
To examine whether the differentiation was inhibited by the presence of the cytokines, 
or due to the differentiation of the ADSCs into a more committed lymphoid 
mesenchyme cell type, ADSCs were primed with cytokine treatment and then 
differentiated. When the cytokine treatment was removed, and differentiation medium 
was added to the cells, ADSCs in all groups were able to differentiate towards both 
osteogenic and adipogenic lineages over 14 days. Only in the continued presence of 
cytokines, was differentiation inhibited. With the addition of 5 days of ‘priming’ prior 
to differentiation, the results mimicked the differentiation seen without cell priming. 
Again the combination of the three factors blocked adipogenesis and osteogenesis, 
while the presence of IL-4 alone was not sufficient. Taken together these results suggest 
the cytokine induced lymphoid mesenchyme phenotype is reversible, or the cytokine 
treatment is only sufficient to promote ADSCs differentiation into an early stromal 
phenotype.  
In addition to examining the differentiation potential of ADSCs with cytokine 
treatment, flow cytometry analysis of ICAM-1 and VCAM-1 was performed on 
adipogenically differentiated ADSCs with 5 days of cytokine priming prior to 
differentiation. ICAM-1 expression on control ADSCs in basal media was much lower 
compared with previous cytokine treatment protocols, which may be the result of the 
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prolonged culture period of 3 weeks in these experiments. This finding could be 
confirmed by measuring ICAM-1 expression of ADSCs in BM following three weeks 
of continued cytokine treatment. The differing SS in the ADSC population following 
adipogenesis with cytokine treatment, may be due to lipid formation within the cells 
during adipogenesis, resulting in increased granularity in the cells. In a recent study 
comparing methods of adipocyte characterisation, two SS scatter populations were also 
observed in MSCs undergoing adipogenesis. The SS high population stained strongly 
for nile red and had higher expression of the adipogenic marker FABP4 compared with 
the SS low population346. The absence of the SShigh population in ADSCs in BM media 
is also indicative that the more granular cells are lipid filled adipocytes. Similarly, 
ADSCs without continued cytokine treatment that underwent adipogenesis, as 
confirmed by ORO staining, also contained two SS populations, where the proportion of 
cells within each population was similar to the control ADSCs in AM. From ORO 
stains it appears most of the cell population are adipogenic, therefore the SShigh 
population may only represent a proportion of the adipogenically differentiated ADSCs, 
which contain very large lipids. Furthermore the presence of large lipids within the 
differentiated ADSCs could cause the cells to become buoyant and lost in the staining 
procedures.  
There was a small reduction in the SShigh population of ADSCs previously treated with 
all three factors, which was accompanied by a small increase in ICAM-1 expression, 
and ICAM-1/VCAM-1 double positive cells suggesting the cytokine treatment may 
have some lasting effects on the ADSCs differential capacity. VCAM-1 expression is 
also higher in the ADSCs without continued cytokine treatment, which may also be a 
lasting effect of the cytokine treatment. Where cytokine treatment was continued, the 
SShigh population was similar to the ADSC control with only IL-4 treatment, and 
decreased to less than 10% in the presence of TNF-α and anti-LTβR or all three factors, 
accompanying the absence of lipid filled cells. Taking into account the low basal 
expression of ICAM-1 following three weeks of cell culture, the ICAM-1 and VCAM-1 
expression under the different cytokine treatments mirrored the expression seen in 
ADSCs following five days of cytokine treatment, with the highest number of double 
positive cells in the ADSCs treated with all three factors.  
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Together these results suggest the lymphoid mesenchyme phenotype achieved through 
cytokine treatment is reversible. This finding is important as it demonstrates the in-vitro 
2D model of lymphoid stroma developed here, is consistent with the in-vivo properties 
of lymphoid tissue stromal networks. As well as being essential for the organogenesis of 
lymphoid tissue, LT and TNF-α signalling are also necessary to maintain the 
compartmentalised structure of secondary lymphoid tissues307,309,347. This includes the 
networks of marginal reticular cells, which may be directly derived from early 
mesenchymal cells found in the developing LN, which require constitutive LTβR 
signalling for their maintenance348. Furthermore the formation of ectopic lymphoid 
tissue in autoimmune diseases also requires continued expression of LT for formation 
and maintenance349. Expression of LT signalling in non-lymphoid tissue can induce the 
formation of tissue structures350, which resemble the structure and function of secondary 
lymphoid organs, including lymphoid stromal networks, B and T-cell regions, germinal 
centres and lymphatic and vascular networks351. Inhibition of LT signalling using LTβR 
fusion proteins can be used to prevent ectopic lymphoid tissue formation, as previously 
demonstrated in transplants of allogenic cardiac grafts in mice352. Furthermore stromal 
cells isolated from tonsils also have plasticity, although they can be induced to express 
ICAM-1 and VCAM-1 following LT and TNF-α treatment, they also express classical 
MSC markers CD73, CD90 and CD105 and display tri-lineage differentiation 
capacity353.  
Unlike other routes of MSC differentiation, lymphoid mesenchyme is a transient 
phenotype, which appears to require constitute expression of LTβR and TNF-α to be 
maintained. To further this, it would be important to study the tri-lineage differential 
capacity of different stromal sub-sets isolated from adult lymphoid tissues. As well as 
TNF-α and anti-LTβR treatment for induction, ADSCs may also require additional 
soluble and physical cues to retain the phenotype. In-vivo lymphoid stromal cells have 
been shown to mature through two stages from ICAM-1int, VCAM-1int cells to ICAM-
1high, VCAM-1high, which requires the interaction of the stromal cells with LTi cells as 
well as signalling through LTβR304. Therefore although the cytokine treatment can 
induce an early stromal phenotype, without co-culture and signalling from LTi cells full 
differentiation may not occur.  
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3.6.3 3D stromal networks can be formed within hybrid gels 
To progress the LN model into 3D, ADSCs were either encapsulated within collagen or 
hybrid gels or formed into dense cell spheroids. The different models enabled 
comparison of a cell only model with cells contained in ECM based scaffolds. Altering 
the microenvironment of the ADSCs to 3D alters the cell morphology, adhesions with 
neighbouring cells and the ECM, the mechanical forces cells are exposed to as exerted 
by adjacent cells and the ECM and changes the distribution of oxygen, nutrients and 
cytokines the cells are exposed to. These biomechanical factors can all influence 
cellular behaviour as discussed within the introduction. 3D engineered tissues could be 
created using spheroids, collagen and hybrid gels. Whether treated or untreated with 
cytokines ADSCs formed 3D networks within collagen gels, however the morphology 
of the cells differed. Without treatment the ADSCs resembled their 2D morphology, 
spread and fibroblastic, while the treated cells were finer and thinner with long extended 
processes, similar in morphology to FDCs354 and in-vitro 3D cultured FRCs311. 
As collagen gels can be prone to contraction, and are weaker than their col-NSN 
counterparts, col-NSN0.5 was chosen for maintaining ADSCs in 3D. Similarly to 
collagen only gels, ADSCs were also able spread out and adhere within the NSN 
containing gels, forming networks of cells throughout the scaffold. Although immuno-
fluorescent imaging could not be used to assess the cell distribution in the hybrid gels, 
spread ADSCs could be viewed within the gels by bright field microscopy and in H+E 
stained sections. Within the hybrid gels the morphology of the cells varied with NSN 
concentration. Within col-NSN1.25 the ADSCs were spread, but had irregular 
morphologies, some smaller and more spherical, while others showed more spreading. 
The shape of some of the ADSCs suggests apoptosis was occurring. However ADSCs 
in the col-NSN0.5 gels were finer and elongated, with multiple processes and resembled 
the morphology of the cytokine treated cells in collagen only gels. Live-dead stains, also 
showed ADSCs in gels with the highest NSN concentration (col-NSN1.25) had altered 
morphology compared with cells in collagen. These apparent differences in cellular 
morphology between the blends is potentially due to the increased porosity within the 
gels with increased NSN concentration, and the aggregation of NSN onto the collagen 
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fibrils within the gel. From these observations of cellular morphology, SEM analysis of 
gel composition, and previous reports on RGD ligand density and spacing151,334,355,356, 
the following is proposed with respect to cell attachment and shape within the different 
hydrogel blends. When the concentration of NSN is low there are a small number of 
collapsed polymer globules interacting with the collagen fibrils and therefore a 
sufficient number of collagen fibrils exposed to facilitate cell attachment. Therefore 
cells exhibit a fibroblastic morphology, becoming more elongated with increasing NSN 
concentration, as spacing between adhesive ligands increases, while at the highest 
concentrations, the adhesive regions are limited and separated by distances to large for 
cells to make multiple attachments, causing cells to adopt a rounded morphology with 
few scaffold adhesions, and potentially undergo apoptosis. Beyond this optimal NSN 
concentration for cell attachment, the hybrid gels are therefore more suitable for 
applications where cells favour a rounded morphology and limited adhesions, therefore 
col-NSN5, which was assumed to have few exposed collagen fibrils was used in the 
chondrogenesis assays described later.  
The effect of NSN concentration on cell adhesion is also observed in the cell invasion 
assays in the hybrid gels. For migration cells require a substratum to adhere to in order 
to produce the force required for movement357, in gels with a higher concentrations of 
NSN, the reduced number of adhesion ligands compared with collagen only gels, may 
contribute to reduced cellular migration. The porosity of the gels increased with NSN 
concentration. To permit migration the scaffold pores need to be large enough to allow 
cells to squeeze through, but not so big that there are minimal contacts between cells 
and the ECM, preventing adhesion and migration358. With increased NSN 
concentration, there is likely to be a reduction in protease degradable sites that are 
accessible on the collagen fibrils, which could contribute towards a reduction in cell 
migration, as the matrix cannot be as easily remodelled by cell proteases, compared 
with collagen only gels. The stiffness of the hybrid gel may also influence migration, as 
the ability of cells to squeeze through pores in the gel may be reduced in stiffer 
materials357.  
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3.6.4 Lymphoid mesenchyme induction in 3D  
Surprisingly in the 3D models of lymphoid stroma, the extent of cytokine induction as 
measured by increases in ICAM-1 and VCAM-1 expression, was lower. As the 3D 
models are more representative of the in-vivo cellular microenvironment, it could be 
expected that the 3D models would further increase the stromal mesenchyme 
differentiation compared with ADSCs in 2D monolayers. Alternatively the 2D model 
may induce artificially high expression of ICAM-1 and VCAM-1, compared with 3D 
models and in-vivo, due to the absence of diffusion gradients. In 3D, cells have an 
altered morphology compared with 2D with increased contacts with neighbouring cells 
and the ECM in multiple directions. These factors could all contribute to the variation in 
lymphoid mesenchyme induction. Without cytokine induction, VCAM-1 expression 
increased 4 to 10 fold in ADSC spheroids and hybrid gels, suggesting the change from 
2D to 3D alone has a small effect of the phenotype. ICAM-1 expression did show 
cytokine independent upregulation in 3D, but this varied between donors.  
The discrepancy between 2D and 3D following cytokine treatment may be result of 
cytokine diffusion. In 2D monolayers the induction may be higher than 3D as the entire 
cell population are directly exposed to the cytokines, whilst in 3D the cytokine 
availability is reduced due to diffusion gradients created by the presence of 
neighbouring cells and ECM, potentially limiting cytokine diffusion to the periphery of 
the spheroid. Limited diffusion has been previously observed in osteosarcoma 
spheroids, where chemotherapy drug penetration was limited to the periphery of the 
spheroids359. However even with priming of the ADSCs in 2D prior to cytokine 
induction, ICAM-1 and VCAM-1 expression was lower in the 3D environment, 
suggesting the ADSCs in the centre of the spheroid lost the lymphoid mesenchyme 
phenotype in the absence of continued cytokine cues, or the 3D environment promotes 
downregulation of the phenotype. A more detailed analysis of the lymphoid 
mesenchyme in spheroids could be achieved by examining the distribution of ICAM-1 
and VCAM-1 expressing cells within the spheroids. In similar spheroids cultures, 
spheroid size has been shown to effect cell responses to TNF-α. MSC treated with TNF-
α had the highest expression of TNF- α stimulated gene/protein 6 (TSG-6), in spheroids 
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containing 25,000 cells. The expression decreased in larger spheroids and was 
accompanied by increases in apoptotic and necrotic cells, suggesting both cytokine and 
oxygen diffusion decreased as spheroid size increased360. In endothelial cell spheroids 
treated with TNF-α, ICAM-1 and VCAM-1 expression was also limited to the periphery 
of the spheroids, where in monolayer culture all cells expressed both adhesion 
molecules361. Mathematical modelling of ESC spheroids supports these results. Oxygen 
and cytokine gradients are observed in spheroids with radii greater than 100 µm, where 
their concentration decreases from the periphery to the centre of the spheroids128. The 
cytokine treated ADSC spheroids described in thesis had radii of 289 ± 2.7 µm after 
formation, which fell to 214 ±3.1 µm after five days of culture, and therefore are likely 
to experience similar cytokine diffusion gradients. Inducing the phenotype into smaller 
spheroids, where diffusion gradients are minimised will determine whether diffusion 
was a key factor in the differences observed in lymphoid mesenchyme induction in 2D 
and 3D environments. 
The use of hybrid gels as a 3D microenvironment for lymphoid mesenchyme modelling 
should have improved diffusion of cytokines compared with spheroids, as the collagen 
NSN hydrogels have porosity as shown by SEM micrographs, and the ADSCs are less 
tightly compacted. During media changes and fixing, DMEM exchanged quickly out of 
the gels, visualised by a colour change in the entire gel. Furthermore for a LN model 
where lymphocytes may later be introduced, porous areas within the gel will be required 
to permit their influx and create follicle regions. The differences in cytokine induced 
ICAM-1 and VCAM-1 expression between ADSCs in spheroids and hybrid gels, 
compared with 2D monolayer treatment were not dissimilar.      
The collagen fibrils within the hybrid gels may have the capacity to bind the cytokines. 
Collagen I has previously been shown to bind TNF-α, and this could produce gradients 
and reservoirs of the cytokines within the gels, reducing the diffusion of cytokines 
throughout the gel362. Although the cytokines may not directly bind with the collagen 
fibrils of the hybrid gel, the cytokines could interact with fibrils and NSN globules 
through electrostatic interactions. Many collagen and PNIPAM hydrogel systems have 
been shown to provide sustained cytokine and drug release in-vitro and in-vivo, 
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although the exact mechanisms involved in the binding are unknown363. This effect in 
the hybrid gels could be confirmed by adding fluorescent sample drug and cytokine 
compounds of variable molecular weight on top of the hybrid gels in a Transwell® 
system, followed by periodic analysis of the compound distribution within the gels and 
the supernatant below the gels to investigate the extent of diffusion.   
Although there are differences between both 3D systems, both models create 
environments that will influence cellular behaviour differently than 2D. As discussed 
within the introduction, topography and the mechanical stiffness of the scaffold, cell 
shape and pore size effect cell fate. Both 3D models introduce cell-cell and cell-ECM 
contacts, provide substrates for cell adhesion which are softer than TCP, are likely to 
generate cytokine gradients and reduce the extent of cell spreading compared with 2D. 
The 3D systems provide microenvironments for ADSCs, which are more comparable to 
each other than to 2D monolayer culture, and therefore the results of cytokine induction 
of the phenotype in the two different 3D models are likely to be similar to each and vary 
from 2D results. There have not been any previous studies examining spheroids with 
cell encapsulation in collagen based gels and their differences in behaviour. To separate 
whether the change in cytokine induction was due to diffusion or changes in cell shape 
and adhesion, which does vary between the two 3D models, is difficult to examine, as 
modifications to the 3D microenvironment of the ADSCs tend to affect all of these 
variables. Encapsulating ADSCs within very thin cell sheets and smaller spheroids 
could be one method to examine the effects of diffusion, while patterned surfaces with 
variable adhesive ligands could provide more insight into the effects of cell shape on the 
induction.  
These results demonstrate the suitability of the hybrid gels as cell scaffolds for 
modelling the lymphoid mesenchyme and stroma. Within the developing LN anlagen 
and the mature organ, there will be variable gradients of soluble LTα and TNF- α as 
well as LTα1β3 expressing LTi cells and lymphocytes348, it is unlikely the entire organ 
contains a similar distribution of the cytokines. Although the exact mechanisms of 
lymphoid stroma maturation to FDCs and FRCs are unknown, signalling through LTβR 
plays a role and the variation in cytokine concentrations and lymphocyte subsets in 
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different regions of the LN are likely to contribute. As previously mentioned, treatment 
in 2D may cause an overexpression of lymphoid markers that is not related to the 
phenotype seen in 3D, and produce a population of lymphoid mesenchymal cells that 
are more homogenous than the stroma of the LN.    
It will be interesting to explore how permanent the lymphoid mesenchyme phenotype is 
following stromal induction in 3D, and whether the 3D microenvironment promotes 
differentiation of the ADSCs to a more committed phenotype. This could be 
investigated by performing differentiation assays of the ADSCs in 3D with the cytokine 
treatment and by examining the differential capacity of the ADSCs previously cultured 
in 3D with cytokine induction and then differentiated in 2D. Analysis of homeostatic 
chemokines produced by the stromal networks of the LN, such as CXCL13, CCL19 and 
CCL21, and their distribution throughout the engineered lymphoid tissues will provide a 
greater understanding of how representative the model is.    
3.6.5 Isolation of bone marrow derived MSCs for cartilage repair 
Primary MSCs were successfully isolated from the knee bone marrow of three patients 
undergoing TKRs, cells from each donor were plastic adherent and displayed 
fibroblastic like morphologies in 2D culture. All donors were positive for MSC cell 
surface markers. Expression of CD106 in all donors was low, which is characteristic of 
MSCs that have aged in-vitro70. The adipogenic and osteogenic differential capacity of 
the BM-MSCs as shown by ORO staining of fat lipids and alizarin red straining of 
calcium deposition, was less prominent than seen in ADSCs. The BM-MSCs used in the 
differentiation assays were sourced from patients aged 69-81 with OA where there had 
been damage to the articular cartilage and underlying bone, whilst the Invitrogen 
brought ADSCs may have been sourced from healthy tissues and younger patients and 
therefore have improved differential capacity. Furthermore several studies have 
suggested ADSCs may contain more adipogenic progenitors than BM-MSCs and this 
improves their adipogenic differentiation68. Cultured in 3D pellets with TGF- β, the 
BM-MSCs produced a chondrogenic like ECM, which intensified over 21 days. Alcian 
blue stained proteoglycans were present from day 7 at the periphery of the pellets, and 
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the depth of the proteoglycan staining, into the centre of the pellets, increased up to day 
21. Collagen II rich ECM was also present at the periphery of the pellets after 7 days of 
culture. Within the ECM, were unstained regions where the BM-MSCs had adopted a 
rounded chondrogenic like morphology. Although these results show BM-MSCs 
isolated from patients with OA have reduced differential capacity compared with 
ADSCs, they could be expanded in-vitro in high enough numbers for chondrogenesis 
and were able to produce a chondrogenic matrix. Furthermore these experiments were 
performed in-vitro, as BM-MSCs have the ability to differentiate into cartilage in-vivo77 
without additional soluble factors, their differential capacity may be improved in-vivo.   
3.6.6 Potential of High NSN content hydrogels for cartilage repair 
As the extent of matrix remodelling of high NSN content by BM-MSCs is unknown, 
there are two potential strategies for using the hybrid gels for cartilage repair. BM-
MSCs could be directly encapsulated within the gel, where they will be able to remodel 
the collagen network, and potentially the NSN aggregates, replacing the gel with a 
newly formed cartilage matrix. Alternatively, acellular hybrid gels could be implanted, 
and BM-MSCs could be promoted to migrate into the gel from the surrounding tissue, 
remodelling the collagen fibrils at the gel-cartilage boundary, to aid with integration of 
the gel into the cartilage. In the second strategy, a cartilage matrix may not be produced 
throughout the implanted gel, but the stiff NSN gel could instead replace the role of the 
cartilage. Initially the encapsulation of BM-MSCs within the hybrid gels was 
investigated, as ultimately replacing damaged cartilage with newly regenerated cartilage 
matrix would be more beneficial than replacement with a synthetic material, which 
could be prone to mechanical degradation over time.         
The potential of the hybrid gels as injectable scaffolds for cartilage repair, was 
investigated by encapsulating a high density of BM-MSCs into col-NSN5 and culturing 
in chondrogenic media for 21 days. Viability of the BM-MSCs over 21 days was 
examined using MTT. In metabolically active cells, MTT is reduced into formazan and 
coloured substrate, and therefore used as a determinant of cell viability. As the cell 
laden gels were dense and had diameters over 2 mm in the widest areas, the gels were 
Tissue engineering applications of hybrid gels 
 
 
185 
sectioned throughout to examine the formazan distribution. One potential caveat of this 
study is the ability of the MTT reagent to diffuse into the centre of the gel. However in 
the sections from the gels, after one day of culture a similar formazan distribution was 
seen in all sections throughout the gels, except for the outermost section. At the later 
time points, there was no discrepancy in formazan distribution in the outermost 
sections. Therefore the increase seen at the periphery of the gels at day 1 is likely due to 
increased cellular metabolism of the cells before they were adapted to 3D culture and 
because they were located at the gel-liquid interface, with similar levels of oxygen and 
nutrients as 2D culture, rather than MTT diffusion. At the later time points the 
distribution of formazan is similar throughout, indicating the increased metabolism at 
the surface at day 1, is likely due to slower changes in cellular behaviour during 
adaptation to 3D. Similarly to the unknown diffusion in the lower NSN content gels, 
diffusion with col-NSN5 could also be examined using a range of fluorescently labelled 
compounds of variable molecular weights. The distribution of formazan within the gels, 
demonstrated metabolically active cells were presence at each time point investigated, 
where the staining decreased with time in culture. It has already been shown the hybrid 
gels do not release anything cytotoxic, therefore any cell death that is occurring must be 
the result of reduced oxygen and nutrient diffusion into the gel or reduction in cell 
attachment and spreading. Where there is a reduction in formazan at day 14 and day 21, 
it is not limited to the periphery of the gels, which would be indicative of a decrease in 
cell metabolism and viability as a result of reduced oxygen concentration in the centre 
of the gels. Instead the formazan is distributed randomly throughout the gel sections, 
therefore suggesting the BM-MSCs are not undergoing apoptosis due to decreased 
oxygen gradients. Although the MTT assay gives an indication of viability of the 
encapsulated cells over the 21 day period, further experiments are required. To confirm 
whether the decrease in formazan production was a result of reduced metabolism or cell 
death, this could be correlated with Ki67 staining to examine cell proliferation, and 
TUNEL and capase-3 staining to identify whether cells were undergoing apoptosis and 
necrosis.   
BM-MSCs encapsulated within the col-NSN5 gels synthesised a GAG matrix, but no 
collagen II staining was observed within the gels after 21 days of culture. The same 
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cells were able to synthesise GAGs and collagen II in cell pellets, therefore the 
reduction in matrix production could be correlated with decreased cell metabolism or 
viability. To confirm this similar viability assays would also need to be performed in the 
BM-MSC cell pellets also undergoing chondrogenesis. The hybrid gels were also larger 
than the pellets, almost 2 mm in diameter. Although hypoxia can induce chondrogenic 
differentiation, when the oxygen content is too low, the differential effect may be 
lost364. It was assumed that cell shape alone might be sufficient to induce 
chondrogenesis when combined with TGF- β3 supplemented media, where the col-
NSN5 gels would reduce cell spreading and give cells a rounded morphology. However 
the absence of direct cell-cell contact and very limited cell attachment could also be 
responsible for the decrease in matrix production. Although there was an absence in 
noticeable matrix production, investigation of the early chondrogenic markers may 
demonstrate the BM-MSCs within the gels are differentiating towards chondrocytes. Q-
PCR analysis of SOX-9, collagen I expression and N-cadherin would provide further 
information of the differential capacity of the cells.  
To improve the potential of the hybrid gels for cartilage repair, matrix deposition and 
cell viability needs to be improved. Incorporation of increased collagen content into the 
hybrids with a high NSN concentration was previously proposed as a method to reduce 
syneresis within the gels, this might also increase matrix deposition by improving cell 
metabolism and viability by cell attachment. Furthermore the hybrid gels contain 
collagen I, which should be quickly remodelled during chondrogenesis, but is not found 
in native cartilage. Incorporation of collagen II into the hybrid gels may improve BM-
MSCs chondrogenesis, as shown in other in-vitro comparison studies of chondrogeneic 
differentiation of MSCs in collagen I and collagen II gels365,366. Lastly, although the 
high NSN content gels approach the mechanical properties of mature native cartilage, 
during endochondral ossification the developing cartilage is softer then the mature 
tissue. Using hybrid gels with a lower NSN concentration that have mechanical 
properties more reminiscent of developing cartilage may be more effective in directing 
MSC differentiation and chondrogenesis.  
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3.7 Conclusion 
The results in this chapter examine two applications of MSCs used in combination with 
collagen-NSN hybrid gels for tissue engineering as a means for generating models for 
experimentation or for tissue repair. In summary ADSCs and BM-MSCs have both been 
shown to be viable within the hybrid gels, and their behaviour is affected by the NSN 
concentration within the gels. These results demonstrate the versatility of the hybrid 
gels, initially varying the composition of the blends focused upon altering the 
mechanical properties to mimic different tissues, but this chapter has demonstrated that 
the variation in hybrid gel composition also alters cell attachment and migration as NSN 
content reduces exposed collagen fibrils for cell adhesion. The reversibility of the 2D 
model of ADSC derived lymphoid mesenchyme was examined, where the results 
demonstrated ADSCs lose the phenotype in the absence of continued cytokine 
treatment, mimicking the results seen in in-vivo experiments of lymphoid tissue. The 
lymphoid mesenchyme model was successfully transferred into 3D using the hybrid 
gels, where the extent of ICAM-1 and VCAM-1 induction decreased in 3D compared 
with 2D, due to the presence of cytokine gradients in 3D. The behaviour of the ADSCs 
in the hybrid gels was mirrored in ADSCs spheroids, thus indicating encapsulating of 
ADSCs within the hybrid gels is an appropriate method for maintaining cells in 3D. 
Lastly high NSN content gels were explored as injectable scaffolds for cartilage repair. 
The results obtained are preliminary, but demonstrate BM-MSCs can remain 
metabolically active for at least 21 days in the gels and that a primitive GAG ECM is 
formed under chondrogenic conditions. The further potential of the hybrid gels as tissue 
engineering scaffolds will be discussed in chapter 4.
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 General Discussion Chapter 4
Tissue engineering requires the development of specific scaffolds to support cells 
within 3D by providing a surface for adherence, a template for new tissue growth and a 
mechanical environment that can withstand the forces at a given site in the body. The 
influence of the microenvironment in which a cell is situated was discussed in chapter 1, 
where the mechanical properties, the surface features, and the porosity of the scaffold 
were all demonstrated to direct cell fate. Furthermore the combination of these factors 
dictates the overall shape and spreading of the cell and its behaviour. Synthetic 
hydrogels have been attractive candidates for cell scaffolds, as their ability to maintain 
high volumes of water makes them good mimics of the ECM, and they can be tailored 
synthetically to alter the mechanical properties and degradability of the scaffold.  
However one drawback of many synthetic hydrogels is their poor biocompatibility, as 
cells are unable to adhere to and remodel the gels. PNIPAM based hydrogels are 
commonly used in tissue engineering as they are thermoresponsive, and therefore can be 
used to encapsulate and release cells, and can be injected to fill a particular shape prior 
to gelation. However, PNIPAM hydrogels are generally non-cell adhesive and not 
degradable218,267. The solution to the poor biocompatibility, investigated in this thesis, is 
the development of a bio-synthetic hydrogel which combines a thermoresponsive 
PNIPAM based synthetic hydrogel that has good mechanical strength, with collagen to 
permit cell attachment and a degree of tissue remodelling within the scaffold.  
Generally scaffolds for tissue engineering are created with a specific application in 
mind, and cannot be easily tailored once fabricated, to amend their physical properties. 
The PNIPAM – biological hybrids that have been produced by other research groups 
can only be tuned by increasing or decreasing the concentration of a polymer dissolved 
in aqueous solution, which effects the mechanical properties of the resulting hydrogel, 
and tends to have a lesser effect on biocompatibility235,250 . However the collagen- NSN 
blends described in this thesis, are tuned by simply mixing solutions of NSN and 
collagen at the time of gelation. Therefore I explored how varying the blend of collagen 
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and NSN in the hydrogels firstly affected the structure, and physical properties of the 
hydrogels, as described in chapter 2, and secondly how different blends could therefore 
be used for different tissue engineering applications, as described in chapter 3. 
1.10 Synthesis and properties of  collagen-NSN hydrogels 
NSN was synthesised by a 3- step procedure, initially creating and functionalising NVP 
macromonomers, followed by in-situ synthesis of the NIPAM – styrene backbone and 
incorporation of the NVP macromonomers. The resulting polymer, had a LCST of 25 
oC, and could therefore be combined with collagen solutions and cell suspensions, to 
produce a bio-synthetic gel, containing a uniform distribution of cells, which could 
gelate at 37oC. As expected, the properties of the resulting hydrogels were dominated by 
the concentration of the two components, as seen in other bio-synthetic hydrogels 
produced, where the mechanical properties decrease when the proportion of biological 
hydrogel is increased250,367. At concentrations below the minimum gelation 
concentration of NSN, the hydrogels had properties similar to collagen only gels, with 
the lowest mechanical properties, a fibrillar network of fibres and an absence or very 
low degree of syneresis, upon gel formation. Within these hydrogels, ADSCs and 
HT1080 cells were able to spread out and attach, where the cell morphologies were 
influenced by the NSN content. The properties of the hydrogels with higher 
concentrations of NSN (2.5 wt% upwards) were dominated by the synthetic component, 
having increased mechanical properties under the application of shear stress. However 
as the concentration of NSN exceeded collagen, syneresis increased, where the size of 
equilibrated NSN5 hydrogels were only 30 % of their original volume. Although the 
morphology of cells in these gels was not examined, it was assumed the high NSN 
content resulted in cells with rounded morphologies.  
The incorporation of collagen into the NSN hydrogels was able to improve their 
potential as cell scaffolds. The scaffolds were cell adhesive and reduced NSN associated 
syneresis, while the presence of NSN improved the mechanical strength of collagen. 
These results highlight the use of the hybrid gels may involve compromising a 
particular property such as biocompatibility versus mechanical strength, in favour of 
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another, when used as cell scaffolds. Given the complexity and variation in tissues and 
organs within the human body, creating a scaffold suitable to mimic all of them is likely 
to be impossible. However these results demonstrate the tunability of the collagen-NSN 
scaffolds and their potential in engineering various tissues, which has not previously 
been achieved for a bio-synthetic PNIPAM based hydrogel. The blends containing low 
concentrations of NSN, will be useful for the tissue engineering of soft biological 
tissues, where the effect of cell morphology in 3D and extent of cell adhesion to a 
collagen based scaffold could be examined, by varying the concentration of NSN within 
the gel to reduce cell adhesion, whilst maintaining constant collagen concentration. To 
date most studies on cell morphology and attachment are performed in 2D123,151,356. The 
collagen-NSN hydrogel system provides a system for investigating these effects in 3D. 
The introduction of NSN, also introduces a non-degradable component into collagen 
based gels, and variation in its concentration is also likely to impact the extent of tissue 
remodelling within the scaffold. Furthermore, the thermoresponsive nature of NSN will 
permit cell release and analysis following experimentation. The inclusion of low 
concentrations of NSN into collagen gels, improved the mechanical properties 
compared with collagen only gels, therefore the hybrids may also have potential as 
collagen based gels for microfluidic engineering, where previously high concentrations 
of collagen were necessary which reduced the ability of cell migration and remodelling 
within the gel171. 
The tougher hydrogels, which contain higher concentrations of NSN, have mechanical 
properties approaching the values experimentally determined for muscle and cartilage. 
Although these gels may be less cell adhesive, due to the low collagen concentration, 
they may be applicable for tissue engineering of these tougher tissues by mimicking the 
mechanics, which are important for tissue function. To demonstrate the applications of 
the collagen-NSN hydrogels, different blends were examined for use as cell scaffolds 
for MSCs, specifically for developing 3D models of lymphoid stroma, and as injectable 
therapies for cartilage repair. The low NSN containing hydrogels were able to support 
viable ADSCs, and preliminary results suggest BM-MSCs were metabolically active in 
high NSN containing gels over 21 days.  
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1.11 Development of an aLN using ADSCs and collagen-NSN hydrogels   
To model the stromal networks of the LN, ADSCs were induced into a lymphoid 
mesenchyme phenotype by treating the cells with IL-4, TNF-α and LTβR. This was 
shown to be an appropriate model, with induced ADSCs expressing lymphoid markers 
ICAM-1, VCAM-1 and podoplanin. The in-vitro phenotype of the cytokine treated 
ADSCs was transient, unlike the more committed differentiation of MSCs into fat and 
bone, as removal of the cytokines permitted classical MSC differentiation, whilst 
continued treatment inhibited adipogenic and osteogenic differentiation. These results 
are in agreement with the in-vivo stromal networks of the lymph node and other 
secondary lymphoid tissues, which require constitutive expression of LT and TNF- α in 
varying degrees in order to develop and maintain stromal networks307,309. Therefore the 
ADSC model builds upon previous research, which demonstrates lymphoid stromal 
networks are mesenchymal in origin and likely to be derived from surrounding adipose 
tissue304,337. The model does however require further experimentation to examine its 
validity as an aLN. Beyond cell surface marker expression and the differential capacity 
of the induced ADSCs, the behaviour of the induced lymphoid mesenchymal cells in 
co-culture with lymphocytes and following activation with antigen, to mimic an 
immune response, should be investigated to demonstrate the functionality of the in-vitro 
model.    
A range of the low NSN content hydrogels were used as scaffolds for translating the 2D 
lymphoid mesenchyme model into 3D. The LN contains networks of reticular ECM 
fibres composed of collagen I, and mechanical tests have demonstrated the LN is a soft 
organ, with elastic moduli in the region of the low NSN gels134. ADSCs were viable and 
formed networks within the gels, presumably through integrin binding to exposed 
collagen fibres. As the NSN aggregates onto the collagen fibres, the cell attachment and 
spreading were reduced with increasing NSN concentration. Therefore an optimal blend 
of col-NSN0.5 was chosen to mimic the morphology of FRCs and FDCs within the 
lymph node. This blend was also more open and porous compared with collagen only 
gels and therefore should permit the migration of lymphocytes and capillaries into the 
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scaffolds in further development of the model. Alongside the hydrogels, spheroids were 
examined as an alternative 3D model for the LN, to produce a dense network of cells.  
Both methods produced 3D networks of ADSCs, which had similar levels of ICAM-1 
and VCAM-1 expression following cytokine induction, however their expression was 
significantly lower than in 2D. As previously discussed, diffusion within the models is 
likely to occur and the extent of this needs to be identified to differentiate between 
whether the reduced expression was caused by diffusion of the cytokines throughout the 
3D models, or whether the 3D model is more representative and accurate, and the lack 
of cytokine gradients and cell shape of ADSCs in monolayers caused the discrepancies. 
These differences in lymphoid mesenchyme induction in 2D and 3D models could be 
used to examine how and why different lymphoid stromal subsets form and mature 
within the LN as a function of gradients of cytokines. Using the variable blends of col-
NSN, I was able to fabricate 3D networks of the ADSCs, where the cell morphology 
and adhesions could be perturbed through NSN concentration, and therefore potentially 
direct the cellular behaviour. Although the lymphoid mesenchyme induction in 
spheroids and col-NSN gels produced similar results, the hybrid gels will be most 
suitable in progressing the aLN model into 3D. The presence of ECM components in 
the hybrid gels provides a starting template for the lymphoid mesenchyme cells to 
organise and potentially develop conduit like structures around the collagen fibrils. 
Current aLN models that have been developed rely on the body as a bioreactor to induce 
the compartmentalisation and remodelling into lymphoid like tissue. Although this 
produces models, which resemble the LN, they still require the use of mice, and 
therefore are not reducing the numbers of animal used in research, one of the key aims 
in developing tissue models. Furthermore the previously developed models use 
transformed murine cell lines. This thesis describes the first 3D human aLN model 
using primary cells.   
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1.12 Potential of collagen-NSN hydrogels for  injectable cartilage 
regeneration  
To examine the potential of the hybrids for cartilage repair, in-vitro chondrogenesis 
assays were performed in the tougher col-NSN5 gels. Within cartilage, chondrocytes are 
isolated in lacunae, making few cell –cell adhesions, mainly interacting with the ECM. 
BM-MSCs were seeded within the liquid gels to create a similar uniform distribution of 
cells, and due to the high NSN concentrations, which were likely to prevent cell 
adhesion to collagen, the cells appeared rounded, in small pockets within the gel. BM-
MSCs were metabolically active within the gels over 21 days, and began to synthesise a 
cartilaginous GAG matrix. As discussed within chapter 3, the application of the high 
NSN hybrid gels for cartilage repair could be approached from two directions, either 
delivering the gel without cells, which would remain within the cartilage defect and 
replace the damaged cartilage, or using the hybrid gels seeded with BM-MSCs as a 
template for cartilage repair, where the collagen network could be remodelled and the 
NSN replaced over time by new ECM and degradation by the mechanics of the joint. 
The exact blend of the hybrid gel would be likely to dictate how the material 
functioned. In col-NSN5, only small amounts of cartilage like ECM were formed 
compared with BM-MSC cell pellets, therefore this blends would be more appropriate 
to replace the damaged cartilage. To improve the chondrogenic capacity of the cells, 
higher concentrations of collagen could be added to the gel, this would improve cell 
attachment and also cell viability. However the mechanical properties of the gel would 
then be compromised. Again this highlights the importance of using the most 
appropriate scaffold for its application and the potential of tunable hydrogel scaffolds.  
1.13 Effect of hydrogel composition on gelation mechanism and resulting 
properties 
The following model is proposed in the relation to the collagen – NSN hybrid gels and 
cellular behaviour, building upon the model proposed in chapter 2 (Figure 4-1). 
Collagen gels take the shape and volume of the parent solution, with cells adhering to 
the fibrils after several hours of culture. The introduction of NSN into the collagen gels 
impairs cell adhesion, and thus affects cell shape and migration, by reducing the area of 
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exposed fibrils and integrin binding sequences. In gels with high NSN concentrations, 
the effect is intensified, and the gelation is also accompanied with syneresis. Cells 
within the high NSN hybrids are rounded, and may also have forces imposed onto them 
by the aggregation of NSN during gelation. The model is also extended into the future 
development of the gels, which aim to maintain the mechanical properties achieved 
through the presence of NSN, whilst aiming to alleviate syneresis and improve cell 
adhesion by increasing the collagen concentration within the hybrid gels from 0.3 wt% 
up to 1 – 2 wt%. Using higher concentrations of collagen, it is proposed that the 
increased number and the presence of thicker collagen fibrils which are forming within 
the gel will be able to reduce the extent of NSN aggregation thus reducing the shrinking 
of the gels, and increasing the sites of cell adhesion. Furthermore, collagen gelation is 
not temperature dependent in the same manner as PNIPAM, although the gelation rate 
increases at higher temperatures, fibril formation and gelation can occur at any 
temperature, therefore these gels could be formed via a two step mechanism to also alter 
the materials properties. Initially collagen would be allowed to gel below the LCST of 
NSN, and subsequently the temperature could then be raised above the LCST to allow 
NSN aggregation to occur, which may be hindered by the pre-formed collagen network 
and therefore may reduce the degree of syneresis associated with NSN gelation. 
1.14 Future Work 
Presented within this thesis are premliminary results for two 3D models utilising the 
collagen-NSN hybrid gels as scaffolds. To further this research further characterisation 
of the hybrid gels will be beneficial. This includes visual analysis of the gelation point 
by an invert test, further analysis of the phase transition to determine the true LCST 
using DSC, AFM analysis of the collagen-NSN blends to examine how efficiently the 
materials blend and further compression mechanical testing. 
The suitably of ADSCs and col-NSN0.5 as a model for an aLN was demonstrated in 
chapter 3. To further this, the model needs to incorporate a co-culture of with 
lymphocytes and requires further validation against in-vivo levels of ICAM-1 and 
VCAM-1 expression within the lymph nodes.Since submitting this thesis, further work 
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has been performed on the hybrid gels for cartilage repair. To improve cell attachment 
the collagen content within the gels has been increased to 0.5 and 0.75 wt%. 
Histological examination of these blends containing BM-MSCs, following 21 days in 
chondrogenic conditions shows production of a significantly improved collagen II and 
GAG rich matrix compared with the col-NSN5 blends. The extent of chondrogenesis in 
several of these new blends will be quantified through qPCR analysis of the 
chondrogenic transcription factor SOX9 and matrix molecules aggrecan, collagen I, 
collagen II, collagen X and lubricin. Where the ratio of collagen I to II will provide an 
indication of the maturity of the matrix and collagen X will identify hypertrophy.  
1.15 Conclusion 
Within this thesis I have developed a unique bio-synthetic hydrogel scaffold, that can be 
used for multiple applications by varying the ratio of NSN to collagen. The gelation 
process is controlled by temperature, and therefore does not require harsh conditions 
that may compromise cell viability. The thermoresponsive nature of the gels also lends 
them to applications, which require injectable scaffolds. Following synthesis of the 
NSN and isolation of collagen, solutions can be produced from each component and the 
hydrogels are straightforward to produce by simply mixing and incubating at room 
temperature. Therefore this hydrogel system also has good commercial potential, as the 
two components could be purchased as a cell scaffold system where the end user can 
easily create a scaffold to meet their desired application. The system could also be 
marketed for testing the effect of natural versus synthetic scaffolds, scaffold elasticity 
and cell adhesion parametres on cell fate and  behaviour.  
 
This thesis examined the variation in NSN on hydrogel properties and cellular 
behaviour and only demonstrates two applications of the resulting gels. This system 
could be furthered by producing an entire range of col-NSN hybrid gels, were collagen 
concentration is also varied, and determining the physical properties of each to blend to 
produce a catalogue of scaffolds. 
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Figure 4-1 Proposed mechanism of col-NSN gelation and cellular adhesion 
Collagen gels form from collagen monomers into aligned fibrils maintaining the volume of the 
parent solution. In contrast, NSN forms hydrogels by aggregation and the gels are prone to 
syneresis. At low concentrations of NSN, similar to collagen, no syneresis is observed and cells 
adhere similarly to collagen gels. As the NSN concentration increases the gels become more prone 
to syneresis, and cell morphology is altered as a result of unexposed collagen fibrils. At high NSN 
concentrations, the combination of high syneresis and unexposed collagen fibrils leads to rounded 
cells, with few adhesions. Therefore it is proposed hybrid gels made from collagen concentrations 
which equal the NSN concentration will have reduced syneresis and improved cell adhesion whilst 
maintaining the high mechanical properties. Dotted lines indicate volume of parent solution and 
syneresis, ΔT indicates a change in temperature. 
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Abbreviations 
1H-NMR – hydrogen nuclear magnetic resonance 
2D – 2 dimensional  
3D – 3 dimensional  
AAc – acrylic acid 
ACI - autologous chondrocyte implantation  
ADSC – adipose derived stromal cell 
AIBN – azobisisobutyronitrile 
aLN- artificial lymph node 
ALP- alkaline phosphatase 
AM – adipogenic media 
APC- antigen presenting cell 
BCM- basal chondrogenic media 
BM – basal media 
BM-MSC – bone marrow mesenchymal stromal cell 
BMP-2 – bone morphogenetic protein 2 
BMSC – bone marrow stromal cell 
BSA - bovine serum albumin 
CD – cluster of differentiation 
CFU-F- colony forming unit fibroblast 
CM – chondrogenic media 
DAPI – 4’,6-diamidino-2-phenylindole 
DCM – dichloromethane 
DEX - dexamethasone 
DLS – dynamic light scattering 
DMA – dynamic mechanical analysis 
DMEM – Dulbecco’s Modified Eagle’s Medium 
DMF – dimethylformamide 
DSC- differential scanning calorimetry 
ECM – extracellular matrix 
EDTA – ethylene diaminetetra acetic acid 
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ESC – embryonic stem cell 
FBS – fetal bovine serum 
FDC- follicular dendritic cell 
FRC- fibroblastic reticular cell 
FS – forward scatter 
g  - graft 
G’-storage modulus 
G’’- loss modulus 
GPC- gel permeation chromatography 
HEV-high endothelial venule 
HSC – haematopoietic stem cell 
ICAM-1 – intercellular adhesion molecule - 1 
IL-4 – interleukin 4 
IL-4R – interleukin 4 receptor 
IMBX - 1-methyl-3-isobutylxanthine 
IPE – 2-isopropoxyethanol 
IPN - interpenetrating network 
GAG – glycosaminoglycan 
GPC – gel permeation chromatography 
HA – hyaluronan 
HUVEC – human umbilical vein endothelial cell 
LCST – lower critical solution temperature 
LT – lymphotoxin 
LTβR – lymphotoxin β receptor 
LTi - lymphoid tissue inducer cell 
LTo - lymphoid tissue organiser cell 
LN- lymph node 
MALDI-ToF - matrix assisted laser desorption time-of-flight spectroscopy 
Mn – number average molecular weight  
MSC – mesenchymal stem/stromal cell 
MTT – 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
MVEC - micro-vascular endothelial cell 
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Mw – weight average molecular weight 
NASI- N-acryloxysuccinimide 
NIPAM – N-isopropylacrylamide 
NVP – N-vinylpyrrolidone 
NSN – poly(NIPAM-co-styrene-graft-NVP) 
OA – osteoarthritis 
OM – osteogenic media 
ONVP – oligo N-vinylpyrrolidone 
ONVP- OH – hydroxyl functionalised oligo N-vinylpyrrolidone 
ONVP-VB – vinyl benzene functionalised oligo N-vinylpyrrolidone 
ORO – Oil Red O 
Pa - Pascal 
PBS – phosphate buffered saline 
PCM - pericellular matrix  
PDEMAC- poly(dimethylacetamide) 
PDI – polydispersity index 
PEG – poly(ethylene glycol) 
PEI – poly(ethylene imine) 
PHEMA- poly(2-hydroxyethyl methacrylate) 
PMVE – poly(methyl vinyl ether) 
pNP- para-Nitrophenol 
pNPP- para-Nitrophenylphosphate 
PNIPAM- poly(N-isopropylacrylamide) 
PP- Peyers patch 
p/s – penicillin/ streptomycin 
PVP – poly(vinylpyrollidone) 
PVCAP- poly(vinylcaprolactam) 
RGD- arginine-glycine-aspartic acid 
SEC – size exclusion chromatography 
SEM – scanning electron microscopy 
sIPN – semi interpenetrating network 
SLS- static light scattering  
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SMC – smooth muscle cell 
SS - side scatter  
TCP – tissue culture plastic 
TGF-β – transforming growth factor β  
TJR – total joint replacement 
TNF-α – tumour necrosis factor α 
UC-MSC – umbilical cord blood mesenchymal stem cell 
VCAM-1 – vascular cell adhesion molecule -1 
VBC – 4-vinylbenzyl chloride 
wt% - weight percent
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